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ABSTRACT 
 
Intervertebral disc (IVD) degeneration is an age-dependent process resulting 
from successive biomolecular and functional failures, highly correlated with low back 
pain (LBP) - the world’s leading cause of years lived with disability. Primarily seeking 
symptomatic relief, clinical approaches targeting disc-related LBP are interventive in 
nature and do not address the underlying pathophysiology, ultimately failing to restore 
tissue function or to slow down IVD disease (IDD) progression. Nonetheless, 
fundamental scientific research on this field has grown tremendously in recent years, 
and major efforts are being put on regenerative therapies. As such, understanding the 
cellular and molecular mechanisms behind disturbance of IVD homeostasis, and 
particularly addressing early age-correlated degenerative changes, will foster the 
creation of safer and more effective therapies to combat IDD. 
The dissertation presented herein aimed to move forward the basic knowledge 
on IVD cell biology, by thoroughly characterizing the phenotypic signature of its 
endemic cell populations, more specifically the ones found within the nucleus pulposus 
(NP), both in homeostasis and aging. For this purpose, novel approaches to this field 
were introduced, namely high-throughput methods of cell analysis, such as flow 
cytometry (FC) and imaging flow cytometry (IFC). 
Firstly, driven by the lack of standardized protocols to isolate and profile primary 
NP cells, an improved method, guarantying high cell yields and viability, was 
established, along with a systematic FC gating procedure. This study demonstrated 
that collagenase-type-XI is an efficient enzyme to obtain single-NP cells suspensions 
in a short-time period. Furthermore, it highlighted the presence of three phenotypically 
distinct subpopulations of cells within young bovine NP in homeostasis. 
The second part of the work focused on the effects of aging on the signature of 
bovine NP cells both at protein and gene levels. Results revealed striking differences 
between young (12 months old) and old (10-16 years old) cells, namely a decrease 
with aging on the prevalence of the mesenchymal stem cells (MSC)-related (CD29 and 
CD44), hematopoietic (CD45) and NP-progenitor (Tie2) markers, along with an 
increase in GD2+ cells (NP-progenitor marker as well), and a stable expression of 
CD146 (MSC marker). Moreover, by changing the analytical system, a fourth distinct 
subpopulation was discovered, and the signature of the subpopulations was also found 
to be altered with aging. Evidence gathered supports the bovine animal model as a 
  
 XIV 
valuable tool to explore age-induced modifications on NP cells, and to identify potential 
anti-aging targets, towards the prevention of IVD degeneration. 
Finally, to validate previous results in the human scenario, IVD cells retrieved 
from patients undergoing microdiscectomy were analysed. Findings from this part of 
the work highlighted remarkable morphological alterations that occur on primary 
human IVD cells with aging and degeneration, namely the gradual shift in cells 
diameter due to deposition of an aberrant pericellular matrix (PCM). Importantly, 
gradual disappearance of an endogenous progenitor cell population expressing either 
CD73, CD90 and Tie2, already reinforced by other reports, was questioned by the 
maintenance of the expression profile of CD146 and GD2 with aging, similar to that 
found in bovine NP cells. This brought renewed hope on the capability of IVD cells to 
pro-actively respond to damage. 
Overall, this doctoral thesis significantly contributed to the advance of 
knowledge on nucleus pulposus cell biology, applying novel cell characterization 
techniques. Importantly, by comparatively exploring cells phenotype in homeostasis 
and aging, it identifies potential anti-aging molecular targets to combat IVD disease. 
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RESUMO 
 
A degeneração do disco intervertebral (DIV) é um processo intrinsecamente 
associado à idade, resultante de falhas biomoleculares e funcionais sucessivas, e 
significativamente correlacionado com a dor lombar – a principal causa de anos 
vividos com incapacidade em todo o mundo. Procurando alivio sintomático, as 
abordagens clínicas atuais focadas na dor lombar de origem discal são interventivas 
por natureza e não direcionadas para a patofisiologia subjacente, consequentemente 
impedindo o restauro da função do tecido ou o abrandar da progressão da doença 
degenerativa do disco intervertebral (DDD). Todavia, nos últimos anos a investigação 
fundamental nesta área científica tem crescido consideravelmente, com um grande 
empenho em torno das terapias regenerativas. Deste modo, compreender os 
mecanismos celulares e moleculares responsáveis pela destabilização da 
homeostasia do DIV, e particularmente as alterações degenerativas associadas à 
idade, promoverá a criação de terapias mais seguras e mais efetivas no combate à 
DDD. 
A presente dissertação procura contribuir para o avanço do conhecimento 
básico da biologia celular do DIV, através da caracterização aprofundada da 
assinatura fenotípica do disco e das suas populações celulares endémicas, 
especificamente as que se encontram no nucleus pulposo (NP), em homeostasia e no 
envelhecimento. Neste sentido, foram aplicadas técnicas inovadoras e pouco 
utilizadas até agora nesta área, como a citometria de fluxo e a citometria de fluxo com 
imagem.  
Motivados pela falta de estandardização dos protocolos de isolamento e 
caracterização das células primárias do NP, na primeira fase deste trabalho foi 
estabelecido um método otimizado de isolamento daquelas células, garantindo 
elevado rendimento e viabilidade celular, assim como uma classificação sistemática 
dos eventos na análise de citometria. Este estudo permitiu destacar a collagenase-
tipo-XI como uma enzima eficaz na dissociação do NP e consequente obtenção de 
suspensões unicelulares, bem como descobrir a existência de três subopulações 
celulares fenotipicamente distintas no NP bovino jovem em homeostasia. 
Numa segunda fase estudou-se o efeito do envelhecimento na assinatura das células 
bovinas do NP ao nível da proteína e do gene. Os resultados revelaram diferenças 
evidentes entre células jovens (12 meses) e as envelhecidas (10-16 anos), 
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nomeadamente uma diminuição na prevalência de marcadores associados a células 
mesenquimais estaminais (MSCs) (CD29 e CD44), hematopoiéticas (CD45) e 
progenitoras do NP (Tie2), acompanhada de um aumento de células GD2+ (também 
marcador de células progenitoras do NP) e manutenção de células CD146+ (marcador 
de MSCs). Adicionalmente, na sequência da mudança de sistema analítico, uma 
quarta subpopulação celular foi identificada. A assinatura das subpopulações foi 
também significativamente afetada pela idade. De notar, os resultados obtidos 
permitiram concluir que o modelo animal bovino representa uma ferramenta de grande 
utilidade no estudo das alterações induzidas nas células do NP pela idade, e 
consequentemente na identificação de potenciais alvos terapêuticos anti 
envelhecimento, tendo em vista a prevenção da degeneração do DIV. 
Finalmente, procurando validar os resultados anteriormente obtidos, células 
isoladas de DIVs humanos, recolhidos após microdiscectomia foram analisadas, e os 
resultados permitiram registar as alterações notáveis que ocorrem a nível morfológico 
nas células humanas do DIV com a idade e a degeneração, mais precisamente a 
gradual transição no diâmetro das células, devida à deposição de uma matrix 
pericelular aberrante. De destacar, o desaparecimento gradual de uma população de 
células progenitoras incluindo células CD73+, CD90+ e Tie2+, suportado por outros 
estudos prévios, foi questionado pela manutenção células CD146+ e GD2+ com a 
idade, semelhante ao averiguado em células do NP bovino. Este facto deposita 
renovada confiança na capacidade das células do DIV responderam proactivamente 
face à lesão do tecido. 
Em resumo, esta tese doutoral vem contribuir significativamente para o avanço 
do conhecimento da biologia celular do nucleus pulposo, utilizando técnicas 
inovadoras de caracterização das células. Adicionalmente, explorando 
comparativamente o fenótipo celular em homeostasia e no envelhecimento, identifica 
potenciais alvos moleculares de combate à doença degenerativa do disco. 
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LOW BACK PAIN, INTERVERTEBRAL DISC DEGENERATION AND DISEASE: 
EPIDEMIOLOGY AND AETIOLOGY 
 
Low back pain (LBP) remains the world’s leading cause of years leaved with 
disability, in both developed and developing countries, according to the Lancet Global 
Burden of disease study 2015 [1]. The estimate costs of LBP are difficult to compare 
between different countries, but its heavy socio-economic impact is evident in modern 
society [2].  Nearly everyone is affected by LBP at some moment in life (70-80% of 
lifetime prevalence) and about 4–33 % of the population at any given point (point 
prevalence) [3-5]. In Portugal, the recent EpiReumaPt study revealed that 26.4% of 
the population self-reported LBP at a given point [6] and 10.4% actually suffered from 
active chronic LBP [7]. This pathology promotes a high consumption of healthcare 
resources, since subjects present a higher likelihood for anxiety symptoms, early 
retirement due to disease and more physician visits [7].  
The aetiology of LPB is still unclear and in 90% of cases the pathoanatomical 
cause is non-specific, i.e. no known disorder that causes LBP can be directly identified, 
such as cancer, vertebral infection, cauda equina syndrome, vertebral compression 
fracture, axial spondyloarthritis, radicular pain or radiculopathy (sciatica), or spinal 
canal stenosis [2]. However, and despite no causal link has been confirmed yet [8], the 
literature suggests that there is a strong positive correlation between degenerative disc 
changes and LBP [9-11]. Physiologically, the pain may arise from the disc per se 
(discogenic), since nerve fibers are present on the surface of the posterior aspect of 
the IVD, or from secondary changes, which may affect adjacent anatomical structures 
[8]. 
Whether symptomatic or not, IVD degeneration begins in youth and is 
ubiquitous in adulthood, despite the wide variation in degenerative findings (i.e. MRI 
signal intensity, disc height narrowing, annular tears, disc buldging, herniation and 
osteophytes) between different disc levels and age groups [11-13]. Prevalence rates 
are difficult to estimate based on reported clinical observations, due to the different 
case definitions, methodologies and samples used [13]. The same happens with 
intervertebral disc disease (IDD) [or degenerative disc disease (DDD)]. Albeit 
considered the most common reason for lumbar fusion in the USA [14], this pathology 
does not have a universally accepted definition, nor it is clearly measurable [13]. 
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Moreover, IDD or DDD are many times synonyms with IVD degeneration. However, 
this may be misleading, since the word disease implies symptoms, and most 
degenerated discs are actually asymptomatic [13, 15, 16]. Hence, one should be 
precise when using the terms IDD or DDD, which should designate painful disc-related 
disorders, comprising naturally aged disc, as well as prematurely degenerated ones 
[17], the latest as a result of hereditary predisposition and/or environmental insults (e.g. 
mechanical trauma, high body weight, tabagism, diabetes or oxidative stress) [18].  
 
CURRENT TREATMENT MODALITIES FOR DEGENERATIVE DISC DISEASE 
 
First stage treatments for DDD rely on physiotherapy and medications. If 
symptoms are not relived after conservative approaches, patients are indicated for 
surgery (Table 1.1). However, spine surgeries have a high risk of complications 
associated [19, 20], and recurrent interventions are many times needed (15-30% of 
cases)[21], increasing the personal and financial costs even further [22]. Crucially, the 
underlying pathophysiology is not being addressed, nor is the restoration of IVD’s 
function or the slowing down of disease progression. 
Alternative biological approaches focusing on IVD regeneration or IVD-
associated pain relief begun in the early 1990s, and have since increased in number 
and diversity, including gene and biomolecular therapies, cell-based therapies and 
tissue engineering solutions for total or partial IVD replacement [23-25]. Indeed, 
researchers are seeking to regenerate the IVD by restoring its native properties, 
namely by: 1) recovering IVD biomechanics; 2) re-establishing cells biological activity, 
including production of healthy ECM; and 3) reducing IVD-associated pain. However, 
such sophisticated solutions are still on its infancy and very few have reached Phase-
I clinical trials [26, 27]. Indeed, the lack of fundamental knowledge on IVD cell biology 
and its intrinsic aging and degenerative mechanisms has been hindering the discovery 
of more effective therapeutic targets. 
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Table 1.1: Current treatment modalities to manage back pain. Adapted from [28]. 
Treatment modality To address Designation Disadvantages/Complications 
No
n-
su
rg
ic
al
 
Education, 
activity 
modification, 
behavioural 
therapy and 
exercise therapy 
Back pain 
Promotion of healthier 
life-style (e.g. reduce 
weight, no smoking); limit 
activity for a short period 
of time; confrontation of 
the fear of pain; trunk or 
core stabilization and 
low-impact aerobic 
activity 
Not proven effective 
Oral and topical 
medication 
 
Back pain 
Non-narcotic analgesics 
(acetaminophen, 
tramadol)  
narcotic analgesics,  
nonsteroidal anti-
inflammatory drugs 
(NSAIDs – COX 
inhibitors),  
muscle relaxants 
(diazepam, carisoprodol)  
oral corticosteroids,  
antidepressants (TCAs 
and SSRIs),  
topical treatments 
(NSAIDS or anesthetics) 
Do not address underling 
disease mechanisms. Only 
postpones surgical intervention 
by temporarily alleviating pain.  
Injected 
medication 
 
Back pain 
Epidural corticosteroids, 
soft tissue, facet-joint, 
sacroiliac joint 
Physical 
modalities Back pain 
Manipulation, traction, 
acupuncture, 
transcutaneous electrical 
nerve stimulation, 
orthoses 
Not proven effective 
Su
rg
ic
al
 
Arthrodesis (+ 
decompressive 
laminectomy)  
Discogenic pain 
(and 
spondylolisthesis) 
 
Failure to achieve solid fusion, 
stiffness, persistent back pain, 
stiffness, possible increased 
degeneration on adjacent 
segments, consequent facet 
arthrosis 
Total disc 
arthroplasty or 
dynamic 
stabilization 
Discogenic pain 
ProDisc-C, Prestige, 
Bryan, SB Charité III, 
ProDisc-L, Nuclear 
replacement, facet 
replacement 
No available long-term clinical 
results, durability and 
complications remain unknown 
Microdiscectomy 
Disc herniation 
(normally with 
radiculopathy 
symptoms) 
 
Inadvertent durotomy, nerve 
root injury, infection, 
postoperative instability, 
recurrent disc herniation, 
fibrosis 
Decompressive 
laminectomy  
Lumbar stenosis 
(neurogenic 
claudication) 
Lamina excision, X-STOP 
spacer 
Incidental dural tears, 
postoperative instability, 
persistent back pain, persistent 
radiculopathy, recurrence of 
stenosis 
NSAIDs: Nonsteroidal anti-inflammatory drugs; COX: cyclooxygenase; SSRIs: serotonin reuptake 
inhibitors; TCAs: tricyclic antidepressants 
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INTERVERTEBRAL DISC ANATOMY AND PHYSIOLOGY 
 
The IVD is a fibrocartilage with a roughly cylindrical structure, which comprises 
1) a well-hydrated central nucleus pulposus (NP), 2) a firm and flexible annulus 
fibrosus (AF) surrounding the NP, and 3) inferior and superior cartilaginous endplates 
(CEP) forming the interface between the disc and the adjacent vertebrae (Figure 1.1). 
During embryogenesis, the NP originates from the notochord, whereas the AF and the 
CEP derive from the somites (scleretome) [29, 30]. As such, distinct cell populations 
are found within these structures, which are responsible for the regional variations and 
for the specialized physiological function of each anatomical part [31, 32]. Overall, the 
IVD guarantees the flexibility of the spine, allowing movements between the axial and 
appendicular skeleton and the head, and also absorbing applied loads [33]. 
 
 
 
 
Figure 1.1: Intervertebral disc anatomy and physiology. The intervertebral discs are 
fibrocartilaginous cushions acting as shock absorbers between each of the vertebrae. The human spinal 
column is composed of a total of 23 intervertebral discs, which allow extension and flexion of the spine 
to some extent, while also guarantying protection to the vertebrae, brain, and other surrounding 
structures (i.e. arthrodial, ligamentous, muscular, vascular, lymphatic and neural elements). Adapted 
from [34]. 
 
The nucleus pulposus. The healthy NP is highly rich in proteoglycans and 
contains collagen fibers randomly organized [35] and elastin fibers arranged radially 
[36]. Daily pressure applied to the nucleus is passed on to both the annulus and the 
endplates.  When loaded from above, the height of the nucleus is reduced, as it 
attempts to expand radially. As a consequence, the collagen rings of the annulus are 
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stretched and the pressure exerted by the nucleus is quickly balanced by the elastic 
tension that develops in the lengthening fibers of the annulus. On the other hand, the 
pressure exerted on the endplates transmits part of the load from one vertebra to the 
next, although other structures of the spine also take some of the strain (i.e. ligaments, 
tendons, muscles, thoracolumbar fascia, facet joints) to resist compressive forces. 
 
The annulus fibrosus. The AF has a laminate structure ranging from 15 
(posterior) to 25 (lateral) concentric layers, with collagen fibers of various diameters 
lying parallel within each lamella [37]. The spaces between the separate lamellae are 
called interlamellar septae, and contain proteoglycan aggregates and a complex 
structure of linking elements creating interlamellar cohesion. At the periphery, some of 
the annulus fibers, i.e. Sharpey’s fibers, pass the endplates to penetrate into the 
apophysial ring. The outermost fibers blend with overlying periosteum and longitudinal 
ligaments. Central fibers either insert into the cartilage of both endplates or bend with 
the NP. Based on structural and cellular differences, the AF can be further 
differentiated into an inner and an outer part. The inner AF is a broad transition zone 
between the highly organized collagenous structure of the outer AF and the highly 
hydrated NP, and consists of a mixture of extracellular matrix (ECM) components of 
both. Mechanically, the inner AF is more subjected to the high hydrostatic pressures 
from the NP than to the tensile forces from the outer AF. These differences have major 
consequences on ECM synthesis and turnover. The proportion of type I collagen 
increases from the inner part towards the outer annulus, whereas type II collagen 
follows a counter wise distribution [38]. This highly organized bioactive structure results 
in a complex anisotropic behaviour, with the tensile, compressive, and shear properties 
differing in the axial, circumferential, and radial directions. The forces experienced by 
the AF tissue can be quite high and therefore an intact AF is critical to proper disc 
function [39]. 
 
The cartilaginous endplates. Each CEP constitutes a thin horizontal layer, 
usually less than 1 mm thick of hyaline cartilage and fibrocartilage, with collagen fibers 
running parallel to the vertebral bodies, and continuing into the disc [40, 41]. Hyaline 
cartilage occurs towards the vertebral body and is most evident in neonatal and young 
discs, while fibrocartilage occurs towards the nucleus pulposus, being formed by 
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invading collagen fibres from the annulus fibrosus. In older individuals the end plates 
become entirely made of fibrocartilage [42]. Although tightly bound to the disc by the 
collagen fibers of the annulus, the endplates are only loosely bound to the vertebral 
bodies, for which they are considered an anatomic part of the IVD. The CEP fills the 
concave depression within the surface of the bony vertebral end plate up to the level 
of the apophyseal ring (outermost part made of cortical bone) (Figure 1.2). The central 
portion of the bony endplate is made of cancellous bone, being less resistant than the 
surrounding apophyseal ring, and is perforated by marrow contact channels, through 
which blood capillaries emerge, connecting the trabecular spaces to the cartilaginous 
endplate [43]. 
 
 
Figure 1.2: End-plates anatomy. A | Gross morphology of the lumbar intervertebral joint. B | Histology 
section showing regions of interest for panels C, D, and E. C | End plate detail showing cartilaginous 
and bony components with hematopoietic marrow elements. D | Insertion of annular fibers into the end 
plate cartilage at the inner annulus junction. E | Vascular sinusoids in the marrow space adjacent to the 
end plate. Note for panels A and B, left side is anterior. From [44]. 
 
Biomolecular components of the IVD. The disc is primarily comprised of 
water, proteoglycans, collagens, and other proteins. Table 1.2 groups the main ECM 
components found within the IVD, and Table 1.3 the main proteinases. Altogether, 
these molecules have a fundamental role in maintaining disc homeostasis. 
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Proteoglycans, particularly aggrecan, maintain matrix hydration and provide the 
appropriate osmotic pressure to facilitate nutrient transport and allow the plastic 
deformation required to disperse compressive forces. Others, such as versican, control 
disc cell differentiation and proliferation in the annulus, whereas leucine-rich 
proteoglycans regulate collagen ﬁbril assembly, transport, and incorporation into ECM 
[45].  
The different biomolecules distribution varies along the depth of the disc (Figure 
1.3), and this correlates with the distinct biomechanical roles of its different anatomical 
parts [42]. The NP, rich in type II collagen, is more subjected to pressure, while the 
annulus fibrosus, containing both type I and type II collagen, is more involved in both 
tension-related and pressure-related processes [42]. In general, collagen fibers are 
densest in regions at the periphery of the disc [46]. On the other hand, PG content 
increases towards the center of the disc, which confers a large negative charge and 
hence high osmotic potential to the NP, attracting cations (mainly Na+, K+ and Ca2+) 
and associated water, causing the tissue to swell [47]. The interaction between the 
proteoglycans and water is critically important, not only with regard to the mechanical 
properties of the disc (acting as a shock absorber), but also in determining the 
environment through which diffusion of nutrients and waste must occur [48]. The ECM 
is composed of many other components, the exact function of which in maintaining the 
biomechanical and biochemical balance in the disc are still unknown. However, ECM 
remodelling is critical to maintain IVD homeostasis. Nutrient supply and correct 
mechanical loading provide a proper environment for cells, which in turn control ECM 
turnover, needed for cell anchorage and to provide loading resistance.  
 
 
 
Figure 1.3: Variation of the main disc constituents’ concentration within the tissue. From [49]. 
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Table 1.2: Main extracellular matrix components of a young and healthy IVD. From [50]. 
 Name Distribution/Localization Putative/Possible Function 
C
ol
la
ge
ns
 
Fibril-forming collagens 
Type I AF and NP Confers tensile stiffness allowing torsion and flexion [51-54] 
Type II AF and NP 
Confines PG within the matrix to retain more water 
to allow larger deformations and withstand greater 
compressive loads [55, 56] 
Type III NP and outer AF Organizes pericellular environment; allows extensibility of tissue [57-59] 
Type V 
AF and NP (increased in AF 
cells when compared to NP 
cells  
Regulates fibril diameter (smaller if this collagen is 
more abundant) influencing mechanical properties 
[59, 60] 
Type XI  All over, mostly NP 
Regulates fibril diameter (smaller if this collagen is 
more abundant) influencing mechanical properties 
[59, 61, 62] 
Beaded-filament forming collagens 
Type VI All over, mostly NP Helps cell fixation to the matrix and facilitates collagen bundles' sliding and lubrication [63, 64] 
FACIT collagens 
Type IX NP Maintains matrix integrity [65, 66] 
Type XII AF Might regulate fibrillogenesis [53, 67] 
Type XIV AF Might regulate fibrillogenesis [53, 67] 
Pr
ot
eo
gl
yc
an
s 
Aggregating PGs 
  
Aggrecan AF and NP 
Maintains IVD's osmotic pressure; may act as an 
anti-angiogenic factor due to its inhibition of 
endothelial cell migration [64, 68, 69] 
Versican All over, mostly AF  
Favors the attachment of adjacent lamellae, 
contributes to resistance to compressive forces and 
facilitates cell migration, since it is an anti-adhesive 
molecule [59, 64] 
Non-aggregating PGs 
  
Sm
al
l L
eu
ci
ne
-r
ic
h 
Pr
ot
eo
gl
yc
an
s 
(S
LR
Ps
)  
Decorin Outer AF and fibrillar NP 
Regulates collagen fibril diameter and spacing, 
maintaining uniform patterning; GFs’ reservoir 
(TGF-β), modulating ECM metabolism [70-72] 
Biglycan Outer AF and NP (fibrillar and pericellular region) 
GFs’ reservoir (TGF-β), modulating ECM 
metabolism [70, 71] 
Asporin Outer and inner AF, rarely NP  
GFs’ reservoir (TGF-β), modulating ECM 
metabolism; may play a major role in modulating 
chondrocyte matrix homeostasis [73, 74] 
Fibromodulin AF and NP  
Regulates collagen fibril diameter and spacing, 
maintaining uniform patterning; GFs’ reservoir 
(TGF-β), modulating ECM metabolism [68, 71] 
Lumican AF and NP  Regulates collagen fibril diameter and spacing, maintaining uniform patterning [68, 75] 
Prolargin (encoded by 
PRELP*) allover, mostly AF 
Anchors basement membranes to the underlying 
connective tissue [68, 76] 
Chondroadherin AF and NP 
Binds integrin ad collagen; regulates cell 
metabolism and ECM structure, promoting matrix 
homeostasis [68, 77, 78] 
Osteoglycin/Mimecan AF and NP  Unknown [68] 
O
th
er
 P
G
s 
Perlecan AF and NP 
Has a role in cell proliferation and differentiation by 
acting as co-receptor for FGFs; matrix organization 
and stabilization; role in FGF signalling [64, 79] 
O
th
er
 m
at
rix
 p
ro
te
in
s 
Fibronectin All over the disc  
Preserves structural integrity of the ECM; involved 
in cell adhesion through interaction with integrins 
[80-82] 
Elastin All over the disc 
Preserves structural integrity of the ECM; help to 
regain disc height and shape after deformation [83-
85] 
COMP All over, mostly AF  
Preserves structural integrity of the ECM; binds 
other matrix proteins and catalyzes polymerization 
of type II collagen fibrils; prevents vascularization of 
cartilage [86, 87] 
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Thrombospondin AF  
Preserves structural integrity of the ECM. Mediates 
cell adhesion, matrix-matrix interactions, cell 
migration and proliferation in other tissues; might 
prevent vascularization of the tissue; activates 
TGF-β complex [88, 89] 
COMP: cartilage oligomeric matrix protein; ECM: extracellular matrix; FACIT: fibril associated collagens with interrupted triple 
helices; NP: nucleus pulposus; AF: Annulus fibrosus; PG: Proteoglycan; PRELP: proline arginine-rich end leucine-rich repeat 
protein; TGF-β: transforming growth factor beta 
 
 
Table 1.3: Main IVD proteinases. From [50]. 
Name Distribution/Localization Putative/Possible Function 
Aggrecanases     
ADAMTS1, 4, 5, 9 and 15 
ADAMTS1: NP and AF; 
ADAMTS4: low levels NP and AF; ADAMTS5: low 
levels NP and AF; ADAMTS9: NP and AF; 
ADAMTS15: low levels NP and AF 
Degrades aggrecan [90-93], as well as 
versican, biglycan, fibromodulin, 
COMP, TSP1, TSP2, nidogen, among 
other substrates [94] 
Collagenases 
  
MMP1, 8 and 13 
MMP1: low levels, mostly inner AF and NP; 
MMP8: low levels; 
MMP13: low levels, mostly NP 
Cleaves fibrillar collagen [90-92] 
Gelatinases 
  
MMP2 and 9 MMP2: low levels, mostly inner AF and NP; MMP9: low levels AF and NP 
Degrades denatured collagen and 
basement membrane collagen [92] 
Stromelysin 
  
MMP3 and 10 MMP3: low levels, mostly in the adult NP; MMP10: only checked in the NP 
Digests noncollagenous matrix proteins 
and denatured collagen [90, 92, 95] 
Matrilysin 
  
MMP7 NP and inner AF 
Degrades aggrecan and collagen type 
II  
cleaves aggrecan, COMP, types I and 
IV collagen, and fibronectin and acts 
on tenascin; can interfere with 
stabilization of capillary-like structures, 
possibly playing a role on the avascular 
status of the disc [96, 97] 
Other MMPs 
  
MMP19 AF and NP 
Regulates IGF-mediated proliferation in 
other tissues by proteolysis of IGFBP3 
[97] 
ADAMTS: a disintegrin and metalloproteinase with thrombospondin motifs; AF: Annulus fibrosus; IGFBP3: Insulin-like growth 
factor binding protein 3; MMP: metalloproteinase; NP: nucleus pulposus; TSP: Thrombospondin 
 
 
IVD nutrition and cell metabolism. The IVD is the largest avascular structure 
in the human body [98]. As such, glycolysis is the main mechanism of cellular 
metabolism in the disc [99].  Nutrients such as glucose and oxygen are supplied to the 
disc by blood vessels at its margins. The outer annulus is supplied by blood vessels 
surrounding the disc's periphery, while the nucleus and inner annulus are supplied with 
nutrients by a capillary bed which arises in the vertebral body, penetrates the 
subchondral plate and terminates at the junction between the cartilaginous end plate 
and bone [100]. Small solutes (e.g. oxygen, glucose, lactate) move primarily by 
diﬀusion under gradients set up by cellular activity, and are additionally oriented along 
the IVD according to the permeability and diﬀusion properties of the disc and end plate 
[101]. On the other hand, large proteins move in and out of the disc attached to water 
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molecules, according to a load induced flow. As a result of the limited blood supply and 
hypoxic conditions, the tissue is more acidic in the inner regions compared to the outer 
regions (Figure 1.4). The pH within the IVD ranges from 6.9 to 7.2, reﬂecting the 
importance of cell specialization within the IVD [41, 102]. For cell-based regenerative 
strategies, one of the most challenging microenvironment condition of the 
intervertebral disc is its matrix acidity [103], which increases with degeneration [104]. 
In general, three main factors are responsible for the acidic conditions in the normal 
IVD:  
i. Diffusion of lactic acid (the product from anaerobic glycolysis) across the 
thick and dense matrix (up to 8 mm for adult lumbar discs) is slow, resulting in 
elevated acidity within the matrix and around the cells, particularly in the centre 
of the disc [105, 106]; 
ii. Due to the presence of many COO– and SO42– groups on the constituent 
glycosaminoglycan chains of the proteoglycans, the IVD has a high negative 
charge density, which attracts high amounts of free cations [105, 107]; 
iii. Although to a lesser extent, acid extrusion mechanisms will acidify the 
pericellular matrix further. The maintenance of a constant intracellular pH is of 
paramount importance for cell viability and function, and therefore disc cells 
possess acid extruding proteins of which the Na+ x H+ exchanger is the most 
prominent [105]. 
 
 
Figure 1.4: Intervertebral disc nutrition pathways. A | Cells of the avascular disc nucleus pulposus 
and inner annulus fibrosus are supplied by vertebral blood vessels. Capillaries penetrate the 
BA
C
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subchondral plate through marrow spaces and terminate in loops at the junction of the subchondral 
plate and cartilaginous endplate. Nutrients (e.g. oxygen and glucose) diffuse from the capillary bed 
through the cartilaginous endplate under gradients arising from metabolic demands of disc cells, while 
metabolic wastes (e.g. lactic acid) diffuse in the reverse direction. Cells of the outer annulus fibrosus 
are supplied by capillaries from blood vessels in the surrounding soft tissues that penetrate a few 
millimetres into the disc. B | The centre of the disc has the lowest levels of nutrients and highest 
concentration of metabolites. C | Schematic showing normalized concentration gradients of glucose, 
oxygen and lactic acid across the nucleus, endplate–endplate. Nutrient concentrations must remain 
above the critical levels to maintain cell viability and activity. From [108]. 
 
However, matrix acidification may be even more exacerbated during 
degenerative processes [101], leading to a decrease in cell proliferation and viability, 
a shift towards matrix catabolism and an increase in pro-inflammatory cytokines and 
pain-related factors expression [104]. 
 
INTERVERTEBRAL DISC CELL POPULATIONS 
 
 Although all the cells of the mature disc are derived from mesenchymal cells, 
the cells of the OAF, IAF and the NP produce distinct extracellular matrices [109-111]. 
These differences are maintained in vitro, when cells are isolated from the tissue, and 
reflect distinct cellular phenotypes rather than environmentally induced differences 
[112, 11end3]. The molecular profile of IVD cells has been subject of intensive 
research in recent years. In order to develop more effective biological strategies that 
address the underlying pathogenesis, ideally by overcoming age-dependent 
degenerative processes, there is the need to better understand the cellular and 
molecular mechanisms behind IVD development, homeostasis and healthy aging. An 
overview on the phenotypic characteristics of the distinct cell populations found within 
the human (unless otherwise stated) IVD is given in next sections. 
 
CEP cells. During IVD development, once Sox9 expression and 
chondrogenesis are initiated in the axial skeleton, chondrocyte differentiation and 
endochondral bone formation occur in the vertebral bodies. When the vertebrae are 
formed, hyaline cartilage is maintained at the end, in close contact with the IVD. Alike 
the articular cartilage, the CEP contains round chondrocytes, at a density of around 
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14x106 cells.cm-3 [114], embedded in a collagen II and proteoglycan-rich ECM, with 
collagen fibers mainly aligned horizontally. Although cells do not undergo terminal 
differentiation, collagen X may also be found in central areas of healthy CEP, possibly 
constituting focal areas of endochondral ossification. In aged or scoliotic discs, 
collagen X staining can be localized across the whole disc surrounding cells, and is 
mainly associated with abnormal calcifications [115, 116]. Contrarily to cells of the AF 
and NP, reports on CEP phenotype are few and essentially based on immunostaining 
of matrix proteins [117-119]. Only recently, Thorpe and colleagues included the CEP 
on their investigation on the regional variations in the expression of the previously 
proposed NP markers [120]. However, only negative discriminating protein markers 
were highlighted, such as KRT-19, as compared with NP cells, and LAM-5, PAX1 and 
FOXF1, as compared with both AF and NP cells. However, alike other mesoderm-
derived tissues, CEPs were recently found to be home for stem cells (CESCs), which 
have been thoroughly characterized. These cells had the ability to form clusters, 
containing similar cells to BM-MSCs, namely, in their morphology, when adhered to 
tissue culture plates, and in their surface markers expression: positive for CD105, 
CD73, CD90, CD44, CD166, Stro-1 and CD133, and negative for CD14, CD34, CD19, 
CD45, and HLA-DR. Moreover, CESCs also exhibited differentiation potential into the 
three mesenchymal lineages [121, 122].  
 
Fibroblast-like cells. Within the adult AF, cell density stays around 9000 
cell/mm3 [123], with higher cell densities registered in the OAF [110]. AF cells, 
particularly in the outer region, tend to be fibroblast-like, elongated, thin, and aligned 
parallel to the collagen fibers [124, 125]. Towards the IAF, some cells become more 
oval (Figure 1.5 A) [126]. In bovine OAF, cells show a complex morphology with 
sinuous processes woven into the extracellular matrix, and some interconnections via 
functional gap junctions [127, 128]. Often, linear cell arrays are found extending 
throughout the lamellae, embedded in an extensive pericellular matrix of collagen VI 
(Figure 1.5 B) [127]. Noteworthy, in pigs, AF cells were shown to exhibit a metabolic 
pathway distinct from that of cells with notochordal origin (i.e. NP cells), with higher 
lactate production and glucose consumption [109]. Numerous studies have assessed 
the phenotype of AF cells, either alone [129-133] or in comparison with NP, CEP or 
AC cells, in various species, including human, bovine, rat, ovine, canine, porcine and 
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rabbit [87, 134, 135]. Importantly, interspecies variations at the gene level were 
sometimes evident, empathizing the value of human samples in this field. For instance, 
in bovine AF cells, higher expression of versican (VACAN), tenomodulin (TNMD), 
alpha-induced protein 6 (TNFAIP6), forkhead box-1 and -2 (FOXF1 and FOXF2) and 
aquaporin (AQP1) was detected, when compared to NP or AC cells. However, from 
this report, only tenomodulin was further validated in normal human AF cells [135]. 
Also seeking validation of previously proposed AF marker genes selected from 
microarray analysis, van der Akker et al., confirmed by qPCR that COL1A1, COL5A1, 
COL12A1, SFRP-2 and ADAMTS17 expression levels positively discriminate AF from 
NP cell cultures [133]. However, these results were retrieved after standardized cell 
culturing and conditioning with TGFß3, which may have forced cells to adopt a 
phenotype in vitro that does not resemble the one in vivo. Hence, further validation 
using different conditioning is required. Moreover, the fact that the AF tissue under 
study was from two scoliotic discs may constitute an additional concern. Further work 
from the same group, with bovine samples, exposed the different transcripts within the 
IAF and OAF in comparison with the NP and AC [132]. COL5A1, COL12A1, SFRP-2 
and ADAMTS17 were again positive markers for OAF cells when compared to NP cell, 
but also in relation to IAF cells. As expected, aggrecan (ACAN) and COL2A1 
expression was higher in the NP, while COL1A1 was higher in the OAF (no differences 
between OAF and IAF). Also, both the IAF and OAF showed less GAG content than 
the NP, while only the OAF showed significant higher DNA content. 
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Figure 1.5: Annulus fibrosus cells morphology across the disc. A | AF cells are elongated in the 
periphery (left) and more rounded near the frontier with the NP (right). Adapted from [126]. B | Schematic 
illustration of the complex disposition and interconnectivity of OAF cells along and within the lamellae.  
Lamellar linear cell arrays are protected from tensile strains through fibril sliding, transferring shear 
strains to the cellular processes and interlamellar cells. Adapted from [127]. 
 
Chondrocyte-like or mature NP cells. The NP, considered the epicentre of 
IVD degeneration [136], as well as home for progenitor cells [137, 138], has attracted 
special attention from the scientific community. In the adult human NP, chondrocyte-
like cells are interspersed at a low density - near 4000 cells/mm3 [123], around 1% of 
the total NP volume [139]. These cells possess Golgi cisternae and a well-developed 
endoplasmic reticulum, indicating their capability to produce and maintain the ECM. 
With age, lipid droplets can be found in the cytoplasm, as well as a distinct pericellular 
matrix around most cells, as identified by electron microscopy, possibly due to 
accumulation of cell products [140]. Frequently two or more cells can assemble in a 
fibrous capsule, forming chondrons similar to those found in articular cartilage [141]. 
While these cells have many times been confounded with AC chondrocytes in the past, 
due to some phenotypic similarities [142], it is now known that they produce a distinct 
kind of ECM, with different aggrecan/collagen II ratios [143], proteoglycan structure 
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[144], collagen network [145], and glycosignature [146]. These differences may as well 
be anticipated by their distinct transcriptional profiles [135, 147, 148]. Besides their 
distinct ontogeny (AC: lateral mesoderm; NP: notochord), the specialized 
biomechanical solicitation and behaviour [149], allied to the particularly challenging 
microenvironment, could be the driving forces behind such differences. During the last 
decade, a plethora of microarray studies have been conducted in different species in 
order to establish a panel of marker genes that distinguish NP cells from AF, CEP and 
AC cells [120, 134, 135, 137, 147, 148, 150]. Generally, the markers proposed are not 
exclusive to any of those cell types, but rather follow an on-off fashion between them. 
Importantly, following the consensus paper by Risbud et al. to define the phenotype of 
young NP cells [151] (Table 1.4), a special interest has arisen on the relevance of the 
proposed markers to NP physiology (prompting more studies at protein level), as well 
as on their evolution with age and degeneration (stimulating the use of  human 
samples) [120, 137, 152].  On another front, the exact origin of mature NP cells remains 
subject of debate. Some believe they may migrate from neighbouring tissues, such as 
the AF [153], CEPs [154, 155] or perichondrium [156], while others consider that the 
transition from a notochordal to a fibrocartilaginous tissue is not an exogenous 
replacement, but an endogenous development, in which NC cells terminally 
differentiate into mature NP cells [157-160]. The latter hypothesis is supported by 
experimental evidence in mouse showing that NP cells express the signalling molecule 
sonic hedgehog (Shh) and the transcription factor brachyury (T), which are otherwise 
not expressed by cells derived from the sclerotome [160], and by lineage-tracing 
studies in mice that established that during normal development and aging all cells of 
the NP are notochord-derived (from E15.5 until 21 months of age) [161-163]. 
Notwithstanding, recent contrasting evidence poses the possibility that the mature NP 
may have a heterogeneous cell population, including both notochordal and non-
notochordal cells [137, 153, 164-167]. Overall, wide-genome analysis alone is not 
fulfilling the need for specific cell markers to aid cell-based therapies on restoring an 
NP-like phenotype [120, 168]. Hence, future research on the phenotypic 
characterization of IVD cells is warranted, particularly regarding the signature of each 
subpopulation in terms of its ontogeny, physiology and function.  
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Table 1.4: Markers proposed by Risbud et al. to define the young healthy NP cells phenotype. 
Adapted from [151]. 
Phenotypic marker Relevance to NP physiology 
 
Primary markers†* 
Stabilized HIF-1/2a Transactivate many pro-survival genes in NP. Necessary for post-natal NP survival.  
GLUT-1 Glucose transporter expressed in hypoxic tissues. Expression controlled by HIF-1.  
Shh Signalling ligand necessary for post-natal function of NP cells.  
Brachyury Transcription factor necessary for notochordal morphogenesis and patterning.  
Aggr/Col II ratio >20 High PG content maintains hydration to resist loads. 
CA3 and 12 Acid-base balance  
CD24 Unknown 
CK-8, -18 and -19** Cellular structural integrity and possibly signalling 
 
Secondary markers‡ 
Integrins a3, a6 and b4* Cell-matrix adhesion 
Annexin A3 
Unknown 
a2-macroglobulin* 
Glypican 3 
Democollin-2 
CD56 
CD155 
CD221 
SNAP25* 
CDH2* 
BASP1 
PAX1* 
SOSTDC1 
FOXF1* 
Hemoglobin b-chain* 
Ovostatin* 
Neurochondrin 
Neuropilin-1 
Lubricin (PRG4)* 
 
Progenitor markers‡* 
Tie2  Receptor for angiopoietin-1. Drives proliferation of progenitor cells. 
GD2 Unknown 
† Selection criteria: 1) specific expression in young healthy NP cells, 2) requirement for proper NP cell function and relevance 
to NP cell physiology, and 3) mRNA and protein expression validated across different species; ‡ Identified in the literature but 
less well validated than primary markers; * Identified in human; ** Indicate a notochordal ontogeny to the NP cells. 
 
 
Notochordal cells. Notochordal cells (NC) are much larger (30-40 µm in 
diameter) than NP mature cells (~10 µm in diameter), with significantly higher 
intracellular glycogen and cellular processes [140, 169, 170]. Additionally, they present 
CHAPTER I 
General Introduction 
 
 40 
large ECM-containing inclusions [170], believed to be fast-acting osmoregulatory 
elements within the cells [171]. During human foetal development, these cells switch 
from a cluster-packed format to being totally separated by the twenty-first week of fetal 
life [140, 170]. In many animal species, with no evidence of IVD degeneration 
(e.g.  non-chondrodystrophic dogs, rabbits, pigs, mice and rat), NCs persist throughout 
life [169, 172], and several reports suggest that they have an important role in 
regulating disc cell function [173-177]. In humans, as well as in other species, such as 
horses, cows, sheep, and chondrodystrpphic dogs, NCs gradually decrease with age, 
and seem to be replaced by chondrocyte-like cells. This is already significant around 
the age of 3 years old for humans [170, 178]. When compared to mature NP cells, NCs 
are also more active metabolically and less resistant to nutrient deprivation [179], 
which could foster their disappearance as the vascular supply retracts gradually with 
age. Furthermore, even though they exhibit some gene-expression profile similarities, 
clear differences can also be found. For instance, in a porcine model, while both cell 
types express common chondrogenic markers (aggrecan, collagen II and Sox9), the 
relative expression of collagen I, as well as biglycan, decorin and lumican was found 
to be higher for mature NP cells [180]. Also, markers such as CK8, -18 and -19, 
cadherin-2 and SOSTDC1, are expressed by both bovine NCs and NP cells, but at 
higher levels in the former [135]. However, there is a growing belief that these 
differences found between NCs and the replacing mature NP cells may be due to 
different stages of cellular activity [180], differentiation [181] or pathological stages of 
aging and degeneration [182, 183], rather than imply different cell lineages. Indeed, 
recent studies have shown that a NC population may still exist within the adult and 
degenerated human NP, given the expression of notochord-specific markers, both at 
gene and protein levels [120, 135, 137, 158, 165, 166]. Nevertheless, these cells 
represent a small subset within the whole adult NP population, and thus the already 
referred hypothesis that some of the existing cells may have migrated from other 
neighbouring areas [137, 153, 164-167] cannot be ruled out. NCs exclusively express 
CK8, -18, -19 and CD24, as recently confirmed in human embryos and foetuses (3.5-
18 weeks post-conception) [184]. Importantly, in this same report, other previously 
proposed NC markers in other species, such as T (a so far widely accepted indicator 
of the common notochordal ancestry [158, 160]), GAL-3, CD55, BASP1 and CTGF, 
where not further validated in human, because of their co-expression with the 
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sclerotome at some point post-conception [184] (Figure 1.6). Hence, if used alone, 
these molecules are unsuitable NC-specific markers. 
 
 
 
Figure 1.6: Schematic representation of the IHC staining of NC cells in the developing human 
spine. CK-8, -18, and -19 are notochord-specific markers at all stages, while CD24 is notochord-specific 
between 5.5 and 18 WPC. GAL3, CD55, CTGF, BASP1, and T expression varies with development 
stage. CD90, Tie2, and E-Cad are not expressed by any developing spine cell anlagen. Modified from 
[179]. 
 
Progenitor cells. The presence of progenitor cells has been reported in the 
human NP [152, 185-188], AF [186, 187, 189] and CEP [121, 186], as well as in several 
other species, such as dog [190], rat [191-193], mice [138], rabbit [193-195], Rhesus 
monkey [196], minipig [193, 197]. Despite some diversity found across the different 
species in terms of cell phenotypic signature and functional response, typically, these 
cells are plastic adherent and present the MSC surface markers profile 
CD105+CD73+CD90+CD45-CD34-CD14-CD11b-CD79-CD19-HLA-DR- after liquid cell 
culture, while being capable of multi-lineage differentiation. When compared to bone 
marrow MSCs, degenerate NP-derived MSCs are less adiponegic [185], while CEP-
derived MSCs show greater osteogenic and chondrogenic potential [121]. This 
observation was also true in relation to AF or NP derived MSCs, as recently confirmed 
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[186]. Of note, NP, AF and CEP derived MSCs had similar morphology and 
proliferation ability between them, and when compared to BM-MSCs, but the latter had 
significantly higher immunophenotypic expression of CD105 [186]. Notably, NP-
derived MSCs are more resistant to the hypoxic [198], hypertonic[191] and acidic 
culture conditions [199], as opposed to adipose-derived MSCs, when both are cultured 
on a IVD-like microenvironment. On a different perspective, areas of proliferative cells 
(BrdU+) expressing migration markers (SNAI1, β1-Integrin) were found within the 
rabbit IVD, as well as expression of progenitor specific markers (e.g. Stro-1, Oct3/4, 
CD105, CD73, CD90, and Notch-1) [193, 200]. Most recently, Sakai et al. identified a 
population of progenitor cells within the NP, with multipotency and self-renewal 
capacity, which changed expression of specific cell-surface markers sequentially from 
angiopoietin-1 receptor (Ti2) positive, to disialoganglioside 2 (GD2) positive, to CD24 
positive cells as they differentiate and lose their proliferative capacity. Also, they 
showed a negative correlation between Tie2 expression and age in human tissue 
[138]. Interestingly, new evidence shows that human notochordal cells do not express 
Tie2, suggesting that the cells isolated by Sakai and colleagues may indeed be of 
mesenchymal and not of notochordal origin [184]. Finally, in a more functional view, 
cell cultures of human degenerated discs positively responded to conditioned medium 
from MSCs, by displaying a more undifferentiated appearance and increasing the 
expression of the multipotency marker POU5F1, the cell-fate regulator Notch-1 and 
the MSC markers CD105, CD90 and Stro-1 [201]. Taken together, these findings 
indicate that degenerated human discs may exhibit an endogenous regenerative 
capacity, with possible paracrine on set, although some evidence shows there might 
be an age-limit for the efficient activation of those native progenitors [138, 148]. 
 
Inflammatory cells. Some studies suggest that the IVD might endogenously 
include inflammatory-like cells [202, 203]. In particular, it has been shown in vitro that 
a population of bovine IVD cells can phagocytize beads and apoptotic bodies [202]. In 
turn, human surgical non-herniated nucleus pulposus (NP) samples presented a high 
number of resident CD68+ cells [203]. The question of whether these cells could be 
resident macrophages or macrophage-like cells remains. Also, infiltrated leukocytes 
(CD11b positive cells) were found in prolapsed IVDs as well, where NP is supposedly 
intact and isolated from any vascular source of immune cells [204]. Most notably, a 
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range of cytokines have been found in human IVDs in varying amounts, presenting 
clear evidence that IVD cells, or at least some of them, are producers of specific 
inflammation-associated molecules, even in basal conditions (non-degenerated NP). 
Table 1.5 groups some of the most important observational studies, which have 
clarified which inflammatory factors are expressed either during homeostasis and with 
degeneration. Importantly, the identity of the cells producing these mediators (i.e. NP 
cells, AF cells, native IVD cells only, native cells plus infiltrating inflammatory cells) is 
highlighted. Although pleiotropic, cytokines and chemokines have three modes of 
action: 1) stimulating the production of other inflammatory mediators and MMPs; 2) 
enhancing matrix degradation; and 3) recruiting inflammatory cells and activating 
phagocytosis [205-210]. Together, these effects can contribute to disease progression 
in the IVD.   
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Table 1.5: Inflammatory mediators found in the human IVD. Adapted from [50]. 
 Mediator Producing cells Ref 
 
inflammatory factors that are expressed during homeostasis 
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TNF-α IVD cells [95, 211, 212] 
IL-1β IVD cells [95, 212-215] 
IL-1α, IL-1Ra, IL-1RI, and 
ICE  
NP and AF cells [215] 
IL-6, IL-8, RANTES AF and NP cells [214] 
NGF NP and AF cells in monolayer and 
alginate bead culture 
[95, 216] 
NGF receptor (trkA) NP and AF cells in monolayer and 
alginate bead culture 
[216] 
Substance P   [95] 
PLA2 NP and AF cells [217] 
CCL3 and CCL4 IVD cells [218] 
NOTCH IVD cells [212] 
MMPs IVD cells [95, 208] 
 
inflammatory factors that are expressed with degeneration 
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TNF-α  
 
 
 
 
 
 
 
 
 
 
IVD cells and infiltrating cells 
[95, 193, 211, 219-
223] 
IL-1β [95, 193, 213, 220, 
221, 223] 
IL-1α [220-222] 
IL1-Ra, NO [220] 
IL-6 [220, 221, 224, 225] 
IL-8 [222, 225] 
IL-12, IL-17, IFN-γ [224] 
IL-20 (and its receptors) [206] 
IL-10, TGF-β, RANTES [222] 
IL-16, CCL2, CCL7, CXCL8 [204] 
Substance P [95, 220] 
PGE2 [220, 225] 
COX-2 [223] 
PLA2 [217, 223] 
NGF [95] 
VEGF, bFGF [219] 
GM-CSF [221] 
CD20, CD45RO, CD68 [226] 
MMPs [95, 219, 220, 226] 
bFGF: basic fibroblast growth factor; CCL: chemokine ligand; CXCL: monokine induced by gamma interferon; GM-CSF: 
granulocyte macrophage colony-stimulating factor;; ICE: IL-1β-converting enzyme; IFN-γ: interferon gamma; IL-1Ra: IL-1 
receptor antagonist; IL-1RI: IL-1 receptor, type I; IL: interleukin; LPS: lipopolysaccharide; MMPs: metalloproteinases; NGF: 
nerve growth factor PGE2: prostaglandin E2; PLA2: calcium-dependent phospholipase 2; TGF-β: transforming growth factor 
beta; TNF-α: tumor necrosis factor alpha; TrkA: high affinity NGF receptor; VEGF: vascular endothelial growth factor; NP: 
nucleus pulposus; AF: Annulus fibrosus; IVD: intervertebral disc. 
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THE HALLMARKS OF INTERVERTEBRAL DISC AGING 
 
Alike every other organ of the human body, the IVD also faces the recognised 
hallmarks of aging [227]: genomic instability [228], telomere attrition[229], epigenetic 
alterations [230], loss of proteostasis [231-235], deregulated nutrient sensing [236], 
mitochondrial dysfunction [237, 238], cellular senescence [239], stem cell exhaustion 
[138], and intercellular communication [146, 240, 241]. Although these features may 
not have all been as thoroughly studied in the disc as in other tissues, particularly with 
regards to epigenetic alterations and deregulated nutrient sensing pathways, it is well 
accepted that systemic disc aging is generally characterized by an initial ossification 
and thinning of the CEP, with marrow contact channels occlusion, and a further drastic 
reduction in the vascular supply to the disc [178, 242]. The consequent compromised 
cell nutrition, accumulation of metabolites and increased acidity of the environment is 
then followed by a decrease in the native cell population together with alterations in 
cell phenotype and response to damage, which hinders the deposition and 
maintenance of healthy ECM, ultimately compromising tissue function. 
Macroscopically, an increased number and size of tissue fissures is detected, along 
with deposition of granular debris and neovascularization inwards the OAF, the tissue 
turns yellowish due to age-related accumulation of oxidized matrix proteins, and the 
NP becomes more fibrous due to a decrease in water and proteoglycan content, 
leading to a loss on NP osmotic pressure and overall disc height. The main 
degenerative findings related to disc aging are grouped in Table 1.6. 
 
Animal models of IVD aging. Together with findings in humans, several animal 
species have served as models to investigate the aging features alterations mentioned 
above, including mouse [243-248], hamster [249], rat [250], sand rat [251-254], rabbit 
[255], pig [256], dog [257], sheep [258], alpaca [259], baboon [260, 261] and rhesus 
monkey [262, 263]. With exception of mouse models, which are genetically modified 
to express an aged phenotype, these animals present naturally occurring 
(spontaneous) and age-correlated disc degeneration, alike what happens with 
humans. However, interspecies variations are obvious [172], hindering the direct 
translation of results to the human scenario. Ideally, studies would be performed 
exclusively in human tissue, either from pathological, cadaveric or organ donor source. 
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Yet, ethical concerns often limit the access to such biological material, slowing down 
the pace of clinically relevant scientific discoveries. As we stand, work with animal 
models is an insurmountable fact, particularly in translational research leading to 
clinical trials. Much depending on the specific question do be addressed, some animal 
models adequate better than others [172, 264, 265]. Intriguingly, despite readily 
available, and commonly used to study the molecular phenotype of IVD cells [36, 132, 
135, 166, 265-270], as well to serve as model for disc degeneration [271-276], bovine 
discs have not yet been posed as potential aging models. Indeed, there is one famous 
study by Demers at al. that concluded that bovine coccygeal discs could be useful to 
study young healthy (< 40 years old) human lumbar discs, but were not suitable to 
address aging [277]. However, the range of ages covered was only 8 months to 4 
years. Demers et al. also suggest that the 8- to 20-month-old bovine coccygeal discs 
appear more representative of the human discs in their growth phase (less than 15 
years old), whereas the older 2- to 4-year-old bovine coccygeal discs appear more 
biochemically comparable to human lumbar discs undergoing maturation and aging 
(15–40 years of age), but without significant degrees of degeneration [277]. Hence, 
changes in elder disc specimens were not covered (> 50 years old), despite the higher 
incidence of degenerative disc changes (and thus substantial clinical relevance) 
registered in this age group [12, 178]. Moreover, although interspecies differences may 
naturally occur, bovine coccygeal discs are becoming increasingly accepted tissues 
for large animal organ culture, majorly because of their large size and similar aspect 
ratios, transport distances, and composition, to study human discs. At the biomolecular 
level, similar types and distribution of aggrecan and collagen are found in human 
lumbar and bovine coccygeal discs [278, 279], as well as rates of in vitro PG synthesis 
[278] and matrix deposition in response to hydrostatic pressure [280, 281]. Also, 
although bovine tails support a lower load than human lumbar discs, the swelling 
pressure of bovine coccygeal discs has been shown to be similar to that of human 
discs in in the prone position. In terms of cellular content, cell density is comparable 
between mature bovine and human NPs [98] and both loose notochordal cells early in 
life (at birth in cattle [282] and at 11-16 years old in human [178], which are replaced 
by chondrocyte-like NP cells). The presence or not of notochordal cells may have a 
profound impact on ECM composition, since the phenotype of these two kinds of cells 
is very different [134]. In terms of aging, similarities between the two species were 
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reported, namely in terms of increased denatured collagen II and decreased 
proteoglycan content in the NP, although age-dependent alterations seem to affect the 
aging human discs more sharply within the young age window selected [277]. Still, 
more studies are owed on the overall hallmarks of aging, before the bovine coccygeal 
disc can be established as a useful tool to investigate age-dependent degenerative 
alterations. 
 
 Young Old 
 
 
Mouse 
 
 
 
 
 
Pig  
 
 
Human 
Figure 1.7: Gross features of aged mammalian discs. Pictures show axial sections of young and 
aged lumbar discs of 3 months- vs 24 months-old mice (A, B), 3 weeks- vs 3 years-old pigs (C, D), and 
16 years- vs 55 years-old humans (E, F). Old discs exhibit an overall loss of hydration, loss of 
demarcation between the AF and NP boundary, and tissue discoloration (old disc more yellowish). 
Adapted from [283]. 
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Table 1.6: Main features of age-related IVD degeneration. Collected from [239, 283-285]. 
Degenerative features 
Gross anatomy changes (Histopathological/MRI findings) 
End-plate sclerosis (calcification and occlusion of marrow contact channels) 
Nurturing blood vessel retraction 
↓ Water content (decreased signal intensity on MRI) 
↓ Disc height  
Inward bulging of AF lamellae 
Loss of demarcation between NP and AF 
Tears and clefts formation  
Vascular and nerve ingrowth (inwards the tears) 
Osteophyte formation 
Altered nutrition and oxygen tension 
↓ diffusion of essential nutrients 
↓ oxygen levels (hypoxia) 
↑ Lactic acid production and accumulation (drop in pH)  
Altered cell response 
↑ cell clusters (with proliferative cells - damage response) 
↑ cell senescence (specially within clusters – secrete pro-aging and catabolic factors) 
↑ autophagy and phagocytosis 
↑ apoptosis 
↑ aberrant deposition of ECM layers around cells 
Deregulation of soluble factors 
↑ pro-inflammatory cytokines (e.g. TNF-a, IL-1a, IL-1b, IL-1R1, IFN-g, PGE2, NOX) 
↑ pro-agiogenic factors (Pleitrophin, VEGF, FGF-2, TGF-b, osteonectin, NGF, BDNF) 
↓ semaphorin in OAF (axonal growth repellent) 
↑ neurotrophic factors (NGF, BDNF) 
Altered ECM composition 
↓ Collagen II (specially in the NP) 
↑ Collagen I (by NP and IAF cells) 
↑ Collagen X (particularly in advanced degeneration, around clefts and clusters) 
↑ Collagen VI (particularly around clusters) 
↓ Collagen crosslinking  
↑ Non-enzymatic glycosilation (AGEs) (tissue becomes more stiff and susceptible to 
damage) 
↑Nonaggregating proteoglycans (from proteolytic degradation of aggrecan) 
↑ Keratan sulfate and ↓ chondroitin sulfate 
↑ Versican, decorin and biglycan 
↑ Fibronectin  
↑ Fibronectin fragments and ECM breakdown products (induce inflammation) 
↑ Crystal deposits of calcium pyrophosphate dihydrate (CPPD), cuboid microstructures 
and hydroxyapatite (HA) (may induce inflammation) 
Deregulation of proteostasis 
↑ MMP-1, 2, 3, 7, 8, 9, and 13 (cleave the majority of ECM constituents) 
Occurrence of cathepsin D, G, K, L in the AF (proteolytic enzymes) 
↑ ADAMTSs 1, 4, 5, 9 and 15 (high degrading activity against aggrecan) 
↑ TIMPs 1, 2 (broad inhibitors of the MMP family) 
TIMP 3 is not altered (aggrecanase inhibitor - imbalance) 
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Figure 1.8:  Molecular and cellular features of the aging disc. Young and aged extracellular matrix 
and cells are schematically compared to summarize important changes that occur during disc aging. A 
| Young matrix is rich in elastin (green, coiled fiber), aggregated aggrecan (dark blue, bottle-brush 
aggregate), and collagen fibers (banded fibers). Aged matrix shows loss of elastin, increased collagen 
and collagen crosslinking, fragmented aggregan, diminished GAG quality, reduced aggregan 
aggregates, increased accumulation of advanced glycation end-products (AGEs) along with lower 
hydration. B | Young AF cells are elongated fibrochondrocytes and NP cells are a mixture of large, 
clustering, notochordal cells and smaller, chondrocyte-like cells. Aged discs show reduced cellularity, 
loss of notchordal cells, and incidence of senescence, apoptosis, and necrosis. Adapted from [283]. 
 
Changes in NP cells molecular profile with age. Since aging and 
degeneration are two faces of a same coin, the majority of molecular alterations 
reported cannot be exclusively attributed to age. Indeed, one inherent struggle when 
studying human disc aging is that young healthy discs available for research purposes 
are seldom (post mortem samples are an example, but are generally difficult to obtain), 
and aged tissue is majorly from diseased samples collected upon microdiscectomies, 
where the degree of degeneration may be exacerbated due to other etiological factors 
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besides age. Additional challenges, such as 1) separating NP from AF tissue upon 
discectomy (the loss on demarcation between AF and NP in elder tissue is evident), 
and 2) in the case of herniated tissues (e.g. extruded, sequestered), avoiding 
contamination by other cell types, make the analysis of molecules released by regions 
of the IVD poorly accurate. Hence, few reports exist on molecular profile alterations of 
NP cells with age. A summary is given in Table 1.7. Interestingly, it was not until very 
recently that researchers started to confirm at protein level (e.g. IHC, FC) previous 
results obtained at mRNA level (microarrays and RT-PCR). Tang et al. confirmed the 
differential expression of 8 genes (Brachyury, CD24, CD90, CD155, CD221, Basp-1, 
Ncdn, Nrp-1) between NP and AF cells, yet, the comparative analysis between the 
different ages was rather difficult to read, as well as the bridging of the different 
methods used. Nrp-1 and CD90 staining were decreased in aged NP and AF, 
respectively, versus immature and mature tissues, and this followed a same genetic 
trend. Brachyury, however, which gene expression was not statistically different 
between immature and aged discs, but was up-regulated in mature disc, at the protein 
level showed an obvious decay on both mature and aged NP. Recently, the same 
author published new data, this time on human samples, allying IHC to flow cytometry, 
and probing the similarity of results between the different species. Nrp-1 and brachyury 
expression were also proven to be decreased during aging and degeneration in human 
NP, but in contrast, CD24, which was found to be highly expressed in the rat NP 
irrespective of age, in the human NP was shown to be decreased in the adult tissue 
(39-69 years old), when compared to juvenile (6-16 years old). Interestingly, new cell 
surface markers, such as CD166 and CD54, were for the first time shown to be 
increased in the human NP during aging and degeneration. However, with exception 
of two patients, the cohort selected for this study included only scoliotic discs, which 
cells were recently shown to express a molecular dysregulated profile when compared 
to normal discs [286, 287]. Hence, further validation is required. Besides studying IVD 
region-specific markers, Thorpe et al. also assessed the expression profile of NP 
samples with degeneration. Within a large cohort of surgical samples (101), FOXF1 
and PAX1 mRNA expression in NP, while differential from AF and AC samples, was 
not increased with degeneration grade (further confirmed by qIHC), which indicate 
these could be good candidate markers for both young and mature NP cells. 
Unfortunately, and although the data was available, no correlation was stablished with 
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patient’s age [120]. Finally, early this year, Richardson and colleagues published new 
data aiming to confirm expression of previously identified NP and NC marker genes in 
adult human NP from a range of ages and degenerate states. Combining gene 
expression analysis with IHC, they confirmed that both NP (FoxF1, Pax-1, KRT8, 
KRT18 and CA12) and NC markers (brachyury, galectin-3 and CD24) are expressed 
consistently by the NP cell population, regardless of age or grade of degeneration 
[137]. Interestingly, they verified that changes at the transcript level in NP markers 
FoxF1 and Pax-1with age find a parallel with changes with degeneration: both are 
significantly decreased with age (study range: 20-80 years old) and histological grade 
of tissue degeneration [grading system according to Sive et al. [142]: non-degenerate 
(grade 0–4); moderately degenerate (grade 5–7); and severely degenerate (grade 8–
12)]. In contrast, KTR19 shows significant increase in expression in elderly adults when 
compared to mature adults, and NC marker LGALS3 is decreased only in mature 
adults (40-59 years old) when compared to young adults (20-39 years old), but no 
difference with degeneration. On the other hand, CD24 is only expressed in severely 
degenerate when compared to moderately degenerate discs, but not altered with 
aging. Noteworthy, IHC findings did not follow the same trend observed at mRNA level, 
where only brachyury showed decreased expression with both age and degeneration. 
Interestingly, opposite to the gene expression profile, Galectin-3 immunopositivity was 
increased in mature adults. Also, CA12 was highly immunoreactive within the NP when 
compared to the AF, and particularly in severely degenerate samples, while not altered 
with aging. This supports previous results pointing CA12 as a marker for IVD 
degeneration [148]. Overall these results represent a substantial contribute to a better 
understanding of the biological phenomena behind disc aging and degeneration, 
particularly in the poorly explored field of IVD epigenetics. Indeed, studies to detail the 
NP phenotype at the protein level are few [87, 120, 137, 148, 152, 288, 289]  and 
validation of gene markers is required, since alterations at the transcriptome level do 
not necessarily translate into changes at the functional level. Crucially, at this point, 
standardization of tissue collection and processing techniques, as well as of primary 
cell isolation and culture is mandatory, so that comparison of results between different 
labs is feasible and a greater consensus regarding IVD cells phenotype can be 
achieved. 
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Table 1.7: Changes in nucleus pulposus cells molecular profile with age.  
 SPECIES BOVINE RAT HUMAN 
MOLECULE 
TYPE 
  Age 
Molecule 
Y:A 3M:24M 1M:12M 1M:21M Y:A Y:A ND:D 
(Age: 45-60 
yo) 
Y:A ND:D 
(Age: NA) 
Y:A 
INTERMIDIATE 
FILAMENT 
PROTEINS 
CK- 8 -          ¯    - -  
CK-18           ¯  -  - -  
CK-19         ¯ ¯ -  -  ­   
CELL SURFACE 
RECEPTORS 
CD24   -   H ¯ ¯     -  - - ­ 
CD54   -    ­ -          
CD166   -    ­ ­          
CD155/PVR   ¯ ¯ ­  ¯ -          
CD325/CDH2    ¯        ¯       
CD221/IGF-1R   - ­ ¯ H ¯ -          
CD168/RHAMM   ¯               
CD90/Thy-1   ¯   N ¯ H          
CD138/SDC1   ¯               
Gal-1/LGAS1,    ¯               
Gal-3/LGAS3,                ¯ ­ ­ 
CA12            ­ -  - H H 
GLUT-1             -     
TRANSCRIPTION 
FACTORS 
Brachyury   NA ­ - ¯ ¯ ¯   -  -  - ¯ ? 
FoxF1           -  - - ¯ -  
FoxA2   -            -   
PAX1             - - ¯ -  
HIF1a   -           H    
ID3   ¯               
ID2   ¯               
OVO-2             -     
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SIGNALLING 
MOLECULES 
SHH             ?     
NOGGIN               -   
NEURONAL-
RELATED 
PROTEINS 
NCDN   ­ - ­ H ¯           
LRRN3   ¯               
DPP6   ¯               
AARD   ¯               
BASP1   - - ­ H ¯    -       
NDN   ¯               
NRP-1   ¯ - ¯ ¯ ¯           
SNAP25           ¯       
ECM-RELATED 
PROTEINS 
COL2A1           -       
ACAN           -       
VCAN           -       
IBSP           -  -     
TNMD           -       
LAMA5             -     
LAMC2             -     
FBLN1           ­       
COMP  ­                
MGP  ­       ­ -        
 Method  
(sample size) 
IHC (6) RT-
PCR (3-
6) 
MA 
(4) 
RT-
PCR 
(4) 
RT-
PCR 
(4) 
IHC 
(3) 
IHC 
(11) 
FC* 
(5) 
RT-
PCR 
(11) 
IHC 
(41) 
MA (10) IHC 
(6) 
MA 
(71) 
qIHC 
(30) 
RT-
PCR 
(60) 
qIHC 
(56) 
FC* (5) 
 Reference [288] [150] [289] [152] [87] [135] [148] [120] [137] 
*FC: flow cytometry after cell expansion in 2D liquid culture; IHC: immunohistochemistry; M: months; Y young; A: adult; D: degenerate; ND: non-degenerate; N: not detected; H: always high; NA: not 
available; ¯ Decreased; ­ Increased; - maintained? contradictory findings 
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PRO-REGENERATIVE THERAPIES TARGETING DETRIMENTAL AGE EFFECTS 
ON INTERVERTEBRAL DISC CELLS 
 
Age-related degenerative changes within the IVD can be found already in 
adolescence, with formation of clefts and tears, particularly in the centre of the disc, 
with substantial loss of notochordal cells and nurturing blood vessels, extensive cell 
death and proliferation of chondrocyte-like cells [178].  Hence, preventive therapies to 
address disc degeneration should take place very early in life. As such, there is a 
growing awareness that a healthier life-style (e.g. muscle-strengthening physical 
activities, un-physiological or excessive loadings avoidance, no smoking, balanced 
nutrition and low body weight) should be the starting point to delay age-accelerated 
disc degeneration [13]. On the other hand, biological approaches to treat IVD 
degeneration are still on its infancy and are mainly focused on counter acting age-
occurring endogenous stressors, such as metabolic malfunctioning, DNA replication 
errors and inflammation. Thus, novel anti-aging strategies to IVD include reducing 
reactive oxygen species (ROS) production [237], minimizing aberrant damage 
response from cells (i.e. targeting intracellular signalling pathways) [290, 291], or 
addressing changes within the ECM or on cells, through protein-, gene- or cell-based 
therapies [27], although the latter have been essentially pursued in the context of disc 
degeneration and not specifically aging [27].  
As a result of various exogenous stimuli, such as mechanical loading, high 
oxygen tension, high glucose stress, and proinflammatory cytokines, excessive 
mitochondria-derived ROS production has been reported in degenerative discs [292], 
as well as in an accelerated aging mice model [293], disturbing the redox homeostasis 
in IVD microenvironment. ROS are responsible for the activation of important signalling 
molecules on disc cells, which are involved in matrix metabolism, inflammation and 
autophagy (e.g ERK, JNK, p38, p65, p53, Akt, Nrf2, ATM, and Chk2) [292, 294-297]. 
Thus, various antioxidants, such as N-acetylcysteine (NAC), resveratrol, ROS 
scavengers, herbal components and growth factors, are under investigation, and were 
already proven effective on preventing the deleterious effects of ROS on human disc 
cells in vitro [237]. Indeed, although their effect on relieving IDD-associated LBP or on 
retarding the establishment and progression of IDD remains unknown, antioxidants 
hold great potential as anti-aging therapeutics. 
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Aging is per-se one of the major risk factors for IDD, implying a time-dependent 
accumulation of cell replication and replicative senescence. In young organisms, 
cellular senescence prevents the proliferation of damaged cells, thus protecting from 
other age-associated diseases as cancer and contributing to tissue homeostasis. In 
old organisms, the gradual systemic damage and the deficient clearance of senescent 
cells result in their accumulation, and this has a number of deleterious effects on tissue 
homeostasis, ultimately contributing to aging. Bearing in mind that senescent cells are 
also producers of ROS, along with catabolic cytokines and degrading enzymes, their 
presence is not desirable. Studies have shown that when the gel-like NP undergoes 
fibrosis, cells proliferate in an attempt to produce new ECM and re-establishing the 
hypertonic microenvironment. However, cells fail to self-repair the damaged tissue and 
replicative senescence is promoted, resulting in accumulation of senescent cell 
clusters [239, 298-300]. Hence, restoring the hydrated aggrecan-rich healthy NP 
matrix, as well as applying overall anti-senescence therapies (e.g. telomerase 
transduction, supply of growth factors and blocking cell cycle inhibitors) may delay 
aging effects on disc cells. 
Research into the specific roles of intracellular signalling pathways in the disc 
has risen sharply in recent years. However, while many different pathways where 
found to be involved in disease progression, only the Nf-kB pathway was directly 
associated with disc aging [301]. Effectively, in two studies using a rodent model of 
accelerated aging, NF-kB signalling was suppressed genetically and 
pharmacologically, and the onset of age-related disc proteoglycan loss, as well as 
other degenerative changes, was delayed [290, 291]. Thus, NF-kB may also be a 
promising target to minimize the aberrant damage response, which exacerbates disc 
damage associated with age, even though its implication in many other biological 
processes [302] would certainly complicate the quest.  
At the intercellular level, inflammaging, i.e., an installed proinflammatory 
phenotype, even in the absence of infection [303], is another prominent aging-
associated alteration, in which the NOD-like receptor family pyrin domain containing 3 
(NLRP3) inflammasome, together with other proinflammatory pathways are activated, 
leading to increased production of IL-1b, TNF-a and interferons. In the disc, while IL-
1b is a recognized proinflammatory promoter of degeneration [211], by eliciting ECM 
degradation and inducing angiogenesis and neo-innervation, the molecular 
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mechanisms associated with its maturation and release remain unclear. Recently, the 
expression level of the NLRP3 inflammasome was shown to be markedly increased in 
the NP of human degenerate IVDs when compared to non-degenerate ones [304]. 
Furthermore, correlation studies from this report suggest that excessive activation of 
this molecule results in overproduction of downstream IL-1b [304]. One hypothesis 
behind this inflammatory response relies on the presence of crystals and ECM 
breakdown products [305]. Crystal deposits of calcium pyrophosphate dihydrate 
(CPPD), cuboid microstructures (characterized as magnesium whitlockite) and 
hydroxyapatite (HA) have been observed in degenerated IVD specimens [287, 306-
308]. In articular cartilage, regions with crystals showed altered amounts of collagen, 
calcium-binding proteins, decorin and large proteoglycan content, as well as abnormal 
pericellular matrix deposition [309, 310]. Phagocytosis of crystals present in joints and 
pericellular tissues can prompt the activation of the NLRP3 inflammasome [311]. This 
cytoplasmic multimolecular protein complex regulates activity of caspase-1 and 
maturation and release of IL-1b [305, 312]. Most recently, another hypothesis points 
the accumulation of advanced glycation end-products (AGEs) within the NP as a 
possible initiator of inflammation-related degeneration, also via NLRP3 activation 
[313]. AGEs are formed by non-enzymatic glycation of macromolecules and 
accumulate in long-lived proteins during aging and degeneration.  These have been 
previously identified throughout the disc and are more abundant with increasing age 
[314-316], eliciting oxidative stress and contributing to stiffness, brittleness and 
biomechanical alterations in collagen-rich tissues [317].  
 
Overall, these findings highlight novel and exciting potential therapeutic targets 
for the prevention of premature age-related disc degeneration, while also proving the 
prompt need for a better understanding on IVD cells phenotypic signature in 
homeostasis, degeneration and aging. Importantly, methodological standardization in 
in field of research is also lacking, particularly regarding IVD primary cells isolation and 
manipulation.  
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AIMS OF THE THESIS 
 
Regenerative medicine-based approaches to degenerated IVD are increasing, 
although with a profound lacuna on the scientific knowledge addressing basic cellular 
and molecular-related phenomena. While the main treatments targeting disc-related 
back pain are interventive in nature, seeking to guarantee symptomatic relief, 
preventive therapies could revolutionize this field of medicine. IVD degeneration is a 
gradual and long-lasting process of successive biomolecular and functional failures, 
starting earlier in life than in other organs, due to the exclusive and harsh 
microenvironment the native cells need to endure, and to their high susceptibility to 
exogenous stressors. Strategies aiming to restore IVD homeostasis, particularly 
addressing early age-correlated degenerative changes, could be more successful in 
combating IDD and contribute to an overall decrease in the estimated years lived with 
disability by the global population.  
The aim of this PhD thesis is to better characterize the phenotypic signature of 
the endemic cell populations of the IVD, more specifically the ones found within the 
Nucleus Pulposus, and shed light on the cellular changes that occur with aging. 
Therefore, the main objectives of the thesis are organized as follows: 
 
1 Improvement of nucleus pulposus primary cells isolation and dissection 
of their main phenotypic characteristics in homeostasis. 
 
In order to achieve this objective, bovine coccygeal discs were chosen as a 
model, and cells from the NP were harvested following three distinct protocols. This 
allowed to establish an improved method for bovine NP (bNP) cell isolation, whose 
procedure is still not consensual among the literature, and the subsequent thorough 
characterization of the cell (sub)populations that exist in the young NP. The results, 
which contribute to a better understanding of NP cell biology and its potential 
endogenous regenerative capacity, are presented in Chapter II, and demonstrate 
that collagenase-type-XI is an efficient enzyme to digest bNP, while highlighting the 
discovery of three phenotypically distinct subpopulations of cells within the bNP. 
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2 Study of aging effects on primary bovine NP cells phenotypic and 
genotypic signature. 
 
Following the rational of previous work, primary cells from bovine coccygeal 
discs were further characterized, this time comparing cells from young (12 months 
old) and old (10-16 years old) animals, in order to uncover age-related alterations 
that occur on cells surface receptors expression, subpopulations signature, cells 
morphology and gene expression. Results from this study are gathered in Chapter 
III, revealing significant changes between the different age groups at both protein 
and gene levels. Importantly, we prove that the bovine animal model is a valuable 
tool to explore age-induced modifications on NP cell and to identify potential anti-
aging targets, towards the prevention of IVD degeneration. 
 
3 Dissection of age-correlated phenotypic alteration in cells isolated from 
human degenerated intervertebral discs with contained hernias. 
 
This part of the work was conducted in collaboration with a team of 
neurosurgeons from Hospital de S. João, Porto, who gave us access to human IVD 
tissue from patients undergoing microdiscectomy. This task was performed taking 
advantage of a multiparameter image analysis tool (Imaging flow cytometry), which 
guaranteed robust quantitation of morphological features. Hence, parameters such 
as IVD cells size, prevalence of clusters and pericellular matrix (PCM) area were 
correlated with age, while changes in expression of known stem cell-related and 
NP-progenitor markers were also monitored. These findings are presented in 
Chapter IV and highlight the remarkable morphological alterations that occur on 
primary human IVD cells with aging and degeneration, while reinforcing previous 
reports on the gradual disappearance of an endogenous progenitor cell population. 
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Abstract 
 
Strategies to promote intervertebral disc (IVD) regeneration have been hindered 
by the lack of knowledge of IVD fundamental cellular/molecular components. One of 
the key points to address is the characterization of nucleus pulposus (NP) cell 
population(s). This study establishes an improved method for bovine NP (bNP) cells 
isolation, whose procedure is still not consensual amongst the literature, allowing a 
thorough characterization of cell (sub)populations that exist in the young NP. bNP was 
digested with distinct enzymes (collagenase-type-I, collagenase-type-II and 
collagenase-type-XI) at different concentrations (0.5, 1.0 and 2.0 mg/ml), for 4 and 19 
h. Cell yield, viability/apoptosis and morphology were analysed by flow cytometry and 
imaging flow cytometry. Identification of cell subpopulations within NP and its 
phenotype was investigated by assessing expression of CD29, CD44, CD45, CD34, 
CD146 and Brachyury. It was found that bNP cells present similar morphology 
independently of the digestive enzyme used. However, cell yield was greatly improved 
by Coll-XI (2 mg/ml) treatment for a short digestion period. Interestingly, three 
subpopulations, with different sizes and auto-fluorescence, were consistently identified 
by flow cytometry. And crucially, differential expression of cell markers was found 
among these subpopulations. This study demonstrated that collagenase-type-XI is an 
efficient enzyme to digest bNP. And most importantly, three phenotypically distinct 
subpopulations of cells where identified within the bovine NP. Such knowledge is key 
for a better understanding of NP cell biology and its potential endogenous regenerative 
capacity.  
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Introduction  
 
The intervertebral disc (IVD) is a complex and bioactive structure within the 
spine. Continuous multidirectional mechanical forces allied to aging activate 
degenerative pathways in the IVD, which are responsible for many disabling back 
diseases, and ultimately imply a heavy socio-economic impact.  
Current treatments include rest, anti-inflammatory medication, physical therapy, 
and, as a last resort, spinal fusion, total disc replacement or discectomy. These 
treatments focus on symptomatic management and do not address the underlying 
pathophysiology of the diseased tissue, resulting in long-term suboptimal outcomes. 
Alternative strategies, such as cell-based therapies, growth factor injection, gene 
therapy, and tissue engineering (TE), aiming to stop or reduce degeneration of the 
IVD, or to promote its regeneration, are being pursued [1, 2]. Recently, our group has 
shown that delivery of a chemoattractor in the IVD can recruit mesenchymal stem cells 
towards the NP, which opened new perspectives for IVD regenerative strategies [3]. 
However, success of current strategies has been hindered by the lack of knowledge 
on the cellular and molecular components of the IVD. 
Cells in the adult IVD are usually divided in two populations, according to the 
different embryonic origin of the tissue where they reside: 1) the fibroblast-like cells in 
the annulus fibrosus (AF), which develop from the somites (sclerotome), and 2) the 
chondrocyte-like cells in the nucleus pulposus (NP), which derive from the notochord 
(both mesenchyme-derived tissues) [4]. NP cells share typical markers of extracellular 
matrix (ECM) with AF cells or articular cartilage (AC) cells, such as type-II-collagen, 
aggrecan and versican [5]. Expression of specific NP markers has been also described 
but is species-dependent. For instance, bovine NP (bNP) cells express synaptosomal-
associated protein, 25 kDa (SNAP25), tenomodulin (TNMD), cytokeratin-8 (CK8) [5, 
6], while human NP cells express carbonic anhydrase-12 (CA12), paired box 1 (PAX-
1), haemoglobin b–chain (HBB) and ovostatin 2 (OVOS2). Rat NP cells exclusively 
express CD24, while rabbit NP cells express type V collagen, matrix Gla protein (MGP) 
and Htra serine peptidase 1 (Htra1). Most recently, a selection of markers has been 
proposed to define the phenotype of NP cells [7]. 
Cells isolated from degenerated and non-degenerated human discs can 
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differentiate into adipogenic, osteogenic and chondrogenic lineages, indicating that the 
IVD may include progenitor cells within its population [8-14]. Also, expression of 
markers associated with progenitors (e.g. Tie2, GD2, Stro-1, Oct3/4, CD105, CD90 
and Notch-1) suggests that precursor cell populations might be present within 
degenerated human discs [8, 9]. These findings indicate that degenerated human discs 
may count on an endogenous regenerative capacity, although the exact nature and 
origin of the participating cells remains unknown. 
Bovine IVDs have been proposed as a suitable model to study Tissue 
Engineering and biological repair of human IVD [15], and many studies have been 
published culturing bovine IVD cells as a model [3, 5, 6, 16-18]. However, the 
nonexistence of a definitive cell marker or clear phenotypic assays to distinguish NP 
cells from other cell types, the lack of standardization of NP cell isolation methods, 
together with differences in NP markers expression among distinct species, raises 
questions concerning the proper identification of cell types in IVD, establishment of in 
vitro cell cultures from these cells, and comparison of results obtained from different 
labs. A more standardized characterization of cell populations within IVD, and 
particularly in NP, is crucial when studying biological phenomena that might contribute 
to both IVD degeneration and its potential regenerative capacity.  
Hence, in this study a bovine model was used to evaluate different isolation 
methods of NP cells. A new isolation method was explored, guarantying high cell yield 
and viability. Moreover, bNP cells morphology and phenotypic expression was 
thoroughly characterized immediately after isolation by image analysis and flow 
cytometry.  
 
Materials and Methods  
 
Bovine nucleus pulposus cells isolation 
Caudal intervertebral discs from 10 to 13-month-old bovine steers were 
dissected until 3h hours after death. NP was harvested from 7-8 IVDs. With a scalpel 
blade, NP was separated from AF and vertebral endplates and finely chopped. Tissue 
digestion was performed in Dulbeccos’s modified Eagle’s medium (DMEM, 21885 
Gibco), supplemented with 5% v/v Penicillin Streptomycin (PAA), 10% v/v 
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Amphotericin B. (PAA), 2.5% (v/v) of HEPES Buffer 1 mM (Lonza), 1.5% (v/v) of NaCl 
5M and KCl 0.4M solution (to adjust osmolarity to 400 mOsm), 1.3 U/mL DNAse, as 
described elsewhere [19], and one of three different enzymatic formulations: 
collagenase-type-I (Coll-I), collagenase-type-II (Coll-II) or collagenase-type-XI (Coll-
XI) (C0130, C6885 and C7657, respectively, Sigma Aldrich), at different 
concentrations (0.5, 1.0 and 2.0 mg/mL). All enzymatic preparations contain a mixture 
of the type I and II forms of the purified collagenase enzyme, which differ in their affinity 
for different substrates, as assessed by the manufacturer (see 
http://www.sigmaaldrich.com/life-science/metabolomics/enzyme-explorer/learning-
center/collagenase-guide.html).  
Tissue/medium ratio was set at 10% w/v to prevent the pH dropping below 6.8 
during incubation. Tissue was digested for 4 h (minimum time required to totally digest 
tissue from at least one of the protocols used) or 19 h (overnight digestion – tissue 
totally digested in all protocols), in a humidiﬁed atmosphere at 37°C/5% CO2, and 
under gentle stirring. ECM contaminants were filtered with a 70 μm cell strainer. 
 
Assessing bNP cell yield, viability and apoptosis 
Immediately upon digestion, cell yield was quantified by trypan blue exclusion 
and subsequently normalized by wet tissue weight. Cell viability and apoptosis were 
assessed by flow cytometry (FACS Calibur, BD Immunocytometry Systems), using 
FITC-Annexin V Apoptosis Detection Kit I (556547, eBioscience), according to 
manufacturer’s instructions. 
 
Characterization of bNP cell morphology by Imaging Flow Cytometry (IFC)  
To examine the morphological features of freshly isolated NP cells, cells were 
fixed in 4% w/v paraformaldehyde (PFA) at room temperature (RT) for 15 min., washed 
with PBS, and then permeabilized with 0.2% v/v Triton, for 5 min.  After washing again 
with PBS, cells were incubated for 20 min at RT, with Phalloidin-AlexaFluor®488 (1:40 
Dil. per 2.0x105 cells, A12379, Life Technologies), previously prepared in a PBS-1% 
w/v bovine serum albumin (BSA) solution, according to manufacturer’s instructions.  
Shortly prior to acquisition, cells were labeled with DRAQ5 (1:1500 Dil. per 2.0x105 
cells, 65-0880, eBioscience), and run on ImageStreamX (IS, Millipore), and analysed 
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with IDEAS software for cell area, diameter, nuclear/cytoplasm ratio, and presence of 
vesicles. To quantify the percentage of cells with bright vesicles and the nuclear to 
cytoplasmic ratio, specific masks were developed and applied to brightfield and 
fluorescence images:  
- Morphology (M01, Bightfield) - mask applied to calculate cell area based on 
brightfield; 
- Morphology (M02, Actin) - to calculate cell area based on actin staining; 
- Erode (M05, 5) - to calculate nucleus area; 
- Spot (M01, Brightfield, Bright, 34, 1) - mask designed to mark bright vesicles 
within cells. 
 
Characterization of bNP cells phenotype 
Cell surface staining. The expression of surface markers (see Table 2.1) was 
analysed by flow cytometry immediately upon cells isolation, without fixation, to 
guaranty dead cells exclusion with PI staining. Firstly, cells were left to recover from 
digestion for 30 min in a humidiﬁed atmosphere at 37°C/5% CO2. Cells were then 
washed with PBS-2% Fetal bovine Serum (FBS) and incubated with primary antibodies 
(Table 1), in the same solution, for 1h at RT. In the case of non-conjugated anti-CD34 
antibody, cells were additionally incubated with a secondary goat anti-mouse-
AlexaFluor488 antibody, in the same conditions. After labeling, cells were washed with 
2mL PBS-2% FBS and run in FACSCalibur. Results were analysed with FlowJo 
software, Version 8.7.  
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Table 2.1: Antibodies used in flow cytometry analysis. 
Antibodies Fluorochrome µg/mL Clone Catalog #, Manufacturer 
Primary antibodies     
Mouse anti-bovine CD29 AlexaFluor®488  TS2/16 303015, Biolegend 
Mouse anti-bovine CD44 FITC 10 IL-A118 MCA2433F, AbD Serotec 
Mouse anti-bovine CD45 FITC 10 CC1 MCA832F, AbD Serotec 
Mouse anti-human CD146 AlexaFluor®647 5 OJ79c MCA2141A647T, AbD Serotec 
Mouse anti-bovine CD34  - 24  Isotype N21, kindly provided by Sakurai M [20] 
Mouse anti-human 
Brachyury FITC 20 3E4.2 FCMAB302F, Millipore 
Secondary antibody     
Goat Anti-Mouse IgG  AlexaFluor®488 20  A-11017, Life TechnologiesTM  
Isotype controls     
Mouse IgG1 k  AlexaFluor®488 10 MOPC-21 400132, Biolegend 
Mouse IgG1 control FITC 10 PPV-06 21275513, Immunotools 
Mouse IgG1  AlexaFluor®647 5  sc-24636, Santa Cruz Biotechnology 
Mouse IgG1 k Purified  20 P3.6.2.8.1 14-4714, eBioscience 
 
Intracellular staining. To quantify brachyury intracellular expression, cells 
were fixed in 4% w/v PFA at RT for 15 min, and permeabilized with 0.2% v/v Triton for 
5 min. Cells were then incubated with FITC-conjugate anti-Brachyury antibody, for 1h 
at 4°C, after which they were washed with PBS-2% FBS and analysed by IFC. 
 
Cell senescence analysis by flow cytometry. The senescence of bNP cells 
was analysed by the detection of beta-galactosidase activity by flow cytometry, as 
described by Debacq-Chainiaux et al. [21]. Briefly, bNP cells were treated with 
Bafilomycin A1 (100 nM) for 1h in fresh culture medium at 37ºC, 5% CO2, to induce 
lysossomal alkalinization. Then, the substrate dodecanoylaminofluoresceindi-β-D-
galactopyranoside (C12FDG, 33 µM) was added to the cell suspension and incubated 
during 1-2h. This substrate, when hydrolyzed by beta-gal, becomes fluorescent. After 
incubation, the cells were washed in ice-cold PBS, stained with Propidium Iodide and 
analysed by flow cytometry in a FACSCalibur. C12FDG was detected on the FL1 
channel. Negative controls of bNP cells incubated only with Bafilomycin A1 or with 
C12FDG were also performed. The data collected was analysed in FlowJo vs 8.7 
software. 
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Statistical Analysis 
Statistical analysis was performed using GraphPad Prism version 6.0a for Mac 
OS X. D’Agostino and Pearson omnibus normality test was used to assess Gaussian 
distribution of data. Results that did not follow a normal distribution (cell yield, viability, 
apoptosis, cell subpopulations sizes (P1, P2 and P3), and markers expression) were 
analysed for statistical differences using non-parametric Kruskal-Wallis and Dunn’s 
multiple comparison tests. In the case of cell morphology data, which followed a 
Gaussian distribution, groups were compared using a two-way ANOVA (Bonferroni’s 
multiple comparisons test). In all cases, a confidence level of at least 95% (*, p < 0.05) 
was considered. 
 
Results 
 
Isolation of bovine nucleus pulposus (bNP) cells  
In order to characterize bNP cells, the cells isolation procedure was firstly 
optimized. For that, three different commercially available collagenase formulations 
were tested: 1) Coll-I, the formulation most used in the literature; 2) Coll-II, a mixture 
with augmented activity of type-II-collagenase; and 3) Coll-XI, with augmented activity 
of both type I and II collagenases. The effect of enzyme concentration (0.5, 1 and 2 
mg/ml) and tissue digestion time (4 h and overnight) on cell yield, viability and 
apoptosis were addressed (Figure 2.1).  
For shorter digestion periods (4 h), cell yield increased in a concentration-
dependent manner with digestion by Coll-XI. In particular, the median cell yield 
obtained with Coll-XI digestion (2.0 mg/ml) ((1.2±0.5) x 106 cells/mg of wet tissue) was 
significantly higher (*, p<0.05) than with Coll-I ((6.3±5.8) x 105 cells/mg of wet tissue) 
or Coll-II ((5.9±3.1) x 105 cells/mg of wet tissue) (Figure 1a, left). With a longer period 
of digestion (overnight) no significant differences could be found between the protocols 
tested, with a high variability being observed (Figure 1a, right). However, lower cell 
yields were observed at higher enzyme concentrations (except for Coll-I). In particular, 
overnight digestion with Coll-II at 2.0 mg/mL resulted in a drop in cell yield to 0.2± 1.6) 
x 105 cells/mg wet tissue.  
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In terms of cell viability, there was also an increase (79-85%) when using Coll-
XI, for shorter incubation periods, and independently of enzyme concentration. Cell 
viability after 4 h digestion with different collagenases ranged from: i) 72±15 to 81±13 
% for Coll-I; ii) 63±33 to 81±19 % for Coll-II; and iii) 79±22 to 85±16 % for Coll-XI 
(Figure 1b, right). With prolonged digestion time, cell viability showed a decrease, with 
exception of protocols using Coll-I, with viability around 80% (Figure 1b, right). Finally, 
the median percentage of apoptotic cells stood majorly below 5%, with no obvious 
differences between formulations (Figure 1c).  
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Figure 2.1: Effect of collagenase (Coll) type, enzyme concentration and digestion time on bovine 
nucleus pulposus (bNP) cell isolation. Coll-I (white bars), Coll-II (light grey) and Coll-XI (dark grey) 
were used at 0.5, 1 or 2 mg/ml to dissociate NP tissue for 4 h or overnight. Cell yield (cells/g of wet 
tissue) (A), cell viability (% of live cells determined by flow cytometry analysis of propidium iodide stained 
cells) (B), and cell apoptosis (C) in the different conditions were determined. Results are presented as 
A 
B 
C 
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box plot and whiskers (Min to Max) with horizontal line at median (n=4-8). Results were analysed for 
statistical differences using non-parametric Kruskal-Wallis and Dunn’s multiple comparison tests. (* p < 
0.05, ** 0.001 < p < 0.01 and *** p < 0.001). 
 
Morphological analysis of bNP cells 
In order to characterize bNP cell morphology immediately upon isolation, freshly 
isolated bNP cells were analysed by IFC, using masks for brightfield images of cells 
and for fluorescence images of the cytoskeleton and nuclei (Figure 2.2). 
Cells area was first quantified based on both brightfield and fluorescence 
images of cells cytoskeleton (Figure 2.2 B). Quantification on the cytoskeleton staining 
revealed that bNP cells present an area ranging from 130±17 μm2 to 138±34 μm2, 
independently of the method of tissue digestion. These values were significantly 
different from the area calculated based on brightfield images, which suggests the 
presence of a structure surrounding the cell cytoskeleton in most of the cells. In the 
case of cells dissociated with Coll-XI, the cell area almost doubled (130±17 μm2 to 
235±38 μm2, for cytoskeleton and brighfield areas, respectively). The presence of a 
pericellular matrix surrounding the cells was confirmed by staining against type VI 
collagen (Supplementary Figure 2.1). Thus, cell diameter was analysed based only in 
images of actin staining (Figure 2.2 C). It was observed that bNP cells have a diameter 
of approximately 17.3±1.3 μm, not varying with tissue digestion method. 
The nuclear to cytoplasmic ratio (N/C, nucleus area/cytoplasm area) of bNP 
cells, a feature that has been previously linked to the presence of progenitor cells [22], 
was quantified from the nuclei and actin staining (Figure 2a, second column). The N/C 
ratio of bNP cells isolated with Coll-I, Coll-II and Coll-XI (2.0 mg/mL, 4 h digestion) 
ranged from 0.5±0.1 (Coll-II) to 0.6±0.1 (Coll-I and Coll-XI), respectively (Figure 2d up), 
with no significant differences found between the isolation methods. Thus, the area 
occupied by the nucleus is about half the cytoplasmic area. Moreover, the distribution 
of N/C ratio was very narrow within bNP cells (Figure 2.2 D bottom). 
In addition, image analysis of bNP cells revealed the presence of putative 
vesicles within the cytoplasm of these cells (Figure 2.2 E top). The percentage of bNP 
cells containing vesicles was quantified by using a mask specifically designed to trace 
bright spots in brightfield images (Figure 2.2 E bottom). The results obtained showed 
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that around 50-60% of NP cells presented one or more cytoplasmic bright vesicles 
(0.5-1.5 μm diameter), independently of the digestion protocol used. 
 
Figure 2.2: Morphological analysis of bNP cells. A | Images of bNP cells obtained by Imaging Flow 
Cytometry (first column: brightfield images of cells; second column: merged fluorescence images of 
cells stained with phalloidin-FITC (actin, green) and DRAQ5 (nuclei, red); B | bNP cells area based on 
brightfield (white bars) and actin staining (black bars) images of tissue digested with different 
collagenases: Coll-I, Coll-II and Coll-XI (2.0 mg/mL, 4 h digestion; C | bNP cell diameter based on actin 
staining for tissue digested with the three collagenases; D | nuclear to cytoplasmic (N/C) ratio of bNP 
cells isolated with the three different methods (top), and  representative histogram of N/C ratio 
distribution of bNP cells isolated with Coll-I, 2.0 mg/mL for 4 h (bottom); E | Percentage of cells 
containing one or more vesicles after isolation with the different collagenases - a light blue mask 
specifically designed to mark and quantify bright vesicles within cells is shown in the bottom brightfield 
images of cells. Results are presented as Mean±StDev of 3 independent experiments, where a total of 
3661 cells for Coll-I, 993 cells for Coll-II and 5385 cells for Coll-XI were analysed. In the case of cell 
area analysis, groups were compared using a two-way ANOVA (Bonferroni’s multiple comparisons test). 
** 0.001 < p < 0.01 and *** p < 0.001. 
 
Characterization of bNP cells by flow cytometry 
bNP cells freshly isolated with the different collagenases (Coll-I, Coll-II and Coll-
XI) were analysed by flow cytometry (Figure 2.3). Discarding PI-positive cells (dead 
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cells), three subpopulations (P1, P2, P3) of live cells could be consistently identified, 
based on their size (FSC-H) and auto-fluorescence (in FL3 channel), evidencing a 
heterogeneous cell population within bovine NP tissue. The presence of nuclei in these 
bNP cells was confirmed by DRAQ5 expression (Figure 2.3 C).  
The subpopulations were distinguishable by: i) small cells with high auto-
fluorescence (P1); ii) large cells with high auto-fluorescence (P2); and iii) median sized 
cells with low auto-fluorescence (P3) (Figure 2.3 A). The frequency of each 
subpopulation obtained with the different isolation methods was assessed (Figure 2.3 
B). P2 is the most abundant subpopulation within bNP cells, with frequencies of 45-
62% (Coll-I), 48-65% (Coll-II) and 66-68% (Coll-XI). The P1 subset is less frequent: 
32-47% (Coll-I), 29-50% (Coll-II) and 25-28% (Coll-XI). Lastly, P3 is the least frequent 
subpopulation (<10%): 4-8% (Coll-I), 3-6% (Coll-II) and 5-8% (Coll-XI). Different 
concentrations of Coll-XI lead to the same distribution of the three populations. The 3 
subpopulations were also identified in old bovine animals (>10 years) but with different 
ratio: lower P3 and higher P1 percentages were observed (Supplementary Figure 2.2). 
Based on the higher cell yield obtained and consistency on the subpopulations 
observed, subsequent assays were performed with cells obtained by 4 h digestion with 
Coll-XI at 2.0 mg/mL. 
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Figure 2.3:  Identification of subpopulations of bNP cells, based on size and auto-fluorescence, 
by flow cytometry. A | Contour plots of freshly isolated bNP cells: PI expression versus forward scatter-
height (FSC-H) (left) and side scatter-height (SSC-H) versus FSC-H (right). Three subpopulations of 
live cells (P1, P2, and P3) could be consistently identified, with distinct size and auto-fluorescence. B 
| Percentages of cells in P1, P2, and P3 subpopulations after NP digestion with Coll-I, Coll-II, and Coll-
XI (0.5, 1.0, and 2.0 mg/mL, 4 h digestion). Results are presented as mean –  SD (n = 4–8), and 
analysed for statistical differences using non-parametric Kruskal–Wallis and Dunn’s multiple-
comparison tests. *p < 0.05 and **0.001 < p < 0.01; C| PI and DRAQ5 staining of bNP cells on isolation. 
Around 80% of all events are DRAQ5 positive (n=5). Colour images available online at 
www.liebertpub.com/tea 
 
Senescence analysis of bNP cells by flow cytometry 
The senescence of bNP cells was analysed by beta-galactosidade activity and 
its distribution within P1, P2 and P3 sub-populations was assessed (Figure 2.4). The 
data collected showed that the bulk bNP cell senescence ranges from 13 to 71 %. 
When analysing in more detail, no senescent cells could be observed within sub 
population P1, while P2 and P3 present 60±7 % and 56±48 % of cell senescence, 
A 
 
B 
C 
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respectively. When cell senescence (C12FDG+) vs viable cells (PI-) is analysed, it is 
clear the existence of 2 populations with senescent cells but with distinct levels of auto-
fluorescence (Figure 2.4, first line).   
 
Figure 2.4: Senescence analysis of bNP cells. Freshly isolated bNP cells were incubated with 
C12FDG, a fluorescent substrate for beta-galactosidase. A | The fluorescence intensity of C12FDG 
cell in whole population of bNP cells is represented in the first line for a representative donor. The second 
line illustrates the intensity of C12FDG cells for subpopulations P1, P2 and P3. C12FDG was assessed 
in FL1 channel. The cells were also stained with Propidium Iodide (FL3 channel), to exclude dead cells. 
B | Quantification of C12FDG expression on bNP cells supopulations, P1, P2 and P3. Results are 
presented as Mean±StDev (n=3 independent donors). 
 
 
 
A 
B 
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Phenotypic characterization of bNP cells by flow cytometry 
To go further on bNP cells characterization, the phenotype of these cells was 
analysed by flow cytometry. A panel of markers for bNP cells was analysed (Table 
2.2). 
Expression of each marker in the whole bNP cell population was quantified 
(Figure 5). Brachyury expression was quantified by IFC, through which it was also 
possible to validate its correct intra-nuclear localization. The majority of bNP cells were 
CD29+ (87.7±4 %) and Brachyury+ (90.8±5 %). Intermediate amounts of cells 
expressing CD44 (18.6±5 %) and CD146 (22.3±8 %) were detected, while only low 
percentages of hematopoietic-lineage markers, CD45 (8.3±4 %) and CD34 (2.3±1 %), 
were identified.  
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A 
 
B 
 
 
Figure 2.5: Phenotypic analysis of freshly isolated bovine nucleus pulposos (bNP) cells, 
obtained after digestion with Coll-XI (2.0 mg/mL, 4 h). A | Flow cytometry contour plots of CD29, 
CD44, CD45, CD146 and CD34 expression of live bNP cells (propidium iodide negative). Gates were 
established according to respective isotype controls (bottom). B | Graph shows the mean percentage of 
live cells expressing each of the markers described, after subtracting the respective isotype control. 
Results are presented as Mean±StDev (n=5-7) and statistical differences were assessed using non-
parametric Kruskal-Wallis and Dunn’s multiple comparison tests, (** 0.001 < p < 0.01 and **** p < 
0.0001). T: Brachyury, transcription factor quantified by imaging flow cytometry. 
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In addition, expression of each marker was analysed in P1, P2 and P3 
subpopulations (Figure 6). The frequency of Brachyury+ cells within the three 
subpopulations was not analysed, since the detection of this transcription factor could 
not be simultaneously performed with PI staining, and almost all bNP cells were 
Brachyury+ (Figure 5). P2, the most frequent subpopulation of bNP cells, was 
characterized by a large number of cells expressing CD29 (98±2%), some cells 
expressing CD44 (16±5%) and only a few expressing CD146 (6±4%), CD45 (7±4%) 
and CD34 (5±8%). P3 (median sized cells with low auto-fluorescence) showed a profile 
similar to P2, with a high percentage of CD29+ cells (85±7%) and lower number of 
CD44+ cells (12±7%). However, no cells expressing CD34, CD45 or CD146 were 
detected in P3. Finally, P1, the subpopulation of smaller cells had a significantly higher 
(**p<0.025) percentage of CD44+ cells (49±2%). A higher percentage of cells 
expressing CD45 (24±13%), CD34 (6±5%) and CD146 (39±17%) was also found 
within this subset. On the other hand, the frequency of CD29+ cells (33±7%) was 
significantly lower (***, p<0.001) from that found in P2 and P3. Observation of the FSC 
vs FL3 plots for the cells positive for each marker, leads to a clearer distinction between 
P2 and P3 (supplementary Figure S3): CD45 and CD146 expression was found in P2 
but not in P3 (even though only a small percentage of cells in P2 expresses these 
molecules).  
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Table 2.2: Findings in the literature and in this study regarding markers selected to characterize bNP cells phenotype. 
Marker Description Species  Method Findings in the literature Findings in this study 
CD29 
(β1-integrin) Cellular adhesion marker. 
Human[13, 23, 
24], Rabbit[25], 
Porcine[24], 
Rat[26] 
IHC, FC 
Protein expressed by NP cells from degenerated human IVDs and 
young AF cells, after monolayer expansion. Also present in rabbit and 
rat IVD and in immature porcine NP and AF. 
Detected in more than 80% of 
bovine NP cells immediately upon 
isolation.  
CD44 
Transmembrane protein. 
Primary hyaluronic acid 
receptor. 
Human[9, 27], 
Rabbit[28-30], 
Rat[26, 31] 
 
FC, IHC, 
RT-PCR 
> 80% expression by human CD24+ NP cells and in cells cultured from 
herniated and degenerated human IVDs, rabbit NP and in the 
developing and adult rat IVD. mRNA detected in rabbit AF-derived stem 
cells.  
 
Detected in nearly 20% of bovine 
NP cells immediately upon 
isolation. One subpopulation (P1) 
with significantly higher percentage 
of CD44+ cells. 
CD45 
Hematopoietic lineage-
restricted surface marker. Human[9, 27] FC 
Not found in CD24+ NP cells nor in  
cells from herniated and degenerated IVDs after culture. 
 
Expressed by only 8% bovine NP 
cells. Subpopulation P1 with higher 
percentage of CD45+ cells. 
Expressed only by cells from P1 
and P2. 
CD146 
(MCAM or 
MUC18) 
Glycoprotein. Marker for 
vascular endothelial cells, 
smooth muscle cells, 
pericytes and mesenchymal 
stem cells. 
Human[9] FC Not found in CD24+ NP cells after culture. 
Expressed by more than 20% of 
bovine NP cells. Expressed only by 
cells from subpopulations P1 and 
P2. 
CD34 
Transmembrane protein. 
Marker for hematopoietic 
progenitors and vascular 
endothelial cells. 
Human [9, 26, 27, 
32-35] IHC, FC 
Detected in blood vessels in degenerated IVDs. Also found in healthy 
AF and in NP obtained by surgery. Not found in CD24+ NP cells, nor in 
cells from herniated and degenerated IVD tissues after culture. 
Expressed by around 2% of bovine 
NP cells.  
Brachyury (T) 
Transcription factor. Marker 
for notochordal cells and NP 
cells 
Human[36, 37], 
Rat[38], 
Mouse[36], 
Bovine[37], 
Dog[39] 
WB, FC, 
IHC, RT-
PCR, 
qPCR 
Expressed in NP from degenerated human IVD. mRNA expression by 
AF and NP cells from normal and degenerated IVDs and in bovine NP 
cells. 15% expression by NP cells from 1m old rats. High expression in 
the developing mouse NP (not found in AF or cartilage endplates). 
Decreased expression with aging and degeneration in 
chondrodystrophic dogs. 
Expressed by more than 90% 
bovine NP cells. 
NP: Nucleus Pulposus; AF: Annulus Fibrosus; IHC: Immunohistochemistry; FC: Flow Cytometry; WB: Western Blot; RT-PCR: Reverse Transcription-Polymerase Chain Reaction; qPCR: quantitative 
Polymerase Chain Reaction
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Figure 2.6: Expression of the cell surface markers CD29, CD44, CD45, CD146 and CD34 within 
P1, P2 and P3 sub-populations, after dead cells exclusion by propidium iodide (PI) staining. 
Results are presented as Mean±StDev (n=4-7) and were analysed for statistical differences using non-
parametric Kruskal-Wallis and Dunn’s multiple comparison tests (** 0.001 < p < 0.01, *** p < 0.001 and 
**** p < 0.0001. A comparative summary of the percentages of cells expressing each surface marker 
for the different subpopulations is presented in the table. 
 
Discussion 
 
Envisaging standardization of NP cell isolation protocols, widely variable within 
the literature [5, 6, 16-18, 40], bNP digestion was compared for different collagenases. 
Until now no commercially available formula was designed to digest NP tissue 
specifically, most likely because it would serve a relatively small, although fast-
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growing, community of researchers in this field. Nevertheless, standardization of NP 
cells isolation method would increase the reliability of results obtained in different labs. 
Herein, the results obtained show that bNP 4 h digestion with Coll-XI (2.0 
mg/mL) originated higher cell yields than with Coll-I or Coll-II. This suggests that for 
short-time periods, it is necessary a simultaneous increase of enzymatic activity 
against both type I and II collagens to better dissociate bNP tissue, although this tissue 
is known to be enriched in type-II-collagen [41]. Besides being faster, treatment with 
Coll-XI did not require any additional step of digestion with other enzymes commonly 
used for NP cell dissociation, such as hyaluronidase [42] or pronase, known to 
negatively affect the expression of surface markers on AC chondrocytes [43]. On the 
other hand, for longer digestion time periods (overnight), Coll-I revealed to be a better 
option than Coll-XI, originating higher cell yields and increased cell viability. 
Surprisingly, Col II digestion at this longer time period caused very high cell death, 
suggesting that with prolonged time of exposure digestion of type-II-collagen is more 
aggressive than type I collagen. In all conditions tested, cell viability was below values 
usually reported (>95%) [40], which may be due to the higher accuracy of the PI-
exclusion method, when compared with the commonly used trypan blue dye exclusion 
assay.  
Morphology of bNP cells after isolation was analysed by IFC, a technique that 
provides high-resolution images of thousands of cells in flow, and analyses a wider 
array of cellular parameters [22], when compared with confocal and electron 
microscopy, traditionally used to characterize IVD cells [44, 45]. bNP cells presented 
a N/C ratio around 0.5 and an area of 120-130 µm2, in agreement with the mean 
surface area of bovine IVD cells previously reported on freshly isolated cells [6].  
Moreover, a structure surrounding bNP cell membrane was detected, resembling a 
pericellular matrix-like structure, frequently described in chondrons in AC [46], and also 
reported in human and rat IVD cells [47, 48]. As expected, this structure stained 
positive for the ECM protein type VI collagen [41]. Interestingly, the presence of bright 
vesicle-like structures (0.5-1.5 μm diameter) was detected in 60% of bNP cells. Other 
authors have already reported the existence of cell vesicles in IVD cells: i) 1-20 μm 
vesicles were described in NP progenitors, i.e. NC, from non-chondrodystrophic 
mongrel dogs [49]; ii) 20 nm-100 μm lipid droplets were described in mature human 
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NP cells’ cytoplasm [50]; and iii)  <1 μm size vesicles were recently described in human 
NP cells [51]. Additionally, it has been suggested that cell communication between NP 
cells can be mediated by these membrane-bound microvesicles [51].  
Three subpopulations of bNP cells (P1, P2, P3) were consistently identified by 
flow cytometry, based on different sizes and auto-fluorescence. NP cells auto-
fluorescence was very recently described and related with cell necrosis and 
subsequent loss of mitochondrial membranes integrity, which could expose 
flavoproteins to oxidation, causing a blue-green shift in cells auto-fluorescence [52]. 
Nevertheless, the auto-fluorescence described herein was exclusive to live cells, i.e. 
PI-negative events. Furthermore, the senescence of each subpopulation of bNP cells 
was analysed by detecting β-galactosidase activity [53]. Results showed that bNP cells 
present a level of senescence around 40%. In the literature β-galactosidase-positive 
cells ranged from 8 to 95%, increasing with patients age and passage number [54]. 
Here, no senescent cells were observed in P1, while both P2 and P3 presented higher 
senescence (approximately 70-80%). Both populations include senescent cells while 
showing different auto-fluorescence levels, thus excluding the possibility that P2 and 
P3 populations are only one subset of cells in a different senescent state. Hence, the 
three subpopulations could instead be at different metabolic states, or at different 
stages of differentiation, as suggested elsewhere [7, 55]. Interestingly, three 
subpopulations of human knee meniscus cells (from a fibrocartilaginous tissue as the 
IVD) have also been described, with similar distribution of auto-fluorescence and size 
[55]. However, in this case P1 (low size) was discarded, while P2 subpopulation was 
distinguishable from P3 by the presence of a cell-associated matrix (CAM) (expressing 
type I and II collagens and aggrecan) [55]. Here, human NP cells obtained from 
patients with degenerated IVDs, but with contained NP, were also analysed 
(Supplementary Figure 2.4). However, there was no distinction of subpopulations, but 
it is unclear if this is due to differences in degenerated versus healthy discs or to 
differences between species.  
Expression of different surface markers was analysed in the 3 populations. 
Table 2 summarizes the main findings reported here and previously published on 
expression of these markers in other animal models. Here, high percentages of cells 
expressing CD29 and Brachyury were detected in bNP cells. CD29 is an anchorage 
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protein involved in cell adhesion and migration, and its expression was particularly 
abundant in P2 and P3 subsets. On the other hand, Brachyury is one of the earliest 
indicators of mesoderm formation during embryonic development. It has been 
suggested as NP marker in IVD [4, 5] and mostly assessed at mRNA level [5]. Tang et 
al. reported much less cells expressing Brachyury (~15%) than what was observed in 
this study (nearly 90%), which may be due to inter-species differences [44]. According 
to this result we could discard AF contamination in the samples analysed. 
In addition, about 20% of bNP cells express CD44, and particularly the P1 
subpopulation. This transmembrane protein is a primary HA receptor that also binds 
to other extracellular proteins, including fibronectin and type I and VI collagens, and 
plays an important role during chondrogenesis [42]. Importantly, although CD44 cell 
surface epitope was reported to be especially sensitive to enzymatic digestion [56], 
herein we assured preservation of CD44 by avoiding hyaluronidase digestion [42]. 
Concerning CD45 and CD34, low expression of these hematopoietic-lineage 
markers was found, and more associated with P1 subset, although tissue 
contamination with blood was not expected. Nevertheless, despite being considered 
an immune privileged site, it is becoming increasingly evident that inflammatory-like 
cells [16, 17, 57] or phagocytic cells [16] might be present in IVD. Although CD34 is 
known as a marker for hematopoietic progenitors [58] and vascular endothelial cells 
[59], its expression has also been reported in other cell types such as skeletal muscle 
satellite cells [60], hair follicle keratinocytes [61], hepatic cells [62] and human 
fibrochondrocytes found within the superficial region of the knee meniscus body [55]. 
Hence, CD34 expression by itself does not elucidate the origin of the small population 
described herein, and future studies will be performed to address this, particularly by 
analysing co-expression with other markers (e.g. CD31 – mature endothelial cells; 
CD38, CD90 – hematopoietic progenitors).  Another study has identified Tie2/Ang-1 
expression, usually associated with angiogenesis, in the avascular hNP 
microenvironment [9]. In fact, although endothelial cells are not expected within the 
NP, some molecules normally expressed by those cells (e.g. Tie2/Ang-1, vascular 
endothelial growth factor-A (VEGF-A) and its receptor, membrane-bound vascular 
endothelial growth factor receptor-1 (mbVEGFR-1)) can also be expressed by NP 
cells, in response to hypoxic conditions [9, 63]. 
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Interestingly, here, a subset of CD146+ cells was found in bNP, particularly in 
P1. CD146 has been suggested as a marker for endothelial cells [64], melanoma cells 
[65], and MSCs [66], but has not been reported in NP cells or cartilage cells before. Its 
expression has been linked to MSCs multipotency and differentiation potential [67]. 
Expression of markers as CD146, together with MSCs non-specific markers, such as 
CD44 or CD73 and absence of blood and endothelial markers has also been linked to 
the existence of vascular pericytes, cells with multipotency and clonal capability [68]. 
Although expression of CD146 has not been found in human IVDs [9], here a subset 
of bNP cells was found to express this marker. 
Overall, the P1 subpopulation appears to be a distinguishable subset of bNP 
cells, enriched in CD146+ and CD44+ cells, while also containing few CD45+ and 
CD34+ cells. Cells within this subset present a more progenitor-like phenotype than 
those found in P2 or P3, which due to their CD29 expression, could represent 
populations with higher migratory capacity. Regarding P2 and P3, senescence does 
not justify the differences in auto-fluorescence, and CD45 and CD146 expression was 
found in P2 but not in P3. Thus, the 3 populations described herein can be identified 
by auto-fluorescence and size or by the combination of markers, but not a single 
marker. 
The data collected with young and old animals suggests morphological changes 
with aging, with a decrease in P3 subset accompanied by an increase in P1. It is widely 
known that age affects NP cells morphology and molecular signature [50]. In particular, 
human/mouse NP progenitor cells identified by Tie2 expression were reported to be 
exhausted with age [9]. However, whether differences in P1/P2/P3 proportion for 
animals with different ages correlate with differences in NP cells phenotype is still being 
addressed. 
In summary, this study presents new evidences on the heterogeneity of young 
NP cells. Future studies will be crucial to understand the contribution of each 
population for NP repair.  
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Supplementary materials and methods 
 
Collagen type VI staining 
Freshly isolated NP cells were permeabilized by incubating for 5 min with PBS/0.2% 
v/v Triton and blocked by incubating with PBS/BSA 3% for another 5 min on ice. Cells 
were then stained by incubating with an anti-collagen VI antibody (Santa Cruz, sc-
20649) at 10 µg/ml in PBS/BSA 3% for 1.5 h on ice. Cells were then washed three 
times with PBS and incubated with the secondary antibody Cy3 conjugated anti-rabbit 
IgG (Jackson Immunoresearch) at 1:500 in PBS/BSA 3% for 1h on ice. Cells were 
again washed twice with PBS and fixed by incubating for 15 min at room temperature 
with 4% paraformaldehyde. Finally, cells were washed twice with PBS prior to imaging. 
For imaging flow cytometry, cells were filtered through a 100µm mesh prior to analysis 
on an ImageStreamx equipped with a 488nm laser, as described in the main text. Cells 
were visualized in Channels 1 (brightfield) and 3 (Fluorescence staining). For confocal 
imaging, 4 µl of cell suspension were placed between a slide and a cover slip. Cells 
were then imaged with a 40x oil objective with a Leica TCS SP5 II laser scanning 
confocal microscope (Leica Microsystems). 
 
Isolation of human NP cells 
Human NP biopsies were isolated from lumbar IVDs in microdiscectomy surgeries of 
patients with IVD pathology (that may include disc herniation, degenerative disc 
disease, spinal stenosis or spondylolisthesis) at Centro Hospitalar S. João under 
approval of the Hospital Ethics Committee and after patients informed consent. Lumbar 
IVDs with grade III ou IV according with the Pfirrmann scale were isolated, but only 
contained fragments of NP were used in this study. Human NP fragments were 
digested and processed as described for bovine NP. 
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Supplementary Figure 2.1: Expression of type VI collagen on the pericellular 
matrix of bovine NP cells. Micrographs show brightfield (left) and fluorescence 
images (right) of freshly isolated bovine NP cells stained against collagen type VI and 
imaged by imaging flow cytometry (a) or confocal microscopy (b). A punctuated 
staining can be observed located in and outside the cytoplasm of the cells. 
Fluorescence and brightfield in b show a maximum projection and single slice, 
respectively. Control refers to cells stained only with the secondary antibody. 
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Supplementary Figure 2.2: Comparison of bNP cells size and auto-fluorescence 
analysed by flow cytometry of young and aged animals. A | Representative dot 
plots of Propidium Iodide expression versus size (FSC) of bNP cells from young and 
old animals. B | Distribution of P1, P2 and P3 subpopulations in young and old bovine 
animals. Results are presented as Mean±StDev (n=5 for old animals, n=4-7 for young 
animals) and were analysed for statistical differences using non-parametric Kruskal-
Wallis and Dunn’s multiple comparison tests (** 0.001 < p < 0.01 and **** p < 0.0001). 
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Supplementary Figure 2.3: Representative analysis of the distribution of each analysed marker 
(CD29, CD44, CD45, CD34 and CD146) within the 3 populations (P1, P2 and P3) of bNP cells. 
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Supplementary Figure 2.4: Representative dot plot of Propidium Iodide expression versus size 
(FSC) of human NP cells obtained from biopsies of degenerated IVD with contained NP. 
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Abstract 
 
Aging is one of the major etiological factors driving intervertebral disc 
degeneration. Novel therapies aiming at counteracting age effects will contribute 
to prevent degenerative disc disease progression.  
This work aimed to uncover phenotypic and genotypic alterations that are 
found in old nucleus pulposus cells as compared to young ones. For that purpose, 
and in line with previous work from our group, bovine coccygeal discs from young 
(12 months old) and old (10-16 years old) animals were dissected and primary 
cells enzymatically isolated from the nucleus pulposus. Using conventional and 
imaging flow cytometry cells were assessed for a panel of surface receptors 
(CD29, CD44, CD45, CD146, GD2, Tie2, CD34 and Stro-1), as well as for their 
subpopulations signature, diameter, prevalence of multinucleated events and 
bright vesicles content. Genetic expression of proinflammatory cytokines (IL-6 
and IL-8), matrix degrading enzymes (MMP1 and 3) and ECM-related proteins 
(collagen type-II and aggrecan) was evaluated by quantitative real-time reverse 
transcription–polymerase chain reaction (RT-qPCR). 
 Cells from elder animals revealed lower percentages of CD29+, CD44+, 
CD45+ and Tie2+ events, but higher numbers of GD2+ events, a recognised 
marker for bone marrow mesenchymal stromal (BM-MSC) cells and NP 
progenitor cells, alongside with a steady prevalence of the MSC marker CD146. 
Moreover, the subpopulations signature was altered, cells diameter was 
increased, and the percentage of cell containing bright vesicles was also 
increased. Finally, Coll II and IL-6 were down-regulated with age. 
 Overall, we showed the value of bovine nucleus pulposus as a model to 
study NP cells phenotype in homeostasis and aging. Moreover, novel potential 
anti-aging targets were identified. All in all, the knowledge gather in this study will 
hopefully contribute to a better understanding of the mechanisms behind disc 
degeneration.  
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Introduction 
 
According to the Lancet Global Burden of disease study 2015, low back 
pain (LBP) remains the world’s leading cause of years leaved with disability, in 
both developed and developing countries [1], representing a heavy socio-
economic impact in modern society [2]. Although the aetiology of LPB is still 
unclear [3], several reports suggest the existence of a strong positive correlation 
between degenerative intervertebral disc (IVD) changes, occurring in 
degenerative disc disease (DDD), and LBP [4-6]. Current treatments for DDD 
neither address the underlying pathogenesis nor seek to restore IVD’s function 
or to slow down disease progression. Notwithstanding, novel regenerative 
therapies, born from solid cellular and molecular knowledge of the IVD, are 
actively being sought [7-9]. 
Considered the epicentre of IVD degeneration [10], as well as home for 
progenitor cells [11, 12], the nucleus pulposus (NP) has attracted special 
attention from the scientific community. During the last decade, various 
microarray studies have been conducted in order to better define NP cells 
phenotypic signature, particularly in relation to neighbouring annulus fibrosus 
(AF) or cartilage endplate (CEP) cells, or to articular cartilage (AC) cells [11, 13-
18]. However, the markers reported so far are not exclusive to any of those cell 
types. Indeed, wide-genome analysis alone is not fulfilling the need for specific 
cell markers to aid cell-based therapies on restoring an NP-like phenotype [18, 
19]. Finally, a consensus paper by Risbud et al. has proposed a panel of markers 
to define the phenotype of young NP cells [20], which were chosen based on their 
specific expression in young healthy NP cells, relevance to NP physiology, and 
validation across different species. This work has prompted new 
immunohistochemical studies, seeking further validation of those markers, and 
others even less explored, in larger human cohorts [11, 18, 21]. Interestingly, 
although widely used for cell characterization, flow cytometry (FC) has seldom 
been used to profile IVD cells. Unlike what is routinely done with blood cells [22], 
no gating strategy, specific surface markers or Forward-Scatter/Side-Scatter 
(FCS/SSC) profile has been proposed for these cells yet.  
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The natural aging process represents one of the major etiological factors 
responsible for disc degeneration, which seems to affect this organ in a 
premature manner, when compared to other tissues of the human body [23, 24] 
(Figure 3.1). Many studies using different animal models have investigated 
distinct features of disc aging [25-45]. However, the molecular profile alterations 
of NP cells with age has been poorly monitored and unmatching results are 
consistently found between microarray data (gene level) and that collected from 
immunohistochemistry (IHC) or FC (protein) [11, 13, 16, 21, 46-48]. Hence, future 
research on the phenotypic characterization of IVD cells is warranted, particularly 
regarding the signature of each subpopulation in terms of its ontogeny, 
physiology and function, and also concerning its evolution with age and 
degeneration.  
Thus, the aim of this study was to discriminate the cellular and molecular 
signature changes that occur on old NP cells as opposed to young NP cells from 
bovine coccygeal IVDs (the latter commonly used to study the molecular 
phenotype of IVD cells [15, 49-57], and previously characterized by us [58]), 
namely in terms of expression of mesenchymal-related (CD29, CD44, CD146 
and Stro-1), hematopoietic (CD45 and CD34) and NP-progenitor (GD2 and Tie2) 
markers, morphology, and gene expression profile. 
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Figure 3.1: Aging of the bovine intervertebral disc. Top image shows one young (12 months 
old) (left) and one old (16 years old) (right) bovine IVD. Differences are evident both at 
macroscopic and ultrastructural (bottom scanning electron microscopy (SEM) images) levels. 
White spots seen in SEM images correspond to calcium deposits, which can be seen already in 
young animals. In the elder NP ECM fibers are thicker, the number of pores diminishes, and there 
is an overall disorganized crosslinking/super positioning of fibers. SEM images with permission 
from Caldeira J. 
 
Materials and Methods 
 
Bovine nucleus pulposus (bNP) cells isolation 
Coccygeal IVDs from young (12-month-old) and old (10 to 16 years old) 
bovine steers were dissected until 3h hours after death. NP was harvested from 
7-8 IVDs and cells were isolated according to previously established protocol 
[58]. Briefly, NP tissue was separated from AF and vertebral endplates with a 
scalpel blade, and finely chopped. Tissue digestion was performed in 
Dulbeccos’s modified Eagle’s medium (DMEM, 21885, Gibco), supplemented 
with 5% v/v Penicillin Streptomycin (PAA), 10% v/v Amphotericin B. (PAA), 2.5% 
(v/v) of HEPES Buffer 1 mM (Lonza), 1.5% (v/v) of NaCl 5M and KCl 0.4M 
solution (to adjust osmolarity to 400 mOsm), 1.3 U/mL DNAse, and collagenase-
type-XI (Coll-XI) (C7657, Sigma Aldrich), at 2.0 mg/mL. Tissue/medium ratio was 
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set at 10% w/v to prevent the pH from dropping below 6.8 during incubation. 
Tissue was digested for 4-5 h (until complete digestion) in a humidiﬁed 
atmosphere at 37°C/5% CO2, and under gentle stirring. Finally, ECM 
contaminants were removed with a 70 μm cell strainer, and cells were 
resuspended in 10 mL DMEM supplemented with 5% FBS, 1% v/v Penicillin 
Streptomycin, 0.5 % v/v Amphotericin B, and osmolarity adjusted to 400 mOsm, 
and left to recover overnight in 15 mL falcon tubes with loosely tightened caps 
prior to any further analysis. 
 
Characterization of young and old bNP cells phenotype 
Cell surface staining. The expression of surface markers (Table 3.1) was 
analysed by FC immediately upon cells isolation, without fixation, to guaranty 
dead cells exclusion with PI staining. Firstly, cells were washed with PBS-2% 
Fetal bovine Serum (FBS) and then incubated with primary antibodies (Table 1), 
in the same solution, for 1h at RT. In the case of non-conjugated anti-CD34 and 
anti-GD2 antibodies, cells were additionally incubated in the same conditions with 
a secondary donkey anti-mouse IgG-AlexaFluor647® antibody, and anti-Stro-1 
with a secondary goat anti-mouse IgM-FITC antibody. After labelling, cells were 
washed with 2mL PBS-2% FBS and run in a FACS Canto (BD). Results were 
analysed with FlowJo software, version 8.7, as in [58]. Additionally, besides 
analysing the subpopulations’ signature (by considering each subpopulation as a 
whole, and applying the gates for positive events on each subpopulation 
individually), the relative distribution of positive events along the distinct 
subpopulations was also quantified (by applying the subpopulations gates on all 
positive events for each marker). The two approaches are depicted in 
Supplementary Figure 3.1. 
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Table 3.1: Antibodies used in flow cytometry analysis. 
 
Antibodies 
 
Fluorochrome 
 
µg/mL 
 
Clone 
 
Catalog #, Manufacturer 
Primary antibodies     
Mouse anti-bovine IgG1,k CD29 AlexaFluor®488 5µL/105cells TS2/16 303015, Biolegend 
Mouse anti-bovine IgG1 CD44 FITC 10 IL-A118 MCA2433F, AbD Serotec 
Mouse anti-bovine IgG1 CD45 FITC 10 CC1 MCA832F, AbD Serotec 
Mouse anti-human IgG1 CD146 AlexaFluor®647 5 OJ79c MCA2141A647T, AbD Serotec 
Mouse anti-human IgG1 Tie-2 PE 5µL/105cells 83715 FAB3131P, R&D Systems 
Mouse anti-bovine IgG1 CD34  
- 24  
Isotype N21, Kindly provided by 
Sakurai M [59] 
Mouse anti-human IgG2a GD2 - 20 14.G2a 554272, BD Pharmigen 
Mouse anti-human IgM,l Stro-1 - 20 STRO-1 14-6688-82, eBioscience 
Secondary antibody     
Goat anti-mouse IgM FITC 5  F0118, R&D Systems 
Donkey anti-mouse IgG AlexaFluor®647 4  A31571, Life Technologies 
Isotype controls     
Mouse IgG1, k  AlexaFluor®488 20 MOPC-21 400132, Biolegend 
Mouse IgG1 FITC/R-PE 5µL/105cells  M1FP, Life Technologies 
Mouse IgG1  AlexaFluor®647 5  sc-24636, Santa Cruz Biotech 
Mouse IgG1 k purified - 20 P3.6.2.8.1 14-4714, eBioscience 
Mouse IgG2a,k purified - 20 G155-178 556651, BD Pharmigen 
Mouse IgM purified - 20 PFR-03 21275051, Immunotools 
 
 
Morphology analysis by Imaging Flow Cytometry (IFC). To examine 
the morphological features of freshly isolated young and old bNP cells, cells were 
fixed in 4% w/v paraformaldehyde (PFA) at room temperature (RT) for 15 min. 
and washed with PBS. Shortly prior to acquisition, cells were labelled with 
DRAQ5 (1:1500 Dil. per 2.0x105 cells, 65-0880, eBioscience), and run on 
ImageStreamX (IS, Millipore), and analysed with IDEAS® software for cell 
diameter, prevalence of multinucleated events, mean nuclei number per cell, 
percentage of cells containing bright vesicles, and mean number of bright 
vesicles per cell. Gating of cell was performed according to the following 
sequential steps: 
1. DRAQ5+ events selection: plot Area_M01 against Intensity_MC_Ch5 
2. Gating of focused events within DRAQ5+ events: plot Gradient 
RMS_M01_Ch1 histogram 
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3. Gating of focuced nuclei within DRAQ5+ focused events: plot Gradient 
RMS_M01_Ch5 histogram  
Additionally, specific masks were developed and applied to brightfield and 
fluorescence images, and respective features were created to characterize cells:  
Masks: 
- Nuclei: Watershed (Threshold (M05, Nucleus, 50)) - mask applied to 
clearly identify the nucleus; 
- Bright vesicles: Intensity (M01, Brightfield, 1000-4095) - mask designed to 
mark bright vesicles within cells. 
Features: 
- Nuclei number: Spot Count (Mask Nuclei) – to quantify the prevalence of 
multinucleated events and the mean percentage of nuclei per cell; 
- Vesicles number: Spot Count (Mask Bright vesicles) - to quantify the 
prevalence of cell with bright vesicles and the mean percentage of bright 
vesicles per cell. 
Analysis and statistics templates were generated and applied to all samples using 
Batch Data Files tool. Overlapping of diameter histograms was achieved through 
compensated image files (.cif) merging. 
 
Gene expression analysis of cells from young and old bNPs  
 
RNA isolation and cDNA synthesis. Gene expression levels were 
determined by quantitative real-time reverse transcription–polymerase chain 
reaction (qRT-PCR) as described by Teixeira et al. [60] with slight modifications. 
Briefly, for RNA isolation, NP samples were digested enzymatically, as described 
above, and cell pellets were recovered by centrifugation at 400 g for 10 min. Total 
RNA was then extracted from NP cells using ReliaPrep RNA Cell Miniprep 
System (Promega), according to manufacturer’s instructions. Total RNA was 
quantified using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific). 
Finally, isolated RNA preparations were pre-treated with Turbo DNA-free kit 
(AM1907, Ambion, Invitrogen) to remove contaminating DNA, and posteriorly 1 
µg of RNA from each sample was reverse transcribed into cDNA using 
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SuperScript III Reverse Transcriptase (18080-093, Invitrogen) completed with 
oligodeoxythymidine primers (5 µM), random hexamer primers (50 µM), and 
RNase inhibitor (10 U) in a total volume of 20 µL. The obtained cDNA was diluted 
at a ratio of 1:4 in RNase-free water (AM9938, Ambion, Invitrogen) and used for 
qRT-PCR. 
 
Gene expression analysis by quantitative real-time reverse 
transcription–polymerase chain reaction. Specific primer sets for bovine 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), collagen type-II, 
aggrecan, IL-6 , IL-8 , MMP1, and MMP3 (Table 3.2) were designed using 
published gene sequences (PubMed, NCBI Entrez Nucleotide Database) and 
Primer3 software [61], and purchased from Thermo Fisher Scientific.  Real-time 
quantitative polymerase chain reactions (PCR) were conducted on a iQ5 Real-
Time PCR Detection System (Biorad), and performed according to the 
SYBR Green method, in triplicate, in PCR 96-well TW-MT-Plates (Biozym 
Scientific), under standard conditions. Reaction mixes contained 12.5 mL of 
Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen) master mix, 0.25 mL of 
ROX Reference Dye (Invitrogen), 1 mL (0.4 mM) of forward primer, 1 mL (0.4 
mM) of reverse primer, 8.25 m L of RNase-free water, and 2 mL of cDNA. For the 
analysis of the mRNA expression, cloned amplification products were provided 
and used as standards for qRT-PCR. Statistical analysis was performed on 
DCt values according to a modified method [62].  The average Ct value of each 
triplicate measurement of each sample was normalized to the house-keeping 
gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in each sample 
[DCT = CT (gene of interest) -  CT (GAPDH)].  
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Table 3.2: Bovine primer sets used for qRT-PCR measurements. 
Gene Sequence (forward and reverse primer) 
Product length 
(bp) 
NCBI reference 
sequence 
    
GAPDH 
5’ -ACC CAG AAG ACT GTG GAT GG-3’ 
5’ -CAA CAG ACA CGT TGG GAG TG-3’ 
178 XM_001252511 
Collagen type-II 
5’ -CCT GTA GGA CCT TTG GGT CA-3’ 
5’ -ATA GCG CCG TTG TGT AGG AC-3’ 
145 X02420 
Aggrecan 
5’ -ACA GCG CCT ACC AAG ACA AG-3’ 
5’ -ACG ATG CCT TTT ACC ACG AC-3’ 
155 NM_173981 
IL-6 
5’ -ACC CCA GGC AGA CTA CTT CT-3’ 
5’ -GCA TCC GTC CTT TTC CTC CA-3’ 
183 EU276071 
IL-8 
5’ -ATT CCA CAC CTT TCC ACC CC-3’ 
5’ -ACA ACC TTC TGC ACC CAC TT-3’ 
148 AF232704 
MMP-1 
5’ -ATG CTG TTT TCC AGA AAG GTG G-3’ 
5’ -TCA GGA AAC ACC TTC CAC AGA C-3’ 
193 NM_174112.1 
MMP-3 
5’ -AAT CAG TTC TGG GCC ATC AG-3’ 
5’ -CTC TGA TTC AAC CCC TGG AA-3’ 
237 AF069642 
GAPDH: glyceraldehyde 3-phosphate dehydrogenase; IL: interleukin; MMP: metalloprotease; qRT-PCR:  quantitative 
real-time reverse transcription–polymerase chain reaction 
 
Statistical Analysis 
Statistical analysis was performed using GraphPad Prism version 7.0a for 
Mac OS X. D’Agostino and Pearson omnibus normality test was used to assess 
Gaussian distribution of data. Results that follow a normal distribution (whole 
population’s CD29 and CD44 expression) were analysed for statistical 
differences using parametric one tailed Welch’s t test. Results that did not follow 
a normal distribution were analysed using non-parametric Mann-Whitney one-
tailed t-Test or Kruskal-Wallis and Dunn’s multiple comparison tests. The cell 
subpopulations sizes (P1, P2, P3 or P2+P3, and P4), as well as all markers 
expression within each subpopulation, the average number of nuclei per event 
and the mean percentage of bright vesicles per event were compared using 
ordinary two-way ANOVA and Sidak’s multi comparisons test. In all cases, a 
confidence level of at least 95% (*, p < 0.05) was considered. 
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Results 
 
Surface markers expression 
To assess the effect of aging on bNP cells surface markers signature, a 
panel of 8 markers was selected, 5 of which had already been studied in our 
previous work on young animals [58]. Young bNP cells showed higher 
percentages of CD29+ (78±15% vs 26±18%, ****p<0.0001, n=16 and 17, 
respectively), CD44+ (41±18% vs 22±17%, **p<0.01, n=16), CD45+ (16±13% vs 
2±3%, **** p<0.0001, n=16) and Tie2+ (86±6% vs 0%, **p<0.01, n=7 and 5, 
respectively) than old bNP cells. In contrast, GD2 showed increased percentages 
in elder animals (3±3% vs 9±7%, *p<0.05, n=12 and 10, respectively). 
Additionally, the percentage of CD146+ cells was maintained with aging (12±11% 
vs 14±9%), while that of CD34 (0% vs 1±2%) and Stro-1 (2±2% vs 9±13%) was 
always low, with exception of some older specimens (Figure 3.2 B). 
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Figure 3.2: Immunophenotypic profile of freshly isolated bovine nucleus pulposus (bNP) 
cells from young and old animals. A | Flow cytometry contour plots of CD29, CD44, CD45, 
CD146, GD2, Tie2, CD34 and Stro-1 expression of live bNP cells (propidium iodide negative). 
Gates were established according to respective isotype controls (top right corners). B | Graphs 
show the mean percentage of live cells expressing each of the markers described, after 
subtracting the respective isotype control. Statistical differences between young and old cells 
were assessed using Welch’s parametric t-test for CD29 and CD44 and Mann-Whitney non-
parametric test for the other markers. P value calculations were based on a one-tailed distribution 
of data (*p<0.05, **p<0.01 and ****p<0.0001). CD29: nY=16, nO=17; CD44: nY=16, nO=16; CD45: 
nY,O=16; CD146: ny=13, nO=16; GD2: nY=12, nO=10; Tie2: nY=7, nO=5; CD34: nY=5, nO=9; Stro-1: 
nY=5, nO=12. 
 
After discarding PI positive events (dead cells), different subpopulations of 
live cells could be consistently identified in both young and old bNPs, in this case 
four populations (P1, P2, P3, P4), with different size and auto-fluorescence 
(Figure 3.3 A), similarly to what has been previously published [58]. In young 
animals, P1 had the lowest percentage of events (7±4% events), which were 
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small sized and highly auto-fluorescent; P2 was the larger subpopulation (48±8% 
events), containing medium-sized events with high auto-fluorescence; P3 (9±6% 
events) also contained medium-sized events, but with low auto-fluorescence, and 
finally P4 (35±11% events) contained large events with high auto-fluorescence. 
In old animals, P1 was significantly increased (34±16%, ****p<0.0001), while P3 
and P4 were significantly decreased (P3: 6±9%, *p<0.05; P4: 11±4, 
****p<0.0001) (Figure 3.3 B). 
To verify whether any particular subpopulation could be responsible for 
the overall age-related profile change in bNP cells (Figure 3.2), the relative 
distribution of the positive events for each marker along the four subpopulations 
was quantified (Figure 3.4). In young animals, the majority of positive events for 
the different markers, with exception of GD2, were found within P2 and P4 
subpopulations. However, with increasing age this pattern was altered. Indeed, 
although the percentage of CD29+ and CD44+ events within P2 increased 
(41±15% vs 63±14%, n=11 and n=9; 42±8% vs 67±10%, n=12, respectively, 
***p<0.001), there was a marked decrease within P4 (50±20% vs 27±12%, n=11 
and n=9; 42±11% vs 19±10%, n=12, respectively, ****p<0.0001), most likely 
responsible for the overall decrease in the prevalence of both markers. 
Interestingly, while P4 revealed a significant decrease in CD45+ events with age 
(60±19% vs 30±21%, n=9 and 6, respectively, **p<0.01), again justifying the 
overall change, P1, containing small-sized events, was enriched in this marker 
(11±16% vs 41±22%, n=9 and 6, respectively, **p<0.01). Regarding CD146, 
besides P2 and P3, P1 also contained high percentages of CD146+ events 
(young: 24±11%, n=9; old: 36±11%, n=8). Notably, no particular changes were 
found on GD2+ events distribution with aging, although an overall increase in 
their prevalence was detected in previous analysis. On the other hand, Stro-1 
prevalence was increased in P1, P2 and P4 subpopulations with age (5±0% vs 
39±8%, ****p<0.0001; 34±1% vs 50±9%, *p<0.05 and 60±0% vs 11±5%, 
****p<0.0001, n=2 and 5, respectively) even though no significant alteration was 
previously detected within the whole cell population. Finally, CD34+ events were 
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only found in older animals, and were curiously abundant in P1 region (55±5%, 
n=3). 
 
A
 
B 
 
Figure 3.3: Effects of aging on primary bNP cell subpopulations. A | Representative flow 
cytometry contour plots showing the gating steps applied on cells from young (top) and old 
(bottom) bNPs to quantify the subpopulations size, based on their distinct size and auto-
fluorescence (n=15 and 11, respectively). B | Graph shows the mean (± standard deviation) 
percentage of PI negative events within each subpopulation.
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Figure 3.4: Relative distribution of positive events along the four subpopulations found 
within young and old bNP. Results from young and old animals were statically compared using 
a two-way ANOVA and Sidak’s multicomparison test, while differences between the 
subpopulations were analysed using Kruskal-Wallis and Dunn’s multicomparison tests or ordinary 
one-way ANOVA and Sidak’s multicomparison test in the case of old CD146+ and young GD2+ 
cells. Legend inside the columns indicates the subpopulations in relation to which each 
subpopulation is statistically different, within the same age group. CD29: ny=11, no=9; CD44: 
ny,0=12; CD45: ny=9; CD146: ny=9, no=8; GD2: no=7; Tie2: ny=7; Stro-1: no=5 (*p<0.05; **p<0.01; 
***p<0.001 and ****p<0.0001). Note: blank spaces correspond to the cases where overall 
expression was already low, and a representative number of events (>1000) was not available to 
proceed with an accurate quantification of subpopulations distribution. 
 
Cell surface receptors expression was further quantified within the 
different subpopulations from young and old NPs to characterize their signature 
(Figure 3.5). Table 3.3 resumes the signature of the four cell subpopulations 
discovered in the young NP, which was additionally supported by previous results 
regarding CD29, CD44, CD45 and CD34 differential expression across P1, P2 
and P3 subpopulations [58]. Importantly, age seemed to negatively affect the 
expression of CD29 within P4 subpopulation only (95±5% vs 61±39%, n=11 and 
10, respectively, *p<0.05), while P1 showed decreased percentages of both 
CD44+ (50±12% vs 8±11%, n=12, ****p<0.0001) and CD45+ (24±14% vs 6±7, 
n=10 and 5, respectively, **p<0.01) events. Interestingly, although the overall 
prevalence of CD146+ events was not altered with age, their prevalence within 
P1 was significantly decrease (46±13% vs 12±9%, n=9 and 7 respectively, 
****p<0.0001), and increased within P4 (16±16% vs 36±21%, n=9 and 7, 
respectively, **p<0.01), highlighting relevant changes on cells signature, which 
were otherwise masked.  
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Table 3.3: Cell surface receptors signature of the four distinct subpopulations found in 
young bNPs. 
 
 % events CD29 CD44 CD45 CD146 GD2 Tie2 CD34 Stro-1 
P1 7±4 +++ ++++ +++ ++++ ? ++++ - ? 
P2 48±8 ++++ +++ + + ? ++++ - ? 
P3 9±6 +++ +++ - - ? ++ - ? 
P4 35±11 ++++ +++ ++ ++ ? ++++ - ? 
 
Legend: 0%: -; <10%: +; 10-20%: ++; 20-50%: +++; >50%: ++++; ? minimum 1000 
events not assured for accurate quantification 
 
 
 
 
 
Figure 3.5: Immunophenotypic signature of P1, P2, P3 and P4 cell subpopulations found 
in young and old bovine NP. Results are presented as mean±standard deviation. Differences 
between age groups were assessed using a two-way ANOVA and Sidak’s multicomparison test. 
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CD29: ny=11, no=9; CD44: ny,0=12; CD45: ny=9; CD146: ny=9, no=8; GD2: no=7; Tie2: ny=7; Stro-
1: no=5 (*p<0.05; **p<0.01 and ****p<0.0001). Note: null values correspond to the cases where 
overall expression was already low, and a representative number of events (>1000) was not 
available to proceed with an accurate quantification of subpopulations signature. 
 
 
Morphology analysis of young and old bovine NP cells 
Morphological changes with aging in bNP cells from young and old 
animals were also assessed using IFC. Data from conventional cytometer and 
from IFC were compared by plotting cells diameter against dark-field intensity 
(Ch06- the equivalent to SSC). Instead of the four subpopulations previously 
mentioned, only three could be distinguished in younger animals (Figure 3.4 A), 
because in conventional FC P2 and P3 are differentiated by their distinct auto-
fluorescence when stained with PI, and this did not happen when plotting PI 
against cells diameter in IFC. Hence, P2 and P3 were analysed as a merged 
subpopulation. Figure 3.4 B shows examples of brightfield and fluorescence 
images of cells and their nuclei, respectively, found within each subpopulation. 
Interestingly, the P2+P3 subpopulation shows a significant decrease with age 
(74±4% vs 35±13%, ***p<0.001, n=3), while P4 is increased (16±7% vs 49±10%, 
***p<0.001, n=3). Contrarily to what was observed by conventional FC, P1 did 
not reveal alterations with aging in terms of DRAQ5+ events content (Figure 3.4 
C). Moreover, an overall shift in cells diameter could be observed with aging 
(18±1 µm vs 23±2 µm, p<0.05) (Figure 3.5 A). Of note, although no changes were 
observed in terms of prevalence of multinucleated events (events with more than 
one DRAQ5+ nuclei), when analysing the subpopulations in particular, P4 showed 
a significant decrease in the mean number of nuclei per cell with aging 
(1.887±0.17 nuclei vs 1.156±0.04 nuclei, ****p<0.0001, n=3) (Figure 3.5 B). 
Finally, the percentage of events containing bright vesicles increased with aging 
(3.051±0.05 bright vesicles vs 3.317±0.13 bright vesicles), although no particular 
differences were detected between subpopulations (Figure 3.5 C).
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Figure 3.6: Imaging flow cytometry analysis of young and old bovine NP cells. A | Panel shows 
conventional FC pseudo-color plots used to identify the subpopulations within the young bNP. 
Subpopulations P2 and P3 are merged in SSC-A vs FSC-A plots. B | IFC analysis of the subpopulations. 
While dark field intensity (Ch6) vs cells diameter was the equivalent to SSC-A vs FSC-A (top left density 
plot), no parallel could be established to PI vs FSC-A, as shown in bottom density plots of PI negative 
cells vs all fluorescence channels available. Top right graph shows the quantification of events 
distribution within P1, P2+P3 and P4 subpopulations in young and old bNP. Results are presented as 
mean± standard deviation and statistical differences were analysed using a two-way ANOVA and 
Sidak’s multicomparison test (n=3, ***p<0.001). A total of 17994 DRAQ5+ events were analysed from 
the three young NPs and 2572 from the three old NPs. 
 
Figure 3.7: Cell Morphology analysis of young and old bNP cells performed with IDEAS software. 
A | Examples of brightfield and fluorescence (DRAQ5 staining of cells nuclei in red) images of cells 
found within subpopulations P1, P2+P3 and P4. B | Histogram showing diameter distribution of young 
(filled) and old (line) bNP cells (top), and respective quantification of the average diameter of cells 
(bottom). C| Quantification of the prevalence of multinucleated events and mean nuclei number per cell. 
D | Quantification of the percentage of cells containing more than one bright vesicle and the mean 
number of bright vesicles per cell. E | Examples of brightfield images of cells and respective mask used 
to analyse bright vesicles (light blue) applied. Results in bars are presented as mean ± standard 
deviation and were analysed for statistical differences using a non-parametric Mann-Whitney test or a 
two-way ANOVA and Sidak’s multicomparison test (n=3, *p<0.05 and ****p<0.0001). A total of 17994 
NP DRAQ5+ events were analysed from the three young animals and 2572 from the three old animals. 
 
 
Gene expression analysis 
To evaluate whether the different phenotypic signature of young and old bovine 
NP cells could impact on cell function, the gene expression of specific NP ECM 
proteins, proinflammatory markers and MMPs of young and old NP cells was also 
quantified. Two out of the six genes selected revealed significant changes, namely the 
ECM protein Coll II (4.3±2 vs 0.4±0.4, **p<0.01, n=6 and 4) and the proinflammatory 
cytokine IL-8 (0.0169±0.006 vs 0.0061±0.004, **p<0.01, n=6 and 4), whose expression 
was downregulated with age (Figure 3.6).  
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Figure 3.8: Differential gene expression profile of freshly isolated primary young and old bNP 
cells. Quantitative analysis of relative mRNA expression of ECM components (Coll II and Agg), 
proinflammatory markers (IL-8 and IL6) and matrix degrading enzymes (MMP1 and -3). Levels of mRNA 
were normalized to GAPDH. Results are presented as scatter plots, each point representing one animal 
(n=4-6, **p<0.01, Mann-Whitney test).) 
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Alike every other organ in the human body, the IVD also ages, but in a fast-
forward fashion. While people steel feel very young and active in life, the IVD starts to 
give signs of functional failure and is many times considered the cause, if not the 
source, of pain and disability. Hence, preventive therapies to address disc 
degeneration should take place very early in life. This work aimed at pin pointing age-
related changes which occur at the NP cell level, in order to inform development of 
more targeted IVD anti-aging/degeneration therapies. Indeed, differences at the 
macroscopic level are evident between young and aged IVDs, and this is further 
reflected on ECM’s ultrastructural features (Figure 3.1) and molecular composition, 
which was further explored within our group [63-66]. On the other hand, the molecular 
profile of IVD cells aging has been poorly studied. Indeed, to the best of our knowledge, 
here we report, for the first time in freshly isolated bovine NP cells, a decrease on the 
MMP1
young old
0.0001
0.001
0.01
Aggrecan
young old
1
10
100
Collagen II
young old
0.1
1
10
R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n 
no
rm
al
iz
ed
 to
 G
A
PD
H
**
IL-6
young old
0.01
0.1
1
R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n 
no
rm
al
iz
ed
 to
 G
A
PD
H
IL-8
young old
0.001
0.01
0.1 **
MMP3
young old
1
10
CHAPTER III 
Profiling nucleus pulposus cells aging using a bovine model 
 
 169 
percentage of the surface markers CD29, CD44, CD45 and Tie2 with age, while GD2 
prevalence is significantly increased in elder animals.  
CD29 (also known as β1-integrin) is an anchorage protein associated with stem 
cell niches and cell migration via cellular adhesion mechanisms, including cell-to-cell 
contacts or cell-to-matrix adhesion [67]. Its high prevalence (72-94%), quantified by 
FC as well, was previously reported in human cells from degenerated NP tissues (age 
range 21-63 years old), albeit cells were subjected to expansion in liquid culture, which 
may have favoured the proliferation of subsets enriched in this molecule, thus likely 
masking the effects of aging. CD44, a transmembrane protein and primary hyaluronic 
acid receptor, was recently shown to be more expressed in IVD cells from degenerated 
human tissue (~100%) than from herniated samples (~80%), but no correlation was 
established with age [68]. Also, the prevalence of CD44+ was much superior than the 
one we report herein. In this case, cells were cultured until passages 6-8 (to generate 
IVD-derived mesenchymal stromal cells (MSCs)), and this is known to heavily affect 
cells phenotype, as reported for articular chondrocytes [69, 70], mouse bone marrow 
derived MSC precursors [71], and rabbit AF and NP cells [72]. Of note, a previous 
immunohistochemical study from Stevens et al. [73] on the developing and aging rat 
NP demonstrates a decrease in expression of CD44 associated with increased 
animals’ age and loss of the notochordal cell population. Regarding CD45, although 
the prevalence of this hematopoietic-lineage marker was highly variable in young 
animals (1.5-36%), and somehow unexpected, bearing in mind the IVD is only 
peripherally irrigated, and care was taken to avoid contamination with blood during 
cells isolation procedure, this result is according to our previous immunophenotypic 
study, where an average 7% of CD45+ was found in young animals [58]. Interestingly, 
CD45 was also detected by FC on human samples (~10-15%, n=21) from both 
degenerated (age range 26-79) and herniated (age range 25-56) tissues, after cell 
expansion in 2D culture. Importantly, the significant decrease associated with age is 
further supported by our most recent study with freshly isolated human IVD cells from 
degenerated discs, where we could not find any expression of CD45 in aged cells (age 
range 43-69, n=7) [74]. However, we believe that further investigation is required to 
validate these results by immunohistochemistry to put aside any suspects of 
contamination with non-endemic cells. Tie2, a recently proposed progenitor cell marker 
for young and healthy NP cells [20], was highly positive (~85%) in young NP cells as 
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opposed to old cells, which showed to expression at all. This was according to Sakai 
et al. [12] report stating that nearly 90% of plastic-culture expanded NP cells from 
young (20 years old) human samples express Tie2, although this expression drops 
dramatically (<10%) in donors older than 30 years old. Our previous study also 
revealed no expression of this marker in four donors aged 33, 34, 38 and 66 years old 
[74]. However, most recently, NP cells from five human donors within the same age 
range: 37-54, but expanded in pellet culture, revealed an average 14.07 ± 8.3% Tie2+ 
cells, as evaluated by FC as well [75]. Importantly, the variability of results was high 
and no correlation was established with donors’ age, besides the fact that the effects 
of the pellet culture on this Tie2+ subset were not explored. Hence, we believe that this 
result validates bovine NP cells as a good phenotypic aging-model. Interestingly, GD2 
followed the opposite tendency to the other markers mentioned so far, with higher 
percentages of GD2+ cells present in old bovine NPs. This molecule is a component 
of the plasma membrane found mainly in the nervous system and has been identified 
before as a marker for bone marrow MSCs [76, 77] and umbilical cord MSCs [76]. 
Although its expression in primary mouse and human NP cells was reportedly very low 
(<2%), its increase during liquid culture was correlated with a high proliferative 
capability in the mouse NP [12]. Hence, bNP cells in old animals may be mounting a 
damage response, through GD2 signalling, as very recently hypothesised to happen 
in healer mice IVDs [78]. Finally, it is important to highlight the maintenance of CD146+ 
events with age, a maker that revealed a pool of chondroprogenitors within late-stage 
osteoarthritic knee joints, with high clonogenic and multi-differentiation potential [79]. 
Of note, this was also true for human IVD tissue from degenerate samples [74]. 
In previous work, we have proven that the NP cell population from young bovine 
animals is heterogeneous, with the consistent identification of three distinct 
subpopulations (P1, P2, P3), when cells were plotted in FL3-H vs. FSC-H in FC 
analysis. Cells within these subpopulations presented different size and auto-
fluorescence. Here, by changing the analysis from FSC-H(eight)/SSC-H(eight) to FSC-
A(rea)/SSC-A(rea) we were able to identify one other distinct subpopulation, P4, 
containing large-sized and highly auto-fluorescent events. This is explained by the fact 
that FSC-A gives full FSC value information of the cell, therefore larger events that 
were not being detected in previous analysis became now evident and assembled into 
subpopulation P4. This is of particular importance when profiling NP cell, which are 
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many times naturally arranged in a chondron [80, 81] or cluster [82, 83] format, and 
thus should not be discarded as doublets or clumps, but rather considered a native 
subpopulation. Moreover, we could confirm by IFC that P4 includes both single and 
multinucleated large events, and surprisingly, is the only subpopulation where the 
percentage of multinucleated events drops significantly with age. The same reasoning 
applies to subpopulation P1, which contains much smaller events (~10µm), which are 
routinely discarded as cell debris. This subset does not stain for PI and contains many 
DRAQ5+ events (~7%), although only few are calcein positive (0.3%), as evaluated by 
conventional FC (Supplementary Figure 3.2 A). IFC also reveals some DRAQ5/Actin 
double positive cells (Supplementary Figure 3.2 B), which further confirms the 
existence of cells within this subset that should not be disregarded. Interestingly, while 
FC results show a substantial decrease in subpopulations P3 and P4, and an increase 
in P1 with age, IFC revealed opposite results for P1 and P4, while P2 and P3, that 
could not be analyzed in separate, together showed an overall decrease. This could 
be explained by the clean analysis that IFC allows, through a sequence of gating steps 
that lead to the ultimate guarantee that we are characterizing cells. Indeed, in 
conventional FC P1 is most likely including several non-cell events, because for this 
analysis no specific stain for live cells was used. This had a great influence on the 
relative percentage of P4 events in old animals, in which the level of contaminating cell 
debris and ECM breakdown products post cell isolation is much higher. Of note, 
because the analysis of surface markers expression is based on specific antigen-
antibody interactions, the immunophenotyping results are not as highly affected by 
debris-related auto-fluorescence as the subpopulations distribution analysis, and thus 
these results should be analyzed independently and not in relation to one another. 
Steel, it remains clear that the four subpopulations have a distinct signature, and some 
are more deeply affected by aging than others.  
At the genotypic level, there were already some reports on the down-regulation 
of Coll II both with degeneration, in human NP cells [15], and aging, in bovine NP cells 
[84]. Interestingly, although in the latter study the age window was rather narrow (9-18 
months old), cells as young as 18 months old were unable to reconstitute their ECM to 
the same extent as the younger cells [84]. This could be a consequence of the high 
levels of senescent cells present in young NP (8-95%), which we and others have 
verified before [58, 85], and which are known reduce the secretion of ECM 
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components, besides arresting cell cycle [86]. Regarding IL-8, while it is reported that 
human NP cells express this proinflammatory cytokine in homeostasis [87-89] and 
DDD [89-91], to the best of our knowledge this is the first time that its down-regulation 
with age in NP cells is reported.  
In order to further characterize the four subpopulations identified, preliminary 
cell sorting experiments were conducted and optimized, using a FACS Aria II sorter, 
BD, to physically separate cells and determine their gene expression profile. Based on 
the phenotypic coordinates gathered using flow cytometry, namely cells different size 
and auto-fluorescence (following PI staining), and CD146 negative expression for P3 
subpopulation, we were able to collect the distinct subpopulations with high purity 
levels (Supplementary Figure 3.3). However, this was a very challenging quest, since 
several parameters had to be optimized. Besides requiring highly concentrated primary 
cell suspensions - 5x106 cells per 0.5 mL, and consuming elevated quantities of PI and 
antibody, the “sticky” nature of events within P2 systematically disturbed the flow, 
contaminating neighbouring collection tubes. Hence, sorting had to be performed in 
two stages, to guarantee P2 segregation. This way, good purity levels could be 
obtained, but cell yields were negatively affected.  Indeed, P1 and P3 cell yields were 
always very low (104), representing an additional challenge for RNA extraction. 
Notwithstanding, gene expression analysis is presently ongoing. 
In conclusion, we were able to profile important phenotypic and genotypic 
alterations that occur in bovine NP cells with age, such as the decrease on CD29+, 
CD44+, CD45+ and Tie2+ events and increase on GD2+ events, together with a stable 
expression of CD146, the change in subpopulations prevalence and its surface 
receptors expression, the shift in cells diameter, the increased number of cells 
containing bright vesicles, and finally the down-regulation of Coll II and IL-8.  
Differentiating age-induced from disease-associated modifications will shed light on 
our understanding of the mechanisms leading to DDD, and we believe that the bovine 
animal model holds great promise in the further identification of anti-aging targets, 
towards the prevention of IVD degeneration. 
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Supplementary Figure 3.1: Schematic showing an example of the normal distribution of PI 
negative events in PerCP-Cy5-5-A vs FCS-A pseudocolor dot plots, allowing the identification of 
P1, P2, P3 and P4 subpopulations (top), A) the analysis of the relative distribution of CD44+ 
events along the distinct subpopulations, and B) the quantification of each subpopulations’ 
immunopositivity for CD44 (subpopulation signature), independently of the others. 
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Supplementary Figure 3.2: Analysis of P1 subpopulation. A | Flow cytometry analysis of young and 
old bNP cells stained with DRAQ5 (binds double stranded DNA) and calcein (enters cells membranes 
and only fluoresces in live cells). DRAQ5 staining of cells’ nuclei showed a subpopulation of small cells 
(within P1) that does not stain with calcein. However, few green spots can be detected in that area 
(n=1), and B| IFC revealed both DRAQ5+ single positive and DRAQ5+actin+ double positive cells within 
P1 subpopulation. For actin staining cells were permeabilized with 0.2% v/v Triton, for 5 min. and 
washed with PBS, prior to incubation for 20 min at RT, with Phalloidin-AlexaFluor®488 (1:40 Dil. per 
2.0x105 cells, A12379, Life Technologies) in a PBS-1% w/v bovine serum albumin (BSA) solution, 
according to manufacturer’s instructions.  
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Supplementary Figure 3.3: Representative example of cell sorting gating sequence to physically 
separate P1 (P4 in purple), P2 (P5 in yellow), P3 (P8 in orange, CD146 negative) and P4 (P6 in 
green) subpopulations for further gene expression profiling.  
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Abstract 
 
Human intervertebral disc (hIVD) cells were isolated from 41 surgically excised 
samples and assessed for their phenotypic alterations with age. Towards the 
design of novel anti-aging strategies to overcome degenerative disc disease 
(DDD), we investigated age-correlated phenotypic alterations that occur on 
primary hIVD cells. Although regenerative medicine holds great hope, much is 
still to be unveiled on IVD cell biology and its intrinsic signalling pathways, which 
can lead the way to successful therapies for IDD. A greater focus on age-related 
phenotypic changes at the cell level would contribute to establish more effective 
anti-aging/degeneration targets. The study was subdivided in four main steps: i) 
optimization of primary cells isolation technique; ii) high-throughput cell 
morphology analysis, by imaging flow-cytometry (FC) and subsequent validation 
by histological analysis; iii) analysis of progenitor cell surface markers 
expression, by conventional FC; and iv) statistical analysis and correlation of cells 
morphology and phenotype with donor age. Three subsets of cells were identified 
based on their diameter: small (SC), large (LC) and super large cells (SLC). The 
frequency of SCs decreased nearly 50% with age, whereas that of LCs increased 
nearly 30%. Interestingly, the increased cells size was due to an enlargement of 
the pericellular matrix (PCM). Moreover, the expression pattern for CD90 and 
CD73 was a reflexion of age, where older individuals show reduced frequencies 
of positive cells for those markers. Nevertheless, the elevated percentages of 
primary positive cells for the mesenchymal stem cells (MSC) marker CD146 
found, even in some older donors, bring refreshed hope for the hypothetical 
activation of the self-renewal potential of the IVD. These findings highlight the 
remarkable morphological alterations that occur on hIVD cells with aging and 
degeneration, while reinforcing previous reports on the gradual disappearance of 
an endogenous progenitor cell population. 
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Introduction 
 
Current treatments for DDD fail to address IVD’s pathophysiology and to 
restore its function, and bioengineered sophisticated solutions are still in their 
infancy, with very few having reached Phase-I clinical trials [1]. In fact, much is 
still to be unveiled regarding the cell biology of the IVD and its intrinsic signalling 
pathways. Particularly, a greater knowledge about age-related cellular changes 
will contribute to establish more effective anti-aging/degeneration targets. 
In the adult IVD, chondrocyte-like cells frequently assemble in a fibrous 
capsule, forming chondrons similar to those found in articular cartilage [2]. It has 
been suggested that these encircling layers result from accumulation of cellular 
products, as a consequence of aging [3, 4] with histopathological analysis 
revealing evident remodeling of the pericelullar matrix (PCM) occurring with age 
and disease progression [3, 5, 6]. On the other hand, PCM plays an important 
role in governing the local mechanical environment of chondrocytes and IVD cells 
[7, 8], as well as in maintaining their phenotype and viability [9, 10]. 
Despite findings indicating that degenerated human discs may have an 
endogenous regenerative capacity [11-15], there might be an age-limit for the 
efficient activation of its cell progenitors [16-18]. 
The aim of this work was to investigate age-related phenotypic alterations 
on primary human IVD cells from degenerated tissue. Taking advantage of a 
multiparameter image analysis tool, that guarantees robust quantitation of 
morphological features, we correlated IVD cells size, clusters prevalence and 
PCM area with age, while monitoring changes in expression of known stem cell-
related (CD90, CD73, CD105, CD146, CD34, Stro1) and NP-progenitor (GD2 
and Tie2) markers. 
 
Materials and methods 
 
Surgical IVD tissue dissection and cell isolation 
Degenerated human lumbar IVD fragments, with grade III-IV (Pfirrmann 
 
CHAPTER IV 
Age-correlated phenotypic alterations in cells isolated from human degenerated intervertebral 
discs with contained hernias 
 
 200 
scale), were isolated from patients undergoing microdiscectomy, after informed 
consent and ethics committee approval. The surgeries were performed under 
general anesthesia in a sterile operating room and prophylactic antibiotic therapy 
with cefazolin 1 g IV was given. Patients were placed in a knee-chest position 
and a standard posterior approach to the appropriate interlaminar window was 
undertaken. After removal of the yellow ligament and medial retraction of the 
nerve root, the disc herniation was exposed. The posterior longitudinal ligament 
and the annulus fibrosus (AF) were incised and IVD fragments were excised, as 
deemed necessary by the surgeon. No more disc samples than those considered 
clinically appropriate were collected. In cases where the disc fragment was in 
contact with the epidural space or indistinguishable from the AF, the excised 
tissue was not included in this study. Thus, AF-contained IVD fragments were 
collected, and cells were isolated by enzymatic digestion, as previously described 
[19], using one of three enzymatic formulations: collagenase-type-I (Coll-I), 
collagenase-type-II (Coll-II), or collagenase-type-XI (Coll-XI) (C0130, C6885, and 
C7657, respectively, Sigma-Aldrich, Sintra, Portugal), at 0.5 mg/mL (more 
detailed information in Supplementary Methods). 
 
Assessment of yield and viability upon isolation 
Immediately upon digestion, cell yield was quantified by trypan blue 
exclusion and subsequently normalized against initial wet tissue weight. Cell 
viability was assessed by flow cytometry (FC) (FACS Calibur; BD 
Immunocytometry Systems, San Jose, CA) upon propidium iodide (PI) staining. 
 
Characterization of cell morphology by imaging flow cytometry (IFC) 
Cells from 9 different donors were fixed in 4% w/v paraformaldehyde (PFA) 
solution at room temperature for 15 min and washed with phosphate-buffered 
saline (PBS). Cells were labeled with DRAQ5 (1:1500 dil. per 2.0 x 105 cells, 65-
0880; eBioscience), run on ImageStreamX (IS; Millipore, Billerica, 
Massachusetts, MA), and analyzed with IDEAS software for: cell diameter, 
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frequency of small (SC), large (LC) and super large cells (SLC), frequency of 
single cells and multinucleated events (See Supplementary Figure 4.1 A, B and 
C: Cell Morphology Analysis Tutorial).  
Cells were identified as SC, LC and SLC based on their diameter: 10 
μm<SC<20 μm; 20 μm<LC<30 μm and 30 μm<SLC<50 μm. To quantify the 
percentage of single and multinucleated events, as well as the number of single 
cells within LC and SLC populations, a specific mask and feature was created 
and applied to images of DRAQ5 stained nuclei (Supplementary Figure 4.1 B). 
To identify the presence of PCM, cells were permeabilized for 5 min with 
0.2% Triton and incubated for 20 min at room temperature with Phalloidin-
AlexaFluor®488 (1:40 dilution per 2.0x105 cells, A12379; LifeTechnologies, 
Porto Salvo, Portugal), previously prepared in a PBS-1% w/v bovine serum 
albumin (BSA) solution, as described in [19]. This allowed the distinction of the 
cells actin cytoskeleton (cell per se) from the surrounding cell-attached matrix, 
when merging brightfield images and the fluorescence images of actin staining 
on IDEAS® software. To further quantify the PCM area, a specific mask was 
designed (Supplementary Figure 4.1 D).  
 
Histological Analysis 
Human IVD fragments were fixed in 10% neutral buffered formalin, 
processed for paraffin embedding and 5 µm sectioned in a microtome (Leica). 
Tissue sections throughout the IVD were stained for Alcian blue/Picrosirius red 
and analyzed by upright optical microscope (Olympus). For each section, 
delimitation of the area of the pericellular matrix (either proteoglycan- or collagen-
rich) was determined for each cluster using ImageJ software. Around 15 sections 
were analyzed per donor and values were plotted as frequency distribution of the 
areas obtained in mm2, using GraphPad Prism. 
 
Analysis of markers expression by flow cytometry (FC) 
Expression of surface markers (Table 4.1) was analyzed by conventional 
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FC, as described in Supplementary Methods.  
 
Statistical Analysis 
Statistical analysis was performed using GraphPad-Prism. All tests used 
are identified in the respective figure legend (additional details in Supplementary 
Methods). 
 
 Table 4.1: Antibodies used in flow cytometry analysis. 
 Function Fluorochrome µg/mL Clone Catalog #, Manufacturer 
Primary 
antibodies  
IgG1 MAH CD34 
Marker for hematopoietic 
progenitors and vascular 
endothelial cells. 
FITC 2.5:50 581 (Class III) 
CD34-581-01, 
Invitrogen 
IgG1 MAH CD45 Hematopoietic lineage- restricted surface marker. PE 3:50 MEM-28 
21270454, 
ImmunoTools 
IgG1 MAH Tie2 
NP progenitor cell markers [20]. 
PE 5:50 83715 FAB3131P, R&D Systems 
IgG2a MAH GD2 - 2:50 14.G2a 554272, BD PharmigenTM 
IgG1,k MAH CD90 
Typical MSCs markers. 
APC 5:50 eBio5E10 17-0909-41, eBioscience 
IgG2a MAH 
CD105 FITC 3:50 MEM-226 
21271053, 
ImmunoTools 
IgG1 MAH CD73 PE 5:50 AD2 550257, BD PharmigenTM 
IgM MAH Stro1 - 10:50 STRO-1 MAB1038, R&D Systems 
IgG1 MAH CD146 
Marker for vascular endothelial 
cells, smooth muscle cells, 
pericytes and MSCs. 
AlexaFluor®647 5:50 OJ79c MCA2141A647T, 
Bio-Rad 
Secondary 
antibodies      
IgM RAM  Biotinylated 1:50  E 0354, Dako 
IgG RAM  AlexaFluor®647 1:500   
Isotype controls      
Mouse IgG1  FITC/R-PE 2.5:50  M1FP, Invitrogen 
Mouse IgG1  AlexaFluor®647 5:50  MCA928A647, Bio-Rad 
Mouse IgG1,k  APC 5:50 P3.6.2.8.1 17-4714, eBioscience 
Mouse IgG2a  FITC 3:50  21275523, ImmunoTools 
Mouse IgG2a  - 2:50 G155-178 
556651, BD 
PharmigenTM 
MAH: Mouse anti-Human; MSCs: Mesenchymal Stem Cells; RAM: Rabbit anti-Mouse 
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Results 
 
Sample characterization 
To characterize the phenotype of primary hIVD cells from degenerated tissue, 
a total of 41 samples were collected from patients undergoing microdiscectomy – 24 
males and 17 females. All samples were collected from disc levels between L3-S1. 
The donors age ranged from 18 to 66 years old for males (average of 45 ± 11 years 
old) and from 25 to 77 years old for females (average of 48 ± 13 years old) (Figure 4.1 
A), whereas donors’ weight ranged from 69 Kg to 110 Kg for males (average of 86 ± 
12 Kg) and from 50 Kg to 90 Kg for females (average of 62 ± 10 Kg) (Figure 4.1 B). 
The weight of collected tissue ranged from 0.2 g to 5.2 g for males (average of 1.7 ± 
1.2 g) and from 0.5 g to 8.0 g for females (average 2.8 ± 2.2 g) (Figure 4.1 C).  No 
correlation was found between tissue weight and donors’ age or weight (Figure 4.1 C1 
and C2, respectively). 
From the 41 human samples collected, 36 were digested to obtain the IVD cells 
to: 1) optimize the protocol for primary cells isolation (n=9), 2) analyse cells morphology 
(n=9), and 3) study cells phenotype by flow cytometry (n=18, of which 2 were discarded 
after cell isolation, due to insufficient number of cells to be acquired). The remaining 5 
tissue samples were formalin fixed for histological validation of the cell morphology 
analysis performed by IFC. 
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Figure 4.1: Sample characterization. A | Donors age. A total of 41 samples were collected – 24 from 
male donors and 17 from female donors. B | Donors weight by gender. Male donors were heavier than 
female donors, ***p<0.001 (non-parametric Mann Whitney test). C | Collected tissue weight. An average 
1.7 g and 2.8 g of tissue was excised from male and female donors, respectively. No correlation was 
found between collected tissue weight and age (C1) or donors weight (C2). Line on scattered dot plots 
presents mean values. 
 
Optimization of cell isolation  
Because surgical tissue excised from human degenerated IVDs is normally 
scarce in cell content, it is important to guarantee that the cell isolation protocol will 
result in a high yield of viable cells. Three different enzymatic digestion protocols (with 
Coll-I, -II or -XI, 0.5 mg/ml, overnight) were tested, similarly to what we did previously 
with bovine NP tissue [19]. Independently of the protocol used, cells viability was 
always above 90%, as determined by FC (PI negative cells) (Figure 4.2 A). In terms of 
cell yield, the protocol using Coll-I originated higher cell numbers ((2.6± 2.7) x 105 
cells/g wet tissue), although no significant differences were detected when comparing 
to the other protocols used (Coll II:(1.4±1.0) x105 and Coll XI:(1.4±0.7) x 105 cells/g 
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wet tissue) (Figure 4.2 B). Thus, subsequent cell isolation procedures were performed 
using Coll-I. Interestingly, although no correlation was found between the amount of 
IVD tissue collected from microsurgery and donor age, the cell content (yield) shows 
a negative correlation (Figure 4.2 C; **p<0.01), suggesting that independently of the 
isolation method used, age is a heavy counterproductive factor for cell yield. 
 
 
Figure 4.2: Optimization of cell isolation protocol. Three different methods to isolate human primary 
cells were evaluated, where cells were incubated overnight with either collagenase-type I, -type II or –
type XI. A | No differences were found in terms of cell viability, as quantified by flow cytometry upon PI 
staining. All protocols rendered high (>90%) cell viability (Coll I: n=9; Coll II: n=3; Coll XI: n=4). B | Tissue 
overnight digestion with collagenase-type-I allowed the isolation of more cells per g of excised tissue, 
although this number decreased with donors’ age (C) (n=9, Pearson r=-0.8, **p<0.01; non-linear 
regression r2=0.78). Data on bars are presented as mean ± standard deviation. 
 
Characterization of cellular morphology  
In order to characterize the morphology of human degenerated IVD cells, along 
with its age-related changes, freshly isolated cells were fixed and analyzed by IFC, 
using masks for brightfield images of cells and for fluorescence images of the 
cytoskeleton and nuclei (representative analysis tutorial is depicted in Supplementary 
Figure 4.1). 
Analysis of the distribution of the cells diameter with age revealed the presence 
of small (SC), large (LC) and super large cells (SLC) (Figure 4.3 A), with an average 
diameter of 16±2 μm, 25±1 μm, and 34±1 μm, respectively (Figure 4.3 B). 
Representative images of these cells are shown in Supplementary Figure 4.1 C. 
Overall, the average frequency of SLC (17±14%) was significantly lower (*p<0.05) than 
the average frequency of SC or LC (39±29% and 43±18%, respectively), although 
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there was a high variability between donors with ages from 36 to 55 years old. 
Interestingly, correlation analysis revealed a decrease in SC frequency with age 
(**p<0.001), while the frequency of LC and SLC increased (**p<0.001 and *p<0.05, 
respectively) (Figure 4.3 C). 
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Figure 4.3: The diameter of human IVD cells increases with age. A | Histograms showing the 
diameter distribution of IVD cells from 9 different donors (left). A shift to the right is visible with increasing 
age (between 36 (up) and 55 (bottom) years old). Donor age, gender and total number of cells analyzed 
is indicated on each histogram (bottom right corner). The observation of distinct diameter peaks with 
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age allowed identification of three cell types based on cells size: Small Cells (SC), Large Cells (LC) and 
Super Large Cells (SLC). B | Average diameter of the gated populations from the same 9 different 
donors. C | Frequency of cells within each gate and its correlation with age. The frequency of cells within 
SLC population was significantly lower than within SC or LC populations (data analyzed for statistical 
differences using ordinary one-way ANOVA and Bonferroni’s multiple-comparisons test, n=9, *p<0.05, 
****p<0.0001). Correlation analysis revealed that SC frequency decreased with age (n=9, one-tailed 
**p<0.01, Pearson r=-0.76, linear regression r2=0.58), whereas LC and SLC increased (n=9, one-tailed 
**p<0.01 and *p<0.05, Pearson r=0.78 and r=0.61, linear regression r2=0.60 and r2=0.38, respectively). 
 
The percentage of single and multinucleated events was also quantified for 
each donor (Figure 4.4 and Supplementary Figure 4.1 B). Interestingly, within the large 
and SLC populations, the majority of events were single cells: 87±9% and 63±19%, 
respectively (Figure 4.4 C), although cells had a diameter above 20 µm. 
Simultaneously, there was no correlation between the prevalence of multinucleated 
events and age (Figure 4.4 B). Together, these results suggest that the increase on 
the frequency of LC with age is not due to cell fusion, but is most probably due to an 
increase of the PCM area surrounding the cells. And indeed, the PCM area of cells 
within single-SLC population was larger than within the SC (*p<0.05) and single-LC 
populations (p=0.5) (Figure 4.5).  
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Figure 4.4: Characterization of Large cells. A | Examples of brightfield (left) and fluorescence (right) 
images of single and multinucleated event and its nuclei. B | No correlation between the frequency of 
single or multinucleated events with age (n=9, p=0.36 and 0.29, respectively).  C | Quantification of the 
percentage of single cell events within SC, LC and SLC populations. Only SLC population revealed a 
significantly lower frequency of single cell events (ordinary one-way ANOVA, Bonferroni’s multiple-
comparisons test, ***p<0.001, n=9). Hence, LC and SLC (~40%) greater diameter is not necessarily due 
to cell clustering. 
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Figure 4.5: Pericellular matrix area quantification. A | Examples of IFC images of IVD cells with 
various morphologies. The panel shows brightfield images of cells (right), alongside with composite 
fluorescence images of the respective DRAQ5-stained nuclei and the phalloidin-FITC stained actin 
(middle). The right column shows the masks (dark green) created to determine the PCM area. Both 
single- and multinucleated events are surrounded by a PCM. B | PCM area was quantified within SC 
(all were single-cell events), single-LC and single-SLC populations from 3 different donors, with 36, 38 
and 41 years old (n=3, Kruskal–Wallis and Dunn’s multiple-comparison tests, *p<0.05). LC and SLC 
cells show an increased diameter due to a greater PCM deposition. 
 
Histological analysis 
The morphological analysis performed by IFC was further validated on 
histological sections of degenerated IVD tissue from 5 donors (ages between 37 and 
62 years old), using Alcian blue/Picrosirius red staining, which differentiates the main 
extracellular components within the tissue, staining collagen in red and proteoglycans 
in blue, readily allowing the identification of the PCM for each cell cluster. Figure 4.6 A 
shows the PCM area distribution for the different donors, as quantified from the images 
represented in Figure 4.6 B, C. This analysis indicates an increase in the prevalence 
of larger events (corresponding to LC and SLC identified by IFC) with age, especially 
evident in older donors (60 and 62 years old), accompanied by a decrease in the 
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frequency of smaller events (SC identified by IFC), resulting in a shift to the right in 60 
and 62 years old donor’s histograms. This effect on clusters area can be observed in 
Figure 4.6 B for a younger donor and in Figure 4.6 C for an older donor. 
 
 
Figure 4.6: Histological analysis of degenerated IVD tissue. A | Histograms showing the distribution 
of cell clusters area from 5 donors with ages from 37 to 62 years old. There is an increase in the 
frequency of larger clusters with age. B, C | Representative images of Alcian blue/Picrosirius red staining 
showing small (B) and large (C) cell clusters producing proteoglycans (Alcian blue) embedded in a 
collagen matrix (Picrosirius red). In (B) a small cell with no PCM (PCM area=0 mm2) is highlighted 
(arrow). In (C) the proteoglycan-rich pericellular matrix (arrow) is surrounded by a deposition of an outer 
pericellular collagenous red stained matrix (arrow heads). Scale bars: 100µm. 
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Analysis of surface markers expression  
To assess the correlation between the presence of progenitor-like cells within 
freshly isolated human IVD cells and aging, expression of 9 surface markers was 
evaluated (Table 4.1 and Supplementary Figure 4.2). No expression of Tie2, CD45 
and CD34 was found, while CD146 expression ranged from 0 to 16%, Stro1 from 0 to 
19%, CD90 from 0.3 to 64%, CD73 from 0 to 55%, CD105 from 0 to 17%, and GD2 
from 2 to 5% (Figure 4.7 A). A negative correlation was established between the 
frequency of CD90+ and CD73+ cells and age (Figure 4.7 B, *p<0.05), but not for the 
other markers. These data suggest there is a decrease, but not elimination of 
progenitor cells with aging. Moreover, seeking to correlate cells size with these 
markers expression, it was verified that, within the positive events for each marker, 
there is a smear, containing small and large events, and no distinct subset was found 
to be more or less prevalent with age (Supplementary Figure 4.3). 
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Figure 4.7: Primary human IVD cells phenotype. A | Expression of 9 different cell surface markers. 
B | Age-related changes on the frequency of CD146, Stro1, CD73, CD90 and GD2 positive events. 
Spearman correlation coefficient analysis revealed a significant decrease of CD90 and CD73 expression 
with age (n=9, one-tailed *p<0.05, spearman r= -0.69 and r=-0.63, respectively). 
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Discussion 
 
The aim of this study was to take advantage of available surgical material from 
microdiscectomy procedures, which in normal circumstances would be discarded as 
surgical waste, to characterize how IVD degenerated tissue changes with aging. 
Hence, the material was not collected for research purposes, but as a necessary 
therapy for the donor. Moreover, in a typical microdiscectomy performed to treat a disc 
herniation through a posterior approach, 
at best 30% of the entire disc can be obtained. Indeed, although in anterior and lateral 
approaches the quantity of material collected may be larger, these are not so common. 
Nevertheless, the tissue collected was quite homogeneous and representative of the 
whole degenerated IVD. 
Cell isolation techniques should be standardized in order to avoid variability 
between different studies. Enzymatic digestion is a common procedure to isolate IVD 
cells, but cell yield is rarely reported, and cells are often expanded in culture prior to 
FC analysis of cells phenotype [18, 21, 22]. Moreover, pronase pre-treatment is many 
times applied, not preserving cells with its PCM attached [23]. Here we apply an 
improved and inexpensive method to efficiently isolate primary hIVD cells, which could 
be further adopted by other researchers in this field. Of note, a clear negative 
correlation between cell yield and donor age is evident, supporting previous 
histological observations on IVD cell depopulation [3]. 
Morphology of IVD cells was assessed using IFC, a technique that provides 
high-resolution images of thousands of cells in flow. A clear shift on the distribution of 
the cells diameter occurred with aging, with a decrease in the frequency of small cells 
and an increase with that of larger cells. The enlarged cell morphology was due to an 
increase in the PCM area (Figure 4.5). This effect was previously reported for 
chondrons in osteoarthritic cartilage [24, 25] and proven to be a consequence of matrix 
synthesis and/or deposition rather than due to an increase in cell hydration [26]. 
Theoretically, this alteration may occur following an inflammatory stimulus (e.g. 
Interleukine-1 [IL-1] exposure), that triggers metalloproteinases (MMPs) upregulation, 
initiating the destruction of fibrilar collagens around the chondrocyte (diminishing its 
tensile capacity), while the high intrinsic concentrations of pericellular aggrecan and 
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hyaluronan ensures the hydrodynamic expansion of the chondron [5]. Of note, even 
though formation of cell clusters has been previously associated with age and 
degeneration, we did not find a significant correlation between the frequency of 
multinucleated events and donors age [27-29]. Histological data validated the results 
from IFC (Figure 4.6), although a discrepancy in cells size was detected. The maximum 
area value quantified for cells in flow (from brightfield images of cells with its attached 
PCM) was about 0.002 mm2, whereas in the tissue some larger events had a PCM 
area (including attached collagens and aggrecan) as great as 0.024 mm2. 
Nevertheless, this result is in accordance with previous studies using enzymatic 
digestion to isolate chondrocytes, where the PCM was shown to be substantially 
reduced in size, due to a loss of some enzyme-sensitive PCM components, such as 
aggrecan, type II collagen, fibronectin and hyaluronic acid [30-33]. However, 
chondrocytes enhanced viability, and particularly that of chondrons, when compared 
to alternative isolation methods, makes enzymatic digestion a better choice [34]. 
To better understand the consequences of aging on IVD cells, expression of 
markers for progenitor and inflammatory cells was assessed. Interestingly, the 
percentage of cells expressing CD73, CD90 were a reflection of age. These findings 
reinforce previous reports stating that, although mature IVDs may endogenously count 
on a progenitor cell population [13, 35], its gradual disappearance with aging and 
degeneration may dictate a limitation in time for its activation [18, 36]. Overall, our 
results are in accordance to a previous report [30], showing low expression (<1%) of 
CD105 on primary unexpanded cells from degenerated IVD tissue. As for Stro1, while 
a low expression profile (<5%) was expected, even in younger individuals [13, 35], 
here we found some young donors with high Stro1+ numbers (~20%), and others with 
no expression at all. However, no correlation with age, gender or weight could be 
determined, that could explain these results. Additionally, CD90 and CD73 expression, 
which was always below 40% (with the exception of one 46 years old donor, also 
showing higher expression of CD105, CD146 and Stro1), is different from other 
studies, where MSC classical markers (including CD105) were expressed by nearly 
90% of cells [11, 12, 14, 15]. Nevertheless, in all those studies, cells were expanded 
prior to acquisition, which might have induced phenotypic alterations, as reported to 
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occur with articular chondrocytes [37, 38], mouse bone marrow derived MSC 
precursors [39], and rabbit AF and NP cells [40]. Moreover, Tie2 was not detected, 
even though others have found around 10% expression in three out of four donors (33-
66 years old) [18]. Again, cells were not expanded in this study and the isolation 
procedure was not the same. Additionally, for GD2 expression, an average 3% 
expression was detected (n=4, 33-66 years old), whereas others reported only 1% 
expression in primary hNP cells [18]. We cannot guarantee that these GD2+ are 
exclusively located in the NP, explaining why we were able to detect higher 
percentages of these progenitor cell markers in IVD surgical samples (NP+AF tissue). 
CD146 was also detected in the great majority of samples analysed. We have 
previously showed that two cell-subsets within the heterogeneous bovine NP cell 
population were enriched in CD146+ [19]. This protein has been suggested as a marker 
for endothelial cells, melanoma cells, and MSCs. Interestingly, sorted CD146+ cells 
isolated from late-stage osteoarthritic knee joints showed high potential of 
clonogenecity and multi-differentiation, while expressing high levels of MSC-specific 
surface antigens. Moreover, when compared to adipose-derived MSCs (ADMSCs) and 
unsorted chondrocytes, this subpopulation showed higher chondrogenesis capacity 
[41], revealing a pool of chondroprogenitors within the diseased tissue. In contrast, 
recent work showed that CD146+ were not capable of multipotent differentiation, and 
were committed to express a contractile phenotype [42]. However, besides distinct 
species and cell isolation methods used, culture conditions were also different (one-
week expansion in normoxia vs three-weeks expansion in hypoxia). Importantly, the 
frequency of CD146+ cells found herein (0-16%, n=16, mean 6.5%) was much higher 
than that found in the OA knee (0.01-2.12%, n=6) [41]. We will address the functional 
characterization of hIVD CD146+ cells in the near future. 
In summary, we were able to accurately distinguish three subsets of hIVD cells 
based on their different sizes, whose frequencies varied significantly with age. Younger 
individuals showed higher prevalence of small cells (diameter below 20 µm), whereas 
older donors had more large cells (diameter above 20 µm). Finally, the analysis of 
specific surface markers expression lead to identification of CD146+ cells within IVD 
degenerated samples, which supported even further the hypothesis that the 
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aged/diseased IVD may still have an intrinsic self-repairing potential. 
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Supplementary Methods 
 
Human IVD cell isolation: Briefly, tissue was collected in Dulbecco’s modified 
Eagle’s medium (DMEM; 21885 Gibco), supplemented with 10% v/v penicillin–
streptomycin (P/S, PAA Laboratories GmbH) and 20% v/v amphotericin B (Amph-B, 
PAA). Within 3h upon collection, tissue was digested in DMEM supplemented with 5% 
P/S, 10% Amph-B, 2.5% (v/v) HEPES buffer 1mM (Lonza), 1.5% (v/v) NaCl 5 M and 
KCl 0.4 M solution (to adjust osmolarity to 400 mOsm), 1.3 U/mL DNAse, and one of 
three different enzymatic formulations: collagenase-type-I (Coll I), collagenase-type-II 
(Coll II), or collagenase-type-XI (Coll XI) (C0130, C6885, and C7657, respectively, 
Sigma Aldrich), at 0.5 mg/mL. All enzymatic preparations contain a mixture of the type 
I and II forms of the purified collagenase enzyme, differing in their affinity for different 
substrates as assessed by the manufacturer (www.sigmaaldrich.com/life-
science/metabolomics/enzyme-explorer/learning-center/collagenase-guide.html). 
Tissue/medium ratio was set at 10% w/v to prevent the pH dropping below 6.8 during 
incubation. Tissue was digested overnight, in a humidified atmosphere at 37°C/5% 
CO2, and under gentle stirring. ECM contaminants were filtered with a 70 μm cell 
strainer. 
 
Analysis of surface markers expression by flow cytometry: Cells were first 
left to recover from digestion for 30 min in a humidified atmosphere at 37°C/5% CO2, 
and then washed with PBS-2% fetal bovine serum (FBS), prior to incubation with 
primary antibodies (Table 4.1), in the same solution, for 1h at 4°C. In the case of non-
conjugated anti-Stro1 antibody, cells were, in addition, incubated with a secondary 
rabbit anti-mouse-Biotinylated antibody, for 30 min at RT, washed again with PBS-
2%FBS and additionally incubated with Streptavidin-APC (BD Pharmigen, #554067; 
dilution 1:1000) for 10 min at RT. After labeling, cells were washed with 2 mL PBS-2% 
FBS, fixed in 1% w/v paraformaldehyde (PFA) solution and run in a FACSCanto II 
within 24h. Results were analyzed with FlowJo software, Version 8.7. Supplementary 
Figure 4.2 shows representative dot plots from flow cytometry analysis of surface 
markers expression. 
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Statistical Analysis: D’Agostino and Pearson omnibus normality test was used 
to assess Gaussian distribution of data. Results that did not follow a normal distribution 
were analyzed for statistical differences using non-parametric Mann-Whitney test 
(donors age and weight by gender) or Kruskal–Wallis and Dunn’s multiple-comparison 
test (cell viability and yield, surface markers expression and PCM Area). When results 
followed a Gaussian distribution (collected tissue weight by gender and frequency of 
single events within LC and SLC gates) an unpaired t test was applied. Finally, cells 
diameter and SC, LC, SLC populations frequency followed a Gaussian distribution, for 
which groups were compared using ordinary one-way ANOVA (Bonferroni’s multiple-
comparisons test). In all cases, a confidence level of at least 95% (*p < 0.05) was 
considered. Correlations with age were analyzed using the Spearman correlation 
coefficient for non-parametric data (surface markers expression), and the Pearson 
correlation coefficient for parametric data (cell yield, frequency of SC, LC, SLC, and 
single and multinucleated events). Data is plotted as linear correlation (straight line) ± 
5% confidence intervals (dashed curves), also presenting the assigned correlation 
coefficient “r” and p value. 
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Supplementary Figures 
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Supplementary Figure 4.1: Imaging flow cytometry morphological analysis flow chart. A | Live 
cells gating procedure. B | Gating of single and multinucleated events, by creating mask for cells nuclei 
and a feature to calculate the number of nuclei within each live cell. C | Diameter histogram analysis, 
smoothing, and subpopulations fractioning by cell size in Small Cells (SC), Larger Cells (LC) and Super 
Large Cells (SLC). D | Pericellular Matrix morphology analysis by creating specific mask based on the 
subtraction of nuclei and actin fluorescent images from brightfield images of whole cells, and a feature 
to calculate PCM area. 
 
D	–	PERICELLULAR	MATRIX	MORPHOLOGY	
PCM mask and “PCM Area” feature 
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Supplementary Figure 4.2: Representative dot plots from conventional flow cytometry analysis 
of Stro1, CD146, CD90, CD73 and GD2 surface markers expression. 
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Supplementary Figure 4.3: Representative dot plots of Stro1, CD146, CD90, CD73 and GD2 
positive events plotted as PerCp-Cy5-5-A/FSC-A (unused fluorochrome), to evaluated cells 
distribution regarding their auto-fluorescence. A smear is detected for all markers, hampering the 
distinction of different cell subsets. 
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The original goal of this doctoral thesis was to move forward the basic 
knowledge on intervertebral disc (IVD) cell biology, particularly focusing on 
nucleus pulposus (NP) cells, by introducing novel approaches to this field, namely 
high-throughput methods of cell analysis, as flow cytometry and imaging flow 
cytometry. 
 Initially enrolled in the FP7 European Project “Disc Regeneration” (2009-
2012) [1], in which our team was committed to develop a biomaterial to 
regenerate and repair the degenerated IVD, we got inspired by the complex and 
fundamental bioactive role of this tissue, so poorly characterized back then. 
Indeed, recent years have been stage for a tremendous growth in this field of 
research, highlighting the need to better understand the pathophysiological 
mechanisms behind disc degeneration, towards improved solutions to treat 
degenerative disc disease (DDD). Major efforts have been put on biological 
regenerative therapies [2-4], and the number of clinical trials has been rising each 
year [5, 6]. Still, much is yet to be uncovered regarding IVD cells signature, 
physiology and function. The deeper we go into these fundamental questions, the 
safer, more personalized and successful novel regenerative therapies to treat 
IVD degeneration and associated LBP will become.  
In this PhD dissertation, we proposed to thoroughly characterize NP cells 
in homeostasis and aging. For this purpose, we have started by using the bovine 
animal model, widely accepted to study the IVD, due to its cellular and 
biomolecular resemblance to the human scenario [7-12]. Three main objectives 
were settled: 1) firstly, to establish an improved method for primary bovine NP 
cells isolation, whose procedure was not consensual among the literature; 2) in 
a second phase, characterize NP cells phenotypic profile in homeostasis and 
evaluate age-related changes at protein and gene level; and finally 3) dissect 
age-correlated phenotypic alterations in primary cells isolated from human 
degenerated IVDs with contained hernias, to assure the exclusive 
characterization of endemic NP cell populations, in collaboration with orthopaedic 
surgeons from a local hospital.  
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As we stand, the nonexistence of a definitive cell marker or clear 
phenotypic assays to distinguish NP cells from other cell types, the lack of 
standardization of NP cell isolation methods [13-18], together with differences in 
NP markers expression among distinct species, raises questions concerning the 
proper identification of cell types in IVD, establishment of in vitro cell cultures from 
these cells, and comparison of results obtained from different labs. Establishing 
standardized methods to profile IVD cell populations will be key to increase 
reproducibility and reliability of results in this field of research.  
Despite the profound impact that cell isolation protocols might have on 
cells yield, viability and phenotype, no specific formula to digest NP tissue is 
commercially available nor consensus exists on the most appropriate protocol to 
isolate IVD cells. Hence, we propose an improved bNP cell isolation protocol, 
which originates high cell yields and viability, besides being less time-consuming 
than the gold standard method (overnight enzymatic digestion). Of note, the 
presented protocol did not require any additional step of digestion with other 
enzymes commonly used for NP cell dissociation (e.g. hyaluronidase [19] or 
pronase), known to negatively affect the expression of surface receptors on 
articular cartilage (AC) chondrocytes [20] and to remove NP and annulus fibrosus 
(AF) native pericellular matrix (PCM) [21]. However, although no morphological 
alterations were observed on primary bNP cells with the different protocols, it 
would be important to monitor their immunophenotypic profile as well. 
A recent consensus paper has proposed a panel of markers to define the 
phenotype of young NP cells [22], which were chosen based on their specific 
expression in young healthy NP cells, relevance to NP physiology, and validation 
across different species. This work prompted new studies seeking further 
validation of those markers (essentially at protein level) in larger human cohorts 
[23-25]. Herein, to uncover new cell markers we firstly analysed an array of 
surface receptor antibodies available at our lab, and this led to the identification 
of new markers on freshly isolated bNP cells, whose profile was altered with age, 
namely CD29, CD44, CD45, Tie2 and GD2. In the case of cells from human 
degenerated tissue, the rational had to be different, since we could not guarantee 
the analysis of NP cells exclusively. Thus, we focused on the regenerative 
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potential of IVD cells, by monitoring specific progenitor cell markers, and verified 
that CD90 and CD73 expression was negatively correlated with age. Importantly, 
we contributed even further to Risbud and colleagues’ phenotypic 
characterization [22] using a unique approach, which combines conventional and 
imaging flow cytometry (FC and IFC). It was not until recent years that 
conventional FC began to be applied in the study of IVD cells [23, 24, 26, 27], 
alternatively or supporting traditional cell characterization methods, such as 
electron [28, 29] and confocal microscopy [30, 31], and (immuno)histochemistry 
[32]. This powerful tool records cytomorphometric data from single cells at high-
speed (105 cells/s), retrieving statistically relevant analysis on cell populations. 
Additionally, when a specific cell marker is available, the high sensitivity of FC 
allows identification of very small subpopulations. Notwithstanding, some 
drawbacks, such as the need to dissociate cells from native tissues, the 
impossibility to visualize cells in flow and being an expensive piece of equipment, 
may have been justifying its seldom use. On the other hand, IFC represents one 
step forward in FC technology, by collecting high-resolution images of thousands 
of cells in flow, and providing a user-friendly image analyses software (IDEAS®) 
to assess an even wider array of cellular parameters [33]. Supported by other 
evidences on the heterogeneous cell population found within the bovine NP 
tissue [23, 34-38], this was the first attempt ever made to systematically profile 
young and healthy NP cells using flow cytometry, similar to what has been done 
for blood cells [39]. Interestingly, in the first part of this study, using a BD 
FACSCaliburTM flow cytometer we could consistently identify three distinct 
subpopulations within young bNPs, solely based on their size and auto-
fluorescence (label-free analysis).  However, in the second part of the work, as 
we upgraded to a more efficient flow cytometer (BD FACSCantoTM II system), a 
fourth subpopulation was detected, due to the analysis transition from forward 
scatter-height (FSC-H) to forward scatter-area (FSC-A). Crucially, a differential 
expression of cell surface receptors was found among these subpopulations. 
Also important was the complementation with IFC robust analysis, which 
ultimately guaranteed the characterization of live cells and not image-orphaned 
events only. This is particularly relevant when dealing with primary cells 
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suspensions, which inevitably include many cell debris and ECM breakdown 
products. Indeed, in cell suspensions from older animals and degenerated human 
tissues this was even more evident. However, in order to discriminate the specific 
role that each subpopulation might play in IVD regeneration and repair, future 
functional studies are required.  
With possible exception of genetics, age is perhaps the factor most 
strongly associated with dis degeneration [40]. The clear correlation between age 
and disc degeneration has been observed since the early XX century [41]. While 
some degenerative findings may be detected already in childhood [42], their 
increase in frequency and severity is most reported from 20 years old on [43]. 
Thus, counter-acting detrimental age effects on IVD integrity should be the first-
in-line therapeutic to address IVD degeneration. In this sense, profiling age-
associated changes on IVD cells phenotype would help to identify potential 
targets to prevent IVD accelerated degeneration and painfully disabling IVD 
disease progression. Inspired by this hypothesis, and in line with another work 
from our team [44], the second part of this thesis focused on the differences found 
between bNP cells from young and old coccygeal discs. Herein, we showed an 
age-associated decrease in the prevalence of mesenchymal stromal cells (MSC)-
related (CD29 and CD44), hematopoietic (CD45) and NP-progenitor (Tie2) 
markers in bNP cells. A negative correlation had already been established 
between Tie2 and age in cells from degenerated human tissues [45], supporting 
the idea that, although the NP may exhibit an endogenous regenerative potential, 
there might be a limit in time for its activation. Interestingly, our study revealed an 
increase in the percentage of GD2+ cells (reported NP-progenitor marker as well 
[45]) with age, along with a stable expression of CD146 (MSC marker). This 
brought renewed hope on NP cells capability to respond to age-provoking 
damage on cells and its surrounding microenvironment, although further 
functional validation of this potential is also needed. 
Finally, we had the exciting opportunity to collaborate with orthopaedic 
surgeons from Centro Hospitalar de São João (University of Porto) and to apply 
the same rational of previous chapters on IVD cells isolated from patients 
undergoing microdiscectomy. This task was particularly challenging for several 
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reasons. Firstly, because the discussed exclusion criteria (contained hernias only 
and tissue collection from the deepest zone possible, avoiding major blood 
contamination) implied a strong commitment from the clinical staff. Secondly, due 
to the unpredictable nature of the sample (e.g. variable age, tissue weight and 
integrity), which was additionally generally scarce in cell content and technically 
impossible to classify as NP, AF or CEP tissue (as far as we are aware this can 
only be achieved by immunohistochemistry [25] and/or by rough macroscopic 
dissection [23, 46]). The restricted access to patient’s radiographic examinations 
was also a limitation of this study, not allowing sample stratification by 
degenerative grade (e.g. using a magnetic resonance imaging (MRI) 
classification systems for lumbar disc degeneration; Pfirrman Scale [47]), and 
consequently any correlation between the alterations registered and the grade of 
degeneration. Here, we began by seeking validation of the cell isolation protocol 
established for the bovine animal model in Chapter II, but the fact that surgeries 
were only performed in the evening technically prevented the use of the 4h 
digestion protocol to rescue fresh primary cells. As such, an alternative method 
had to be used, which rendered equivalent high levels of cell viability, but cell 
yields were always much lower. Interestingly, a negative correlation was found 
between cell yield and age, leading to the conclusion that not only the digestion 
method, but also age may have a deep negative impact on this parameter, critical 
for both flow cytometry analysis and in vitro cultures of IVD-representative cell 
populations. Aging effects on hIVD cells were also evident on MSC-related 
surface receptors CD90 and CD73, which, as somehow expected, showed a 
negative correlation with age. Surprisingly however, CD146 was not age-
correlated and was found in practically all samples analyzed, as well as GD2, two 
recognized progenitor cell markers [48, 49]. However, the most striking age-
dependent alteration recorded, and for the first time quantified, was cells average 
diameter shift, which dissected to the subpopulation level by IFC morphology 
analysis, revealed that aging induces the overall deposition of a large PCM 
around hIVD cells, similar to what has been hypothesized to occur with 
osteoarthiritic chondrons, following an inflammatory stimulus (e.g. Interleukine-1 
[IL-1] exposure) [50]. Notwithstanding, and despite the molecular constitution of 
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this encapsulating structure is apparently well determined [9, 28, 32, 51, 52], the 
effects it might have on cell-cell or cell-ECM interactions are still unknown. 
Interestingly, the specific effects of aging on NP cells microenvironment 
(matrisome) are also being explored by our team, and putative effectors for disc 
regeneration have already been identified [44]. Combining cells signature and 
matrisome mapping data from young healthy discs may constitute a more 
efficient strategy to face the complex interconnected cascade of degenerative 
events occurring in IDD. 
Overall, the findings presented in this dissertation may better inform future 
therapies aiming to 1) re-establish homeostasis, through the recapitulation of 
healthy NP cells signature and/or reversion of age-dependent degenerative 
changes, or 2) to enhance endogenous repair by progenitor cells activation. 
Recapitulation of healthy NP cells signature could be achieved either by gene- or 
cell-based approaches. Indeed, seeking to mitigate the degenerative process and 
also to enhance tissue regeneration, gene therapies have successfully 
introduced anabolic genes on IVD cells, such as growth and differentiation factor-
5, BMPs, transforming growth factor-beta (TGF-b) and Sox-9[53]. This strategy 
could also be applied to promote over expression of CD29 and CD44, two 
important mediators of cell-matrix interactions and MSC markers [19, 54-57], or 
GD2, Tie2 and CD146 progenitor cell-related surface receptors, which may have 
a fundamental role in IVD repair [45, 48, 49, 58, 59]. On the other hand, cell-
based approaches could enrich therapeutic cell suspensions on cells positive for 
those markers and repopulate the NP. Focusing on age-specific degenerative 
changes, one could also promote the downregulation of collagen-VI production 
(its main constituent) as a hypothetical approach to avoid extensive PCM 
deposition. Finally, activating the native regenerative cell machinery could be 
achieved by in situ delivery of key bioactive molecular cues [60]. 
Taken together, the results described in this dissertation represent a 
scientific contribution to a better understanding of nucleus pulposus cell biology, 
both in homeostasis and aging. Moreover, potential anti-aging molecular targets 
for novel therapies were highlighted, that ideally would help to mitigate age-
related disc disease. 
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Improvement of Bovine Nucleus Pulposus Cells
Isolation Leads to Identification of Three
Phenotypically Distinct Cell Subpopulations
Maria Molinos, Msc,1–3 Catarina R. Almeida, PhD,1,2
Raquel M. Gonc¸alves, PhD,1,2 and Ma´rio A. Barbosa, PhD1–3
Objective: Strategies to promote intervertebral disc (IVD) regeneration have been hindered by the lack of
knowledge of IVD fundamental cellular/molecular components. One of the key points to be addressed is the
characterization of nucleus pulposus (NP) cell population(s). This study establishes an improved method for
bovine NP (bNP) cell isolation, whose procedure is still not consensual among the literature, allowing a thorough
characterization of cell (sub)populations that exist in the young NP.
Methods: bNP was digested with distinct enzymes (collagenase-type-I, collagenase-type-II, and collagenase-
type-XI) at different concentrations (0.5, 1.0, and 2.0mg/mL), for 4 and 19 h. Cell yield, viability/apoptosis, and
morphology were analyzed by flow cytometry and imaging flow cytometry. Identification of cell subpopulations
within NP and its phenotype was investigated by assessing expression of CD29, CD44, CD45, CD34, CD146, and
Brachyury.
Results: It was found that bNP cells present a similar morphology independently of the digestive enzyme used.
However, cell yield was greatly improved by Coll-XI (2mg/mL) treatment for a short digestion period. Inter-
estingly, three subpopulations, with different sizes and auto-fluorescence, were consistently identified by flow
cytometry. And crucially, differential expression of cell markers was found among these subpopulations.
Conclusion:This study demonstrated that collagenase-type-XI is an efficient enzyme that is used for digesting bNP.
And most importantly, three phenotypically distinct subpopulations of cells where identified within the bNP. Such
knowledge is key for a better understanding of NP cell biology and its potential endogenous regenerative capacity.
Introduction
The intervertebral disc (IVD) is a complex andbioactive structure within the spine. Continuous multi-
directional mechanical forces allied to aging activate degen-
erative pathways in the IVD, which are responsible for many
disabling back diseases, and, ultimately, imply a heavy so-
cioeconomic impact.
Current treatments include rest, anti-inflammatory medi-
cation, physical therapy, and, as a last resort, spinal fusion,
total disc replacement, or discectomy. These treatments focus
on symptomatic management and do not address the under-
lying pathophysiology of the diseased tissue, resulting in
long-term suboptimal outcomes. Alternative strategies, such
as cell-based therapies, growth factor injection, gene therapy,
and tissue engineering, aiming at stopping or reducing de-
generation of the IVD, or at promoting its regeneration, are
being pursued.1,2 Recently, our group has shown that delivery
of a chemoattractor in the IVD can recruit mesenchymal stem
cells toward the nucleus pulposus (NP), which opened new
perspectives for IVD regenerative strategies.3 However,
success of current strategies has been hindered by the lack
of knowledge on the cellular and molecular components of
the IVD.
Cells in the adult IVD are usually divided in two popula-
tions, according to the different embryonic origin of the tissue
where they reside: (1) the fibroblast-like cells in the annulus
fibrosus (AF), which develop from the somites (sclerotome),
and (2) the chondrocyte-like cells in the NP, which derive
from the notochord (both mesenchyme-derived tissues).4 NP
cells share typical markers of extracellular matrix (ECM)
with AF cells or articular cartilage (AC) cells, such as type-II-
collagen, aggrecan, and versican.5 Expression of specific NP
markers has been also described but is species dependent. For
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instance, bovine NP (bNP) cells express synaptosomal-asso-
ciated protein, 25 kDa (SNAP25), tenomodulin (TNMD), and
cytokeratin-8 (CK8),5,6 while human NP cells express car-
bonic anhydrase-12 (CA12), paired box 1 (PAX-1), hae-
moglobin b–chain (HBB), and ovostatin 2 (OVOS2). Rat NP
cells exclusively express CD24, while rabbit NP cells express
type V collagen, matrix Gla protein (MGP), and Htra serine
peptidase 1 (Htra1). Most recently, a selection of markers has
been proposed to define the phenotype of NP cells.7
Cells isolated from degenerated and non-degenerated
human discs can differentiate into adipogenic, osteogenic,
and chondrogenic lineages, indicating that the IVD may
include progenitor cells within its population.8–14 In addi-
tion, expression of markers associated with progenitors (e.g.,
Tie2, GD2, Stro-1, Oct3/4, CD105, CD90, and Notch-1)
suggests that precursor cell populations might be present
within degenerated human discs.8,9 These findings indicate
that degenerated human discs may count on an endogenous
regenerative capacity, although the exact nature and origin
of the participating cells remains unknown.
Bovine IVDs have been proposed as a suitable model to
study Tissue Engineering and biological repair of human
IVD,15 and many studies have been published culturing
bovine IVD cells as a model.3,5,6,16–18 However, the non-
existence of a definitive cell marker or clear phenotypic
assays to distinguish NP cells from other cell types, the lack
of standardization of NP cell isolation methods, together
with differences in NP marker expression among distinct
species, raise questions regarding the proper identification of
cell types in IVD, establishment of in vitro cell cultures
from these cells, and comparison of results obtained from
different labs. A more standardized characterization of cell
populations within IVD, and particularly in NP, is crucial
when studying biological phenomena that might contribute
to both IVD degeneration and its potential regenerative
capacity.
Hence, in this study, a bovine model was used to evaluate
different isolation methods of NP cells. A new isolation
method was explored, guarantying high cell yield and via-
bility. Moreover, bNP cell morphology and phenotypic ex-
pression was thoroughly characterized immediately after
isolation by image analysis and flow cytometry.
Materials and Methods
bNP cell isolation
Caudal IVDs from 10- to 13 month-old bovine steers
were dissected until 3 h after death. NP was harvested from
7 to 8 IVDs. With a scalpel blade, NP was separated from AF
and vertebral endplates and finely chopped. Tissue digestion
was performed in Dulbecco’s modified Eagle’s medium
(DMEM; 21885 Gibco), supplemented with 5% v/v penicil-
lin–streptomycin (PAA Laboratories GmbH), 10% v/v am-
photericin B (PAA), 2.5% (v/v) of HEPES buffer 1mM
(Lonza), 1.5% (v/v) of NaCl 5M and KCl 0.4M solution (to
adjust osmolarity to 400mOsm), 1.3U/mL DNAse, as de-
scribed elsewhere,19 and one of three different enzymatic for-
mulations: collagenase-type-I (Coll-I), collagenase-type-II
(Coll-II), or collagenase-type-XI (Coll-XI) (C0130, C6885, and
C7657, respectively, SigmaAldrich), at different concentrations
(0.5, 1.0, and 2.0mg/mL). All enzymatic preparations contain a
mixture of the type I and II forms of the purified collagenase
enzyme, which differ in their affinity for different substrates, as
assessed by the manufacturer (www.sigmaaldrich.com/life-
science/metabolomics/enzyme-explorer/learning-center/
collagenase-guide.html).
Tissue/medium ratio was set at 10% w/v to prevent the
pH dropping below 6.8 during incubation. Tissue was di-
gested for 4 h (minimum time required to totally digest
tissue from at least one of the protocols used) or 19 h
(overnight digestion—tissue totally digested in all proto-
cols), in a humidified atmosphere at 37!C/5% CO2, and
under gentle stirring. ECM contaminants were filtered with
a 70 mm cell strainer.
Assessing bNP cell yield, viability, and apoptosis
Immediately on digestion, cell yield was quantified by
trypan blue exclusion and subsequently normalized by wet
tissue weight. Cell viability and apoptosis were assessed by
flow cytometry (FACS Calibur; BD Immunocytometry
Systems), using FITC-Annexin V Apoptosis Detection Kit I
(556547; eBioscience), according to the manufacturer’s
instructions.
Characterization of bNP cell morphology by imaging
flow cytometry
To examine the morphological features of freshly isolated
NP cells, cells were fixed in 4% w/v paraformaldehyde
(PFA) at room temperature for 15min, washed with phos-
phate-buffered saline (PBS), and permeabilized with 0.2%
v/v Triton, for 5min. After washing again with PBS, cells
were incubated for 20min at room temperature, with Phal-
loidin-AlexaFluor"488 (1:40 dil. per 2.0·105 cells, A12379;
Life Technologies), previously prepared in a PBS-1% w/v
bovine serum albumin solution, according to the manufac-
turer’s instructions. Shortly before acquisition, cells were
labeledwith DRAQ5 (1:1500 dil. per 2.0·105 cells, 65-0880;
eBioscience), run on ImageStreamX (IS; Millipore), and an-
alyzed with IDEAS software for cell area, diameter, nuclear/
cytoplasm ratio, and presence of vesicles. To quantify the
percentage of cells with bright vesicles and the nuclear-to-
cytoplasmic ratio, specific masks were developed and applied
to brightfield and fluorescence images:
—Morphology (M01, Bightfield): mask applied to cal-
culate cell area based on brightfield;
—Morphology (M02, Actin): to calculate cell area based
on actin staining;
—Erode (M05, 5): to calculate nucleus area;
—Spot (M01, Brightfield, Bright, 34, 1): mask designed
to mark bright vesicles within cells.
Characterization of bNP cell phenotype
Cell surface staining. The expression of surface markers
(Table 1) was analyzed by flow cytometry immediately on
cell isolation, without fixation, to guarantee exclusion of
dead cells with propidium iodide (PI) staining. First, cells
were left to recover from digestion for 30min in a humid-
ified atmosphere at 37!C/5% CO2. Cells were then washed
with PBS-2% fetal bovine serum (FBS) and incubated with
primary antibodies (Table 1), in the same solution, for 1 h at
room temperature. In the case of non-conjugated anti-CD34
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antibody, cells were, in addition, incubated with a secondary
goat anti-mouse-AlexaFluor488 antibody, in the same con-
ditions. After labeling, cells were washed with 2mL PBS-
2% FBS and run in FACSCalibur. Results were analyzed
with FlowJo software, Version 8.7.
Intracellular staining. To quantify brachyury intracellular
expression, cells were fixed in 4% w/v PFA at room tem-
perature for 15min and permeabilized with 0.2% v/v Triton
for 5min. Cells were then incubated with FITC-conjugate
anti-Brachyury antibody, for 1 h at 4!C, after which they
were washed with PBS-2% FBS and analyzed by imaging
flow cytometry (IFC).
Cell senescence analysis by flow cytometry. The senes-
cence of bNP cells was analyzed by the detection of beta-
galactosidase activity by flow cytometry, as described by
Debacq-Chainiaux et al.20 Briefly, bNP cells were treated
with Bafilomycin A1 (100 nM) for 1 h in fresh culture me-
dium at 37!C, 5% CO2, to induce lysossomal alkalinization.
Then, the substrate dodecanoylaminofluorescein di-b-D-
galactopyranoside (C12FDG, 33 mM) was added to the cell
suspension and incubated during 1–2 h. This substrate, when
hydrolyzed by beta-gal, becomes fluorescent. After incuba-
tion, the cells were washed in ice-cold PBS, stained with PI,
and analyzed by flow cytometry in an FACSCalibur.
C12FDG was detected on the FL1 channel. Negative con-
trols of bNP cells incubated only with Bafilomycin A1 or
with C12FDG were also performed. The data collected were
analyzed in FlowJo vs 8.7 software.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
version 6.0a for Mac OS X. D’Agostino and Pearson om-
nibus normality test was used to assess Gaussian distribution
of data. Results that did not follow a normal distribution
(cell yield, viability, apoptosis, cell subpopulations sizes
[P1, P2, and P3], and marker expression) were analyzed for
statistical differences using non-parametric Kruskal–Wallis
and Dunn’s multiple-comparison tests. In the case of cell
morphology data, which followed a Gaussian distribution,
groups were compared using a two-way ANOVA (Bonfer-
roni’s multiple-comparisons test). In all cases, a confidence
level of at least 95% (*p < 0.05) was considered.
Results
Isolation of bNP cells
In order to characterize bNP cells, the cell isolation pro-
cedure was first optimized. For that, three different com-
mercially available collagenase formulations were tested:
(1) Coll-I, the formulation most used in the literature; (2)
Coll-II, a mixture with augmented activity of type-II-colla-
genase; and (3) Coll-XI, with augmented activity of both
type I and II collagenases. The effect of enzyme concen-
tration (0.5, 1, and 2mg/mL) and tissue digestion time (4 h
and overnight) on cell yield, viability, and apoptosis were
addressed (Fig. 1).
For shorter digestion periods (4 h), cell yield increased in
a concentration-dependent manner with digestion by Coll-
XI. In particular, the median cell yield obtained with Coll-
XI digestion (2.0mg/mL) ([1.2–0.5]·106 cells/mg of
wet tissue) was significantly higher (*p< 0.05) than with
Coll-I ([6.3–5.8]·105 cells/mg of wet tissue) or Coll-II
([5.9–3.1]·105 cells/mg of wet tissue) (Fig. 1a, left). With
a longer period of digestion (overnight), no significant dif-
ferences could be found between the protocols tested, with a
high variability being observed (Fig. 1a, right). However,
lower cell yields were observed at higher enzyme concen-
trations (except for Coll-I). In particular, overnight digestion
with Coll-II at 2.0mg/mL resulted in a drop in cell yield to
0.2–1.6·105 cells/mg wet tissue.
In terms of cell viability, there was also an increase (79–
85%) when using Coll-XI, for shorter incubation periods,
and independently of enzyme concentration. Cell viability
after 4 h digestion with different collagenases ranged from
(1) 72%–15% to 81%–13% for Coll-I; (2) 63%–33% to
81%–19% for Coll-II; and (3) 79%–22% to 85%–16% for
Coll-XI (Fig. 1b, right). With prolonged digestion time, cell
viability showed a decrease, with exception of protocols
using Coll-I, with viability around 80% (Fig. 1b, right).
Finally, the median percentage of apoptotic cells stood
majorly below 5%, with no obvious differences between
formulations (Fig. 1c).
Table 1. Antibodies Used in Flow Cytometry Analysis
Fluorochrome lg/mL Clone Catalog no, manufacturer
Primary antibodies
Mouse anti-bovine CD29 AlexaFluor"488 TS2/16 303015, Biolegend
Mouse anti-bovine CD44 FITC 10 IL-A118 MCA2433F, AbD Serotec
Mouse anti-bovine CD45 FITC 10 CC1 MCA832F, AbD Serotec
Mouse anti-human CD146 AlexaFluor"647 5 OJ79c MCA2141A647T, AbD Serotec
Mouse anti-bovine CD34 — 24 Isotype N21, kindly provided
by Sakurai M44
Mouse anti-human Brachyury FITC 20 3E4.2 FCMAB302F, Millipore
Secondary antibody
Goat anti-mouse IgG AlexaFluor488 20 A-11017, Life Technologies#
Isotype controls
Mouse IgG1 k AlexaFluor488 10 MOPC-21 400132, Biolegend
Mouse IgG1 control FITC 10 PPV-06 21275513, Immunotools
Mouse IgG1 AlexaFluor647 5 sc-24636, Santa Cruz Biotechnology
Mouse IgG1 k purified 20 P3.6.2.8.1 14-4714, eBioscience
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Morphological analysis of bNP cells
In order to characterize bNP cell morphology immedi-
ately on isolation, freshly isolated bNP cells were analyzed
by IFC, using masks for brightfield images of cells and for
fluorescence images of the cytoskeleton and nuclei (Fig. 2).
Cells area was first quantified based on both brightfield
and fluorescence images of cell cytoskeleton (Fig. 2b).
Quantification on the cytoskeleton staining revealed that
bNP cells present an area ranging from 130–17 mm2 to
138–34mm2, independently of the method of tissue diges-
tion. These values were significantly different from the area
calculated based on brightfield images, which suggests the
presence of a structure surrounding the cell cytoskeleton in
most of the cells. In the case of cells dissociated with Coll-XI,
the cell area almost doubled (130–17 mm2 to 235–38 mm2,
for cytoskeleton and brighfield areas, respectively). The
presence of a pericellular matrix surrounding the cells was
confirmed by staining against type VI collagen (Supplemen-
tary Fig. S1; Supplementary Data are available online at
www.liebertpub.com/tea). Thus, cell diameter was analyzed
based only on images of actin staining (Fig. 2c). It was ob-
served that bNP cells have a diameter of*17.3–1.3 mm, not
varying with the tissue digestion method.
The nuclear-to-cytoplasmic ratio (N/C, nucleus area/
cytoplasm area) of bNP cells, a feature that has been pre-
viously linked to the presence of progenitor cells,21 was
quantified from the nuclei and actin staining (Fig. 2a, second
column). The N/C ratio of bNP cells isolated with Coll-I,
Coll-II, and Coll-XI (2.0mg/mL, 4 h digestion) ranged from
0.5–0.1 (Coll-II) to 0.6–0.1 (Coll-I and Coll-XI), respec-
tively (Fig. 2d, up), with no significant differences found
between the isolation methods. Thus, the area occupied by
the nucleus is about half the cytoplasmic area. Moreover, the
distribution of N/C ratio was very narrow within bNP cells
(Fig. 2d, down).
In addition, image analysis of bNP cells revealed the
presence of putative vesicles within the cytoplasm of these
cells (Fig. 2e, up). The percentage of bNP cells containing
vesicles was quantified by using a mask specifically de-
signed to trace bright spots in brightfield images (Fig. 2e,
down). The results obtained showed that around 50–60%
of NP cells presented one or more cytoplasmic bright ves-
icles (0.5–1.5 mm diameter), independently of the digestion
protocol used.
Characterization of bNP cells by flow cytometry
bNP cells freshly isolated with the different collagenases
(Coll-I, Coll-II, and Coll-XI) were analyzed by flow cy-
tometry (Fig. 3). Discarding PI-positive cells (dead cells),
three subpopulations (P1, P2, and P3) of live cells could be
consistently identified, based on their size (forward scatter-
height [FSC-H]) and auto-fluorescence (in FL3 channel),
evidencing a heterogeneous cell population within bNP
tissue. The presence of nuclei in these bNP cells was con-
firmed by DRAQ5 expression (Fig. 3c).
The subpopulations were distinguishable by (1) small
cells with high auto-fluorescence (P1); (2) large cells with
high auto-fluorescence (P2); and (3) median sized cells with
low auto-fluorescence (P3) (Fig. 3a). The frequency of each
subpopulation obtained with the different isolation meth-
ods was assessed (Fig. 3b). P2 is the most abundant sub-
population within bNP cells, with frequencies of 45–62%
(Coll-I), 48–65% (Coll-II), and 66–68% (Coll-XI). The P1
subset is less frequent: 32–47% (Coll-I), 29–50% (Coll-II),
and 25–28% (Coll-XI). Lastly, P3 is the least frequent
subpopulation (<10%): 4–8% (Coll-I), 3–6% (Coll-II), and
FIG. 1. Effect of collagenase (Coll) type, enzyme con-
centration, and digestion time on bovine nucleus pulposus
(bNP) cell isolation. Coll-I (white bars), Coll-II (light gray),
and Coll-XI (dark gray) were used at 0.5, 1, or 2mg/mL to
dissociate NP tissue for 4 h or overnight. Cell yield (cells/g of
wet tissue) (a), cell viability (% of live cells determined by
flow cytometry analysis of propidium iodide [PI] stained
cells) (b), and cell apoptosis (c) in the different conditions
were determined. Results are presented as box plot and
whiskers (min to max) with horizontal line at median (n = 4–
8). Results were analyzed for statistical differences using non-
parametric Kruskal–Wallis and Dunn’s multiple-comparison
tests (*p < 0.05, **0.001 < p < 0.01 and ***p < 0.001).
4 MOLINOS ET AL.
5–8% (Coll-XI). Different concentrations of Coll-XI lead to
the same distribution of the three populations. The three
subpopulations were also identified in old bovine animals
(>10 years) but with a different ratio: Lower P3 and higher
P1 percentages were observed (Supplementary Fig. S2).
Based on the higher cell yield obtained and consistency of
the subpopulations observed, subsequent assays were per-
formed with cells obtained by 4 h digestion with Coll-XI at
2.0mg/mL.
Senescence analysis of bNP cells by flow cytometry
The senescence of bNP cells was analyzed by beta-
galactosidade activity and its distribution within P1, P2, and
P3 subpopulations was assessed (Fig. 4). The data collected
showed that the bulk bNP cell senescence ranges from 13%
to 71%. When analyzing in greater detail, no senescent cells
could be observed within sub population P1, while P2 and
P3 present 60%–7% and 56%–48% of cell senescence,
respectively. When cell senescence (C12FDG
+) versus via-
ble cells (PI-) is analyzed, the existence of two populations
with senescent cells is clear but with distinct levels of auto-
fluorescence (Fig. 4, first line).
Phenotypic characterization of bNP cells
by flow cytometry
To deal with bNP cell characterization further, the phe-
notype of these cells was analyzed by flow cytometry. A
panel of markers for bNP cells was analyzed (Table 2).
Expression of each marker in the whole bNP cell popu-
lation was quantified (Fig. 5). Brachyury expression was
FIG. 2. Morphological analysis of bNP cells. (a) Images of bNP cells obtained by Imaging Flow Cytometry (first column:
brightfield images of cells; second column: merged fluorescence images of cells stained with phalloidin-FITC (actin, green)
and DRAQ5 (nuclei, red); (b) bNP cell area based on brightfield (white bars) and actin staining (black bars) images of tissue
digested with different collagenases: Coll-I, Coll-II, and Coll-XI (2.0mg/mL, 4 h digestion); (c) bNP cell diameter based on
actin staining for tissue digested with the three collagenases; (d) nuclear-to-cytoplasmic (N/C) ratio of bNP cells isolated
with the three different methods (top), and representative histogram of N/C ratio distribution of bNP cells isolated with Coll-
I, 2.0mg/mL for 4 h (bottom); (e) Percentage of cells containing one or more vesicles after isolation with the different
collagenases—a light blue mask specifically designed to mark and quantify bright vesicles within cells is shown in the
bottom brightfield images of cells. Results are presented as mean–SD of three independent experiments, where a total of
3661 cells for Coll-I, 993 cells for Coll-II, and 5385 cells for Coll-XI were analyzed. In the case of cell area analysis, groups
were compared using a two-way ANOVA (Bonferroni’s multiple-comparisons test). **0.001< p < 0.01 and ***p< 0.001.
Color images available online at www.liebertpub.com/tea
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FIG. 3. Identification of subpopulations of bNP
cells, based on size and auto-fluorescence, by flow
cytometry. (a) Contour plots of freshly isolated bNP
cells: PI expression versus forward scatter-height
(FSC-H) (left) and side scatter-height (SSC-H) versus
FSC-H (right). Three subpopulations of live cells (P1,
P2, and P3) could be consistently identified, with
distinct size and auto-fluorescence. (b) Percentages of
cells in P1, P2, and P3 subpopulations after NP di-
gestion with Coll-I, Coll-II, and Coll-XI (0.5, 1.0, and
2.0mg/mL, 4 h digestion). Results are presented as
mean–SD (n = 4–8), and analyzed for statistical dif-
ferences using non-parametric Kruskal–Wallis and
Dunn’s multiple-comparison tests. *p < 0.05 and
**0.001< p < 0.01; (c) PI and DRAQ5 staining of bNP
cells on isolation. Around 80% of all events are
DRAQ5 positive (n = 5). Color images available on-
line at www.liebertpub.com/tea
FIG. 4. Senescence analy-
sis of bNP cells. Freshly
isolated bNP cells were in-
cubated with C12FDG, a
fluorescent substrate for beta-
galactosidase. (A) The fluo-
rescence intensity of C12FDG
cell in the whole population
of bNP cells is represented in
the first line for a represen-
tative donor. The second line
illustrates the intensity of
C12FDG cells for subpopula-
tions P1, P2, and P3. C12FDG
was assessed in FL1 channel.
The cells were also stained
with PI (FL3 channel), to
exclude dead cells. (B)
Quantification of C12FDG
expression on bNP cell sub-
populations, P1, P2, and P3.
Results are presented as
mean–SD (n = 3 indepen-
dent donors).
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Table 2. Findings in the Literature and in This Study Regarding Markers Selected to Characterize Bovine Nucleus Pulposus Cell Phenotype
Marker Description Species Method Findings in the literature Findings in this study
CD29
(b1-integrin)
Cellular adhesion marker. Human,13,51,52
rabbit,53
porcine,52 rat11
IHC, FC Protein expressed by NP cells from degenerated
human IVDs and young AF cells, after
monolayer expansion. Also present in rabbit
and rat IVD and in immature porcine NP and AF.
Detected in more than 80%
of bNP cells immediately
on isolation.
CD44 Transmembrane protein.
Primary hyaluronic
acid receptor.
Human,9,54
rabbit,55–57
rat11,58
FC, IHC,
RT-PCR
> 80% expression by human CD24+ NP cells
and in cells cultured from herniated and
degenerated human IVDs, rabbit NP, and in the
developing and adult rat IVD. mRNA detected in
rabbit AF-derived stem cells.
Detected in nearly 20%
of bNP cells immediately
on isolation. One
subpopulation (P1) with
significantly higher
percentage of CD44+ cells.
CD45 Hematopoietic lineage-
restricted surface marker.
Human9,54 FC Not found in CD24+ NP cells nor in cells from
herniated and degenerated IVDs after culture.
Expressed by only 8% bNP
cells. Subpopulation P1
with higher percentage
of CD45+ cells. Expressed
only by cells from P1
and P2.
CD146 (MCAM
or MUC18)
Glycoprotein. Marker for
vascular endothelial cells,
smooth muscle cells,
pericytes and mesenchymal
stem cells.
Human9 FC Not found in CD24+ NP cells after culture. Expressed by more than 20%
of bNP cells. Expressed
only by cells from
subpopulations P1 and P2.
CD34 Transmembrane protein.
Marker for hematopoietic
progenitors and vascular
endothelial cells.
Human9,11,54,59–62 IHC, FC Detected in blood vessels in degenerated IVDs.
Also found in healthy AF and in NP obtained
by surgery. Not found in CD24+ NP cells nor
in cells from herniated and degenerated IVD
tissues after culture.
Expressed by around 2%
of bNP cells.
Brachyury (T) Transcription factor. Marker
for notochordal cells and
NP cells
Human,63,64 rat,65
mouse,63
bovine,64 dog66
WB, FC, IHC,
RT-PCR,
qPCR
Expressed in NP from degenerated human IVD.
mRNA expression by AF and NP cells from
normal and degenerated IVDs and in bNP cells.
15% expression by NP cells from 1 month-old
rats. High expression in the developing mouse
NP (not found in AF or cartilage endplates).
Decreased expression with aging and
degeneration in chondrodystrophic dogs.
Expressed by more than
90% bNP cells.
bNP, bovine nucleus pulposus; AF, annulus fibrosus; IHC, immunohistochemistry; FC, flow cytometry; WB, Western blot; RT-PCR, real-time polymerase chain reaction; qPCR, quantitative
polymerase chain reaction; IVD, intervertebral disc.
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FIG. 5. Phenotypic analy-
sis of freshly isolated bNP
cells, obtained after digestion
with Coll-XI (2.0mg/mL,
4 h). (a) Flow cytometry
contour plots of CD29,
CD44, CD45, CD146, and
CD34 expression of live bNP
cells (PI negative). Gates
were established according to
respective isotype controls
(bottom). (b) Graph shows
the mean percentage of live
cells expressing each of the
markers described, after sub-
tracting the respective iso-
type control. Results are
presented as mean–SD
(n = 5–7), and statistical dif-
ferences were assessed using
non-parametric Kruskal–
Wallis and Dunn’s multiple-
comparison tests
(**0.001 < p < 0.01 and
****p < 0.0001).
FIG. 6. Expression of the
cell surface markers CD29,
CD44, CD45, CD146, and
CD34 within P1, P2, and P3
subpopulations, after dead
cell exclusion by PI staining.
Results are presented as
mean–SD (n = 4–7) and
were analyzed for statistical
differences using non-para-
metric Kruskal–Wallis and
Dunn’s multiple-comparison
tests (*p < 0.05, **0.001<
p < 0.01, ***p < 0.001 and
****p < 0.0001). A compara-
tive summary of the per-
centages of cells expressing
each surface marker for the
different subpopulations is
presented in the table.
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quantified by IFC, through which it was also possible to
validate its correct intra-nuclear localization. The majority
of bNP cells were CD29+ (87.7%–4%) and Brachyury+
(90.8%–5%). Intermediate amounts of cells expressing
CD44 (18.6%–5%) and CD146 (22.3%–8%) were de-
tected, while only low percentages of hematopoietic-lineage
markers, CD45 (8.3%–4%) and CD34 (2.3%–1%), were
identified.
In addition, expression of each marker was analyzed in P1,
P2, and P3 subpopulations (Fig. 6). The frequency of Bra-
chyury+ cells within the three subpopulations was not ana-
lyzed, since the detection of this transcription factor could not
be simultaneously performed with PI staining, and almost all
bNP cells were Brachyury+ (Fig. 5). P2, the most frequent
subpopulation of bNP cells, was characterized by a large
number of cells expressing CD29 (98%–2%), some cells
expressing CD44 (16%–5%), and only a few cells expressing
CD146 (6%–4%), CD45 (7%–4%), and CD34 (5%–8%).
P3 (median-sized cells with low auto-fluorescence) showed a
profile similar to P2, with a high percentage of CD29+ cells
(85%–7%) and lower number of CD44+ cells (12%–7%).
However, no cells expressing CD34, CD45, or CD146 were
detected in P3. Finally, P1, the subpopulation of smaller
cells, had a significantly higher (**p < 0.025) percentage of
CD44+ cells (49%–2%). A higher percentage of cells ex-
pressing CD45 (24%–13%), CD34 (6%–5%), and CD146
(39%–17%) was also found within this subset. On the other
hand, the frequency of CD29+ cells (33%–7%) was signifi-
cantly lower (***p < 0.001) than that found in P2 and P3.
Observation of the FSC versus FL3 plots for the cells positive
for each marker leads to a clearer distinction between P2 and
P3 (Supplementary Fig. S3): CD45 and CD146 expression
was found in P2 but not in P3 (even though only a small
percentage of cells in P2 expresses these molecules).
Discussion
Envisaging standardization of NP cell isolation protocols
is widely variable within the literature,5,6,16–18,22 bNP di-
gestion was compared for different collagenases. Until now,
no commercially available formula was designed to digest
NP tissue specifically, most likely because it would serve a
relatively small, although fast-growing, community of re-
searchers in this field. Nevertheless, standardization of the
NP cells isolation method would increase the reliability of
results obtained in different labs.
Here, the results obtained show that bNP 4 h digestion
with Coll-XI (2.0mg/mL) originated higher cell yields than
with Coll-I or Coll-II. This suggests that for short-time pe-
riods, it is necessary to have a simultaneous increase of
enzymatic activity against both type I and II collagens to
better dissociate bNP tissue, although this tissue is known to
be enriched in type-II-collagen.23 Besides being faster,
treatment with Coll-XI did not require any additional step of
digestion with other enzymes commonly used for NP cell
dissociation, such as hyaluronidase24 or pronase, known to
negatively affect the expression of surface markers on AC
chondrocytes.25 On the other hand, for longer digestion time
periods (overnight), Coll-I revealed to be a better option
than Coll-XI, originating higher cell yields and increased
cell viability. Surprisingly, Col II digestion at this longer
time period caused very high cell death, suggesting that with
prolonged time of exposure, digestion of type-II-collagen is
more aggressive than type I collagen. In all conditions tes-
ted, cell viability was below values usually reported
(>95%),22 which may be due to the higher accuracy of the
PI-exclusion method, when compared with the commonly
used trypan blue dye exclusion assay.
Morphology of bNP cells after isolation was analyzed by
IFC, a technique that provides high-resolution images of
thousands of cells in flow, and analyses a wider array of
cellular parameters,21 when compared with confocal and
electron microscopy, traditionally used to characterize IVD
cells.26,27 bNP cells presented an N/C ratio around 0.5 and
an area of 120–130 mm2, in agreement with the mean surface
area of bovine IVD cells previously reported on freshly
isolated cells.6 Moreover, a structure surrounding bNP cell
membrane was detected, resembling a pericellular matrix-
like structure, frequently described in chondrons in AC,28
and also reported in human and rat IVD cells.29,30 As ex-
pected, this structure stained positive for the ECM protein
type VI collagen.23 Interestingly, the presence of bright
vesicle-like structures (0.5–1.5 mm diameter) was detected
in 60% of bNP cells. Other authors have already reported
the existence of cell vesicles in IVD cells: (1) 1–20 mm
vesicles were described in NP progenitors, that is, NC, from
non-chondrodystrophic mongrel dogs31; (2) 20 nm–100 mm
lipid droplets were described in mature human NP cells’
cytoplasm32; and (3) <1 mm size vesicles were recently de-
scribed in human NP cells.33 In addition, it has been sug-
gested that cell communication between NP cells can be
mediated by these membrane-bound microvesicles.33
Three subpopulations of bNP cells (P1, P2, and P3) were
consistently identified by flow cytometry, based on different
sizes and auto-fluorescence. NP cells auto-fluorescence was
very recently described and related with cell necrosis and
subsequent loss of mitochondrial membranes integrity,
which could expose flavoproteins to oxidation, causing a
blue-green shift in auto-fluorescence of cells.34 Never-
theless, the auto-fluorescence described here was exclusive
to live cells, that is, PI-negative events. Furthermore, the
senescence of each subpopulation of bNP cells was analyzed
by detecting b-galactosidase activity.35 Results showed that
bNP cells present a level of senescence of around 40%. In
the literature, b-galactosidase-positive cells ranged from 8%
to 95%, increasing with patients’ age and passage number.36
Here, no senescent cells were observed in P1, while both P2
and P3 presented higher senescence (*70–80%). Both
populations include senescent cells while showing different
auto-fluorescence levels, thus excluding the possibility that
P2 and P3 populations are only one subset of cells in a
different senescent state. Hence, the three subpopulations
could instead be at different metabolic states, or at different
stages of differentiation, as suggested elsewhere.7,37 Inter-
estingly, three subpopulations of human knee meniscus cells
(from a fibrocartilaginous tissue as the IVD) have also been
described, with a similar distribution of auto-fluorescence and
size.37 However, in this case, P1 (low size) was discarded,
while the P2 subpopulation was distinguishable from P3 by
the presence of a cell-associated matrix (expressing type I and
II collagens and aggrecan).37 Here, human NP cells obtained
from patients with degenerated IVDs, but with contained NP,
were also analyzed (Supplementary Methods ‘‘Isolation of
Human NP cells’’, Supplementary Fig. S4). However, there
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was no distinction of subpopulations, but it is unclear whether
this is due to differences in degenerated versus healthy discs
or to differences between species.
Expression of different surface markers was analyzed in
the three populations. Table 2 summarizes the main findings
reported here and previously published on expression of
these markers in other animal models. Here, high percent-
ages of cells expressing CD29 and Brachyury were detected
in bNP cells. CD29 is an anchorage protein involved in
cell adhesion and migration, and its expression was partic-
ularly abundant in P2 and P3 subsets. On the other hand,
Brachyury is one of the earliest indicators of mesoderm
formation during embryonic development. It has been sug-
gested as an NP marker in IVD4,5 and is mostly assessed
at mRNA level.5 Tang et al. reported much less cells ex-
pressing Brachyury (*15%) than what was observed in
this study (nearly 90%), which may be due to inter-species
differences.65 According to this result, we could discard AF
contamination in the samples analyzed.
In addition, about 20% of bNP cells express CD44, and
particularly the P1 subpopulation. This transmembrane
protein is a primary HA receptor that also binds to other
extracellular proteins, including fibronectin and type I and
VI collagens, and plays an important role during chon-
drogenesis.24 Importantly, although CD44 cell surface epi-
tope was reported to be especially sensitive to enzymatic
digestion,38 here we assured preservation of CD44 by
avoiding hyaluronidase digestion.24
Regarding CD45 and CD34, low expression of these he-
matopoietic-lineage markers was found, and more associ-
ated with P1 subset, although tissue contamination with
blood was not expected. Nevertheless, despite being con-
sidered an immune privileged site, it is becoming increas-
ingly evident that inflammatory-like cells16,17,39 or
phagocytic cells16 might be present in IVD. Although CD34
is known as a marker for hematopoietic progenitors40 and
vascular endothelial cells,41 its expression has also been
reported in other cell types such as skeletal muscle satellite
cells,42 hair follicle keratinocytes,43 hepatic cells,44 and
human fibrochondrocytes found within the superficial region
of the knee meniscus body.37 Hence, CD34 expression by
itself does not elucidate the origin of the small population
described here, and future studies will be performed to ad-
dress this, particularly by analyzing co-expression with
other markers (e.g., CD31—mature endothelial cells; CD38,
CD90—hematopoietic progenitors). Another study has
identified Tie2/Ang-1 expression, usually associated with
angiogenesis, in the avascular hNP microenvironment.9 In
fact, although endothelial cells are not expected within the
NP, some molecules usually expressed by those cells (e.g.,
Tie2/Ang-1, vascular endothelial growth factor-A [VEGF-
A], and its receptor, membrane-bound vascular endothelial
growth factor receptor-1 [mbVEGFR-1]) can also be ex-
pressed by NP cells, in response to hypoxic conditions.9,45
Interestingly, here, a subset of CD146+ cells was found in
bNP, particularly in P1. CD146 has been suggested as a
marker for endothelial cells,46 melanoma cells,47 and
MSCs,48 but had not been reported in NP cells or cartilage
cells earlier. Its expression has been linked to MSCs mul-
tipotency and differentiation potential.49 Expression of
markers as CD146, together with MSCs non-specific
markers, such as CD44 or CD73 and absence of blood and
endothelial markers have also been linked to the existence
of vascular pericytes, cells with multipotency and clonal
capability.50 Although expression of CD146 has not been
found in human IVDs,9 here a subset of bNP cells was found
to express this marker.
Overall, the P1 subpopulation appears to be a distin-
guishable subset of bNP cells, enriched in CD146+ and
CD44+ cells, while also containing few CD45+ and CD34+
cells. Cells within this subset present a more progenitor-like
phenotype than those found in P2 or P3, which, due to their
CD29 expression, could represent populations with higher
migratory capacity. Regarding P2 and P3, senescence does
not justify the differences in auto-fluorescence, and CD45
and CD146 expression was found in P2 but not in P3. Thus,
the three populations described here can be identified by
auto-fluorescence and size or by the combination of mark-
ers, but not a single marker.
The data collected with young and old animals suggest
morphological changes with aging, with a decrease in P3
subset accompanied by an increase in P1. It is widely known
that age affects NP cell morphology and molecular signa-
ture.32 In particular, human/mouse NP progenitor cells
identified by Tie2 expression were reported to be exhausted
with age.9 However, whether differences in P1/P2/P3 pro-
portion for animals with different ages correlate with dif-
ferences in NP cells phenotype is still being addressed.
In summary, this study presents new evidence on the
heterogeneity of young NP cells. Future studies will be
crucial to understand the contribution of each population for
NP repair.
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Supplementary Figure S1: Expression of type VI collagen on the pericellular matrix of bovine NP cells. 
Micrographs show brightfield (left) and fluorescence images (right) of freshly isolated bovine NP cells stained 
against collagen type VI and imaged by imaging flow cytometry (a) or confocal microscopy (b). A 
punctuated staining can be observed located in and outside the cytoplasm of the cells. Fluorescence and 
brightfield in b show a maximum projection and single slice, respectively. Control refers to cells stained only 
with the secondary antib dy.  
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Supplementary Figure S2: Comparison of bNP cells size and auto-fluorescence analysed by flow cytometry of 
young and aged animals. A) Representative dot plots of Propidium Iodide expression versus size (FSC) of 
bNP cells from young and old animals. B) Distribution of P1, P2 and P3 subpopulations in young and old 
bovine animals. Results are presented as Mean±StDev (n=5 for old animals, n=4-7 for young animals) and 
were analysed for statistical differences using non-parametric Kruskal-Wallis and Dunn’s multiple 
comparison tests (** 0.001 < p < 0.01 and **** p < 0.0001).  
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Supplementary Figure S3: Representative analysis of the distribution of each analysed marker (CD29, CD44, 
CD45, CD34 and CD146) within the 3 populations (P1, P2 and P3) of bNP cells.  
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Supplementary Figure S4: Representative dot plot of Propidium Iodide expression versus size (FSC) of 
human NP cells obtained from biopsies of degenerated IVD with contained NP.  
29x27mm (300 x 300 DPI)  
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Intervertebral disc (IVD) degeneration is one of the major causes of low back
pain, a problem with a heavy economic burden, which has been increasing
in prevalence as populations age. Deeper knowledge of the complex spatial
and temporal orchestration of cellular interactions and extracellular matrix
remodelling is critical to improve current IVD therapies, which have so far
proved unsatisfactory. Inflammation has been correlated with degenerative
disc disease but its role in discogenic pain and hernia regression remains
controversial. The inflammatory response may be involved in the onset of
disease, but it is also crucial in maintaining tissue homeostasis. Furthermore,
if properly balanced it may contribute to tissue repair/regeneration as has
already been demonstrated in other tissues. In this review, we focus on
how inflammation has been associated with IVD degeneration by describing
observational and in vitro studies as well as in vivo animal models. Finally,
we provide an overview of IVD regenerative therapies that target key
inflammatory players.
1. Introduction
Between 70 and 85% of all people have low back pain (LBP) at some time in
their life. LBP can limit the activity in people younger than 45, causing a tre-
mendous socio-economic impact [1]. The aetiology of LBP is unclear but in
40% of cases it is related to intervertebral disc (IVD) degeneration [2]. In 90%
of sciatica cases, it is also associated with a herniated IVD that compresses a
nerve root causing pain [3]. Novel strategies such as gene therapy, growth
factor injection, cell-based therapies and tissue engineering approaches are
being developed towards impairing degeneration or promoting regeneration
of the IVD [4]. However, to achieve full IVD regeneration it is also necessary
to recover the biomechanical properties of a native IVD and restore the biologi-
cal behaviour of resident cells, including production of healthy extracellular
matrix (ECM), while ensuring reduction of IVD-associated pain.
Traditionally, inflammation has mostly been seen as detrimental and corre-
lated with disease progression, but it remains unclear whether it is a cause or
consequence of IVD degeneration and herniation. A balanced inflammatory
response may be required for restoring IVD function as recently suggested
for other tissues [5,6]. In this review, we will discuss the inflammatory reaction
in IVD, both in homeostasis and IVD degeneration, and comprehensively
cover the strategies applied to inflammatory cells and factors targeted towards
IVD regeneration.
2. The origin of inflammation in intervertebral disc
Inflammation has mostly been regarded as a response to infection or tissue
injury, but the scientific community has been increasingly researching its phys-
iological role in maintaining tissue homeostasis [7]. In general, the mechanisms
of inflammation are dependent on the inducing agent and context, with the
inflammatory response in the context of infection having been investigated
the most. In the infection instigated inflammatory response, plasma and
& 2015 The Author(s) Published by the Royal Society. All rights reserved.
leucocytes are recruited to the site of infection and soluble
mediators that lead to recruitment and activation of other
cell types are secreted. A complex cascade of events is trig-
gered that eventually leads to clearing infection from the
tissue and resolution of inflammation. In response to tissue
injury, there also exists a vascular response and an orche-
strated recruitment and activation of various cell types.
However, the IVD is an avascular tissue and therefore it is
unsurprising that the inflammatory response is different in
this context.
The process of IVD degeneration implies a cascade of
structurally disrupting events, normally starting with declin-
ing nutrition of cells within the central IVD, followed by
accumulation of cell waste products and degraded matrix
molecules. This creates an increasingly acidic environment
which further compromises cell viability [8]. Various causes
have been hypothesized to play a role in the pathogenesis
of degenerative disc disease (DDD), such as endplate calcifi-
cation, leading to an impairment of normal nutrition routes,
excessive mechanical loading, genetic pre-disposition,
unhealthy habits, ageing and spine infection [9–16]. Regard-
less of the cause, inflammation is an omnipresent player, and
its association to LBP is clear [17]. Yet, it remains uncertain
what may trigger the recruitment of immune cells to IVD
and the associated inflammatory response (figure 1).
One hypothesis for the cause of the IVD inflammatory
response relies on endogenous factors, such as crystals
and ECM breakdown products, which could induce the
inflammatory response [7]. Crystal deposits of calcium pyro-
phosphate dihydrate (CPPD), cuboid microstructures
(characterized as magnesium whitlockite) and hydroxyapa-
tite (HA) have been observed in degenerated IVD
specimens [15,18–20]. In articular cartilage, regions
with crystals showed altered amounts of collagen, calcium-
binding proteins, decorin and large proteoglycan content,
as well as abnormal pericellular matrix deposition [21,22].
Phagocytosis of crystals present in joints and pericellular tis-
sues can trigger activation of the NOD-like receptor family
pyrin domain containing 3 (NALP3) inflammasome. This
cytoplasmic multimolecular protein complex regulates
activity of caspase-1 and maturation and release of inter-
leukin (IL)-1b [7,23], the latter being commonly found in
degenerated IVD [24].
ECM breakdown products generated during tissue dys-
function or damage may also promote an inflammatory
response as has been shown in various models [25,26]. The
IVD is mostly composed of ECM molecules, including col-
lagens, proteoglycans and other matrix proteins (see table 1
for more information), which are continuously synthesized
and degraded by local existing proteases to maintain
extruded NP
exogenous inflammatory cells:
macrophages, lymphocytes,
dendritic cells (?), ...
ageing
foreign bodies
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IL-1b
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IL-6
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IL-12
IL-17
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Figure 1. Inflammation in the IVD. It is unclear whether inflammation is the cause or consequence of disc degeneration and herniation, and what may trigger
activation and recruitment of different immune cells. The normal ageing process allied to some genetic pre-disposition causes the IVD to degenerate giving rise to
profound changes in the ECM—loss of proteoglycan content, dehydration, malnutrition, decrease of native cell population, matrix breakdown and calcifications. In
this scenario, the natural response to mechanical loading is compromised and the IVD becomes prone to microfissures and consequent ingrowth of blood and nerve
vessels. (1) Disc herniation may also occur when the AF is no longer able to sustain the NP. ECM fragments and microcrystals may internally elicit an inflammatory
response, stimulating endogenous IVD cells to produce pro-inflammatory mediators, that will further feed the cascade of tissue degeneration—IL-1b, IL-8, IL-6.
(2) NP is recognized as non-self by the immune system. Hence, its exposure (both in microfissures and herniation) may propagate an immunologic response, with
recruitment of macrophages, lymphocytes and other possible inflammatory cells, in order to eliminate the foreign body. Discogenic pain has been many times
attributed to TNF-a, PGE2, NO and IFN-g secretion by macrophages, concomitantly with NGF and substance P production, accompanying the processes of
nerve ingrowth and angiogenesis inwards the degenerated IVD. Activated B and T lymphocytes are also recruited to the site, contributing to the positive pro-
inflammatory feedback loop established. It is not well understood how endogenous IVD cells interact with exogenous inflammatory cells and whether they positively
contribute to tissue resorption and regeneration or not. Spontaneous disc regression is currently believed to be a consequence of macrophage activity.
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Table 1. Main extracellular matrix components of a young and healthy IVD.
name distribution/localization putative/possible function
collagens
fibril-forming collagens
type I AF and NP confers tensile stiffness allowing torsion and flexion [27–30]
type II AF and NP confines PG within the matrix to retain more water to allow larger deformations
and withstand greater compressive loads [31,32]
type III NP and outer AF organizes pericellular environment; allows extensibility of tissue [33–35]
type V AF and NP (increased in AF cells
when compared to NP cells)
regulates fibril diameter (smaller if this collagen is more abundant) influencing
mechanical properties [35,36]
type XI [37] all over, mostly NP regulates fibril diameter (smaller if this collagen is more abundant) influencing
mechanical properties [35,38]
beaded-filament forming collagens
type VI all over, mostly NP helps cell fixation to the matrix and facilitates collagen bundles’ sliding and
lubrication [39,40]
FACIT collagens
type IX NP maintains matrix integrity [41,42]
type XII AF might regulate fibrillogenesis [29,43]
type XIV AF might regulate fibrillogenesis [29,43]
proteoglycans
aggregating PGs
aggrecan AF and NP maintains IVD’s osmotic pressure; may act as an anti-angiogenic factor due to its
inhibition of endothelial cell migration [40,44,45]
versican all over, mostly AF favours the attachment of adjacent lamellae, contributes to resistance to compressive
forces and facilitates cell migration, since it is an anti-adhesive molecule [35,40]
non-aggregating PGs
small leucine-rich proteoglycans (SLRPs)
decorin outer AF and fibrillar NP regulates collagen fibril diameter and spacing, maintaining uniform patterning; GFs’
reservoir (TGF-b), modulating ECM metabolism [46–48]
biglycan outer AF and NP (fibrillar and
pericellular region)
GFs’ reservoir (TGF-b), modulating ECM metabolism [46,47]
asporin outer and inner AF, rarely NP GFs’ reservoir (TGF-b), modulating ECM metabolism; may play a major role in
modulating chondrocyte matrix homeostasis [49,50]
fibromodulin AF and NP regulates collagen fibril diameter and spacing, maintaining uniform patterning; GFs’
reservoir (TGF-b), modulating ECM metabolism [44,47]
lumican AF and NP regulates collagen fibril diameter and spacing, maintaining uniform patterning
[44,51]
prolargin (encoded
by PRELP*)
all over, mostly AF anchors basement membranes to the underlying connective tissue [44,52]
chondroadherin AF and NP binds integrin ad collagen; regulates cell metabolism and ECM structure, promoting
matrix homeostasis [44,53,54]
osteoglycin/
mimecan
AF and NP unknown [44]
other matrix proteins
other PGs
perlecan AF and NP has a role in cell proliferation and differentiation by acting as co-receptor for FGFs;
matrix organization and stabilization; role in FGF signalling [40,55]
(Continued.)
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homeostasis (table 2) [66,74–76]. However, when an imbalance
occurs, degradation products might trigger inflammation. For
instance, fibronectin fragments alleviate metalloproteinase
(MMP) inhibition and so promote monocyte migration
in vitro [77]. This certainly facilitates their recruitment into
the inflamed region. Fragments of laminin, collagen type
XIV and fibrin can also modulate inflammatory cell
infiltration and proliferation in other systems [26]. In cartilage
explant cultures, fibromodulin fragments are produced fol-
lowing IL-1 stimulation [78]. In different in vitro settings,
fragments originated from elastin, laminins, collagen (type I
and IV), fibronectin, ectactin/nidogen, thrombospondin and
hyaluronan also induce protease and cytokine production,
independent of their chemotactic activity [79]. Some of the
Table 1. (Continued.)
name distribution/localization putative/possible function
fibronectin all over the disc preserves structural integrity of the ECM; involved in cell adhesion through
interaction with integrins [56–58]
elastin all over the disc preserves structural integrity of the ECM; helps to regain disc height and shape after
deformation [59–61]
COMP all over, mostly AF preserves structural integrity of the ECM; binds other matrix proteins and catalyses
polymerization of type II collagen fibrils; prevents vascularization of cartilage
[62,63]
thrombospondin AF preserves structural integrity of the ECM; mediates cell adhesion, matrix–matrix
interactions, cell migration and proliferation in other tissues; might prevent
vascularization of the tissue; activates TGF-b complex [64,65]
Table 2. Main IVD proteinases.
name distribution/localization putative/possible function
aggrecanases
ADAMTS1, 4, 5, 9 and 15 ADAMTS1: NP and AF
ADAMTS4: low levels NP and AF
ADAMTS5: low levels NP and AF
ADAMTS9: NP and AF
ADAMTS15: low levels NP and AF
degrades aggrecan [66–69], as well as versican, biglycan,
fibromodulin, COMP, TSP1, TSP2, nidogen, among other
substrates [70]
collagenases
MMP1, 8 and 13 MMP1: low levels, mostly inner AF and NP
MMP8: low levels
MMP13: low levels, mostly NP
cleaves fibrillar collagen [66–68]
gelatinases
MMP2 and 9 MMP2: low levels, mostly inner AF and NP
MMP9: low levels AF and NP
degrades denatured collagen and basement membrane
collagen [68]
stromelysin
MMP3 and 10 MMP3: low levels, mostly in the adult NP
MMP10: only checked in the NP
digests non-collagenous matrix proteins and denatured
collagen [66,68,71]
matrilysin
MMP7 NP and inner AF degrades aggrecan and collagen type II [72]
other MMPs
MMP19 AF and NP cleaves aggrecan, COMP, types I and IV collagen, and
fibronectin and acts on tenascin; can interfere with
stabilization of capillary-like structures, possibly playing
a role in the avascular status of the disc; regulates IGF-
mediated proliferation in other tissues by proteolysis of
IGFBP3 [73]
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aforementioned studies were performed in highly vascular-
ized model systems (i.e. cardiovascular, lung or renal
tissues). While these systems are very different from healthy
adult IVDs, which are largely avascular, their findings might
still be of relevance when studying phenomena associated
with disc herniation or sequestration, in which blood vessels
are much more abundant [80].
It appears that fragment release initiates and propagates
the inflammatory response locally. Many of these fragments
(e.g. originated from biglycan, fibronectin, hyaluronan)
signal through toll-like receptor-2 (TLR2) and/or TLR4 in
other model systems [81,82]. TLR4, in particular, is a well-
known pattern recognition receptor involved in innate
immune responses that has been implicated in inflammatory
degeneration [83]. In human IVD cells, hyaluronic acid frag-
ments (fHA) lead to increased mRNA expression levels of
inflammatory and catabolic genes IL-1b, IL-6, IL-8, cyclooxy-
genase (COX)-2, metaloprotease-1 and -13, and IL-6 [84].
However, while IL-6 production is dependent on TLR2 it is
independent of TLR4. It should be noted that low and high
molecular weight molecules can have different effects, even
through the same pathways. For example, high molecular
weight hyaluronan protects epithelial cells against pro-
apoptotic stimuli through NF-kB activation, in a TLR
dependent way. Low molecular weight degradation products
can induce inflammation, promoting macrophage media-
ted production of IL-1b and tumour necrosis factor alpha
(TNF-a), through activation of the NF-kB/IkBa complex
[82]. It is difficult to assess the overall role of ECM proteins
within an immune setting because of their dual roles and
because many proteases and a variety of fragments are
released simultaneously. This difficulty is exacerbated by
the scarcity of in vivo data, owing to limitations in the tech-
niques used to detect fragments and immune cells, which
are present at low concentrations and are short lived [85].
Numerous studies suggest that the IVD might endogen-
ously include inflammatory-like cells [86,87]. In particular, it
has been shown in vitro that a population of IVD cells can
phagocytize beads and apoptotic bodies [86]. In turn,
human surgical non-herniated nucleus pulposus (NP) samples
presented a high number of resident CD68þ cells [87].
Furthermore, a recent robust analysis of cytokine/chemokine
expression profile of human NP cells has presented clear evi-
dence that NP cells, or at least some of them, are producers
of specific inflammation-associated molecules, even in basal
conditions (non-degenerated NP) [88]. In addition, infiltrated
leukocytes (CD11b-positive cells) were found even in pro-
lapsed IVDs, where NP is supposedly intact and isolated
from any vascular source of immune cells [88]. The question
of whether these cells could be resident macrophages or macro-
phage-like cells remains. Although pleiotropic, cytokines and
chemokines have three modes of action: (i) stimulating the
production of other inflammatory mediators and MMPs,
(ii) enhancing matrix degradation, and (iii) recruiting inflam-
matory cells and activating phagocytosis [89–94]. Together,
these effects can contribute to disease progression in the IVD.
It should be stressed that extreme mechanical loading has
also been shown to alter ECM properties (through proteinase
activation) and promote inflammation, contributing to IVD
degeneration [95]. Apart from in vitro studies, organ cultures
of bovine caudal IVDs have shown that compression induces
apoptosis, produces inflammatory mediators and alters
matrix integrity, leading to development of the disease [96].
In a more advanced degenerative stage, the well con-
tained and apparently ‘sealed’ NP (immune privileged)
becomes exposed to immune cells, which, responding to an
inflammatory stimulus, may arise from newly formed blood
vessels that invade pathological clefts and tears found in
the annulus fibrosus (AF). Nociceptive nerve fibre ingrowth
also accompanies angiogenesis and is believed to be the
origin of discogenic pain that actively contributes to LBP
[97–100]. Indeed, while the probable sites for focal damage
and inflammation are vertebral endplates and AF (the only
sites where the IVD is vascularized) [101], the NP is capable
of attracting leukocytes and increasing vascular permeability
when implanted subcutaneously [100]. An increase in
expression of some cytokines and MMPs in herniated IVD
may occur when molecules seen as ‘non-self’ by immune
cells become exposed. This may also be linked to the
phenomenon of spontaneous regression or disappearance of
extruded IVD fragments, which has been attributed to
matrix degradation and phagocytosis by recruited/infiltrated
macrophages [102–106]. In cases with transligamentous
extrusion, which can occur when the NP is potentially
more exposed to immune cells, regression occurs [107]. Fur-
thermore, the survival rate of subcutaneously transplanted
rat NP cells is higher in immunocompromized NOD mice,
and both rat macrophages and NK cells lyse autologous NP
cells in vitro, indicating that immune cell populations respond
to NP tissues [108].
In the next sections, we will review observational, in vitro
and in vivo studies of the inflammatory milieu in IVD.
3. Inflammatory key players in intervertebral disc
3.1. Observational studies
A range of cytokines have been found in human IVDs in vary-
ing amounts, depending on whether the IVD is healthy,
degenerated or herniated. Table 3 groups by methodology
(observational, in vitro or pathway analysis) some of the
most important studies that have clarified which inflammatory
factors are expressed during homeostasis and with degener-
ation. Importantly, the identity of the cells producing these
mediators (i.e. NP cells, AF cells, native IVD cells only,
native cells plus infiltrating inflammatory cells) is highlighted.
3.1.1. Post-mortem samples
Separating NP from AF tissue upon discectomy is a very
challenging task, particularly when dealing with degenerated
human IVD tissue. In cases of disc herniation (e.g. extruded,
sequestered), the IVD is invaded by other cell types, con-
founding analysis of molecules released by regions of the
IVD. Samples taken post-mortem, which are not contamina-
ted by infiltrating inflammatory cells (or at least not to the
same extent as herniated discs), are therefore superior when
investigating IVD homeostasis. For instance, TNF-a was sub-
stantially expressed in autopsy material in fetal/infantile and
older adult NP, whereas it was sparsely expressed in adoles-
cent and young adult NP. It was not found in the AF of
young adults (below 25 years), but significantly increased
in older individuals [24]. Also, calcium-dependent phospho-
lipase A2 (PLA2), a regulator of prostaglandin E2 (PGE2)
production, has been found in both cadaveric and surgical
samples, and IVDs of middle-aged cases had higher PLA2
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Table 3. Inflammatory mediators found in the human IVD.
mediator condition producing cells references
inflammatory factors that are expressed during homeostasis
observational studies
TNF-a post-mortem and non-degenerate samples IVD cells [24,71,109]
IL-1b IVD cells [71,109–112]
IL-1a, IL-1Ra, IL-1RI, and
ICE
NP and AF cells [112]
IL-6, IL-8, RANTES AF and NP cells [110]
NGF NP and AF cells in monolayer and alginate
bead culture
[71,113]
NGF receptor (trkA) NP and AF cells in monolayer and alginate
bead culture
[113]
substance P [71]
PLA2 NP and AF cells [114]
CCL3 and CCL4 IVD cells [115]
NOTCH IVD cells [109]
MMPs IVD cells [71,92]
inflammatory factors that are expressed with degeneration
observational studies
TNF-a herniations (including subligamentous and
transligamentous), protrusion, extrusion,
sequestration, spondylosis, scoliosis,
degenerated or discogenic pain
IVD cells and infiltrating cells [24,71,116–121]
IL-1b [71,111,117,118,120,121]
IL-1a [117–119]
IL1-Ra, NO [118]
IL-6 [17,117,118,122]
IL-8 [17,119]
IL-12, IL-17, IFN-g [122]
IL-20 (and its receptors) [90]
IL-10, TGF-b, RANTES [119]
IL-16, CCL2, CCL7, CXCL8 [88]
substance P [71,118]
PGE2 [17,118]
COX-2 [121]
PLA2 [114,121]
NGF [71]
VEGF, bFGF [116]
GM-CSF [117]
CD20, CD45RO, CD68 [107]
MMPs [71,107,116,118]
in vitro studies
TNF-a degenerate, sciatica, discogenic pain,
extrusion, sequestration
IVD cells and infiltrating cells treated with
different inflammatory stimulus
(including IL-1b, TNF-a, substance P,
IL-17, IL-20, IFN-g, LPS) in monolayer
or three-dimensional cell culture, or co-
cultured with macrophage-like cells, or
exposed to high mechanical strain
[95,121,123–125]
(Continued.)
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activity than those of younger and older subjects, indicating
an important physiological role in maintaining homeostasis
[114]. Like TNF-a or PLA2, many other inflammatory key
players have been localized in non-degenerated human IVD
tissue (table 3). Importantly, IVD native enzyme activity
has also been studied. It was shown in the intact IVD that
IL-1 is a key cytokine mediating IVD matrix degradation,
by measuring enzyme activity (in situ zymography (ISZ))
against gelatin, collagen II and casein matrices [92]. Also,
MMP-10 expression (at mRNA and protein levels) was
increased in the symptomatic degenerate IVD, when com-
pared to non-symptomatic one—possibly contributing to
matrix degradation and initiation of nociception [71].
An additional perspective is given by studies that identified
factors not naturally produced by native IVD cells: immuno-
reactivity for IL-4, IL-6, IL-12 and interferon (IFN)-g was
modest in surgical IVD tissue, being higher in herniated
IVD samples and virtually non-existent in the control
Table 3. (Continued.)
mediator condition producing cells references
IL-1b discogenic pain and post-mortem [110,112,124–126]
IL-1a, IL-1Ra, IL-
1RI, and ICE
degenerate and post-mortem [112]
IL-6 discogenic pain, scoliosis, sciatica, extrusion,
sequestration, degenerate, myelopathy or
radiculopathy and post-mortem
[89,90,95,110,124,126–
129]
IL-8 discogenic pain, scoliosis, sciatica, extrusion,
sequestration, degenerate, myelopathy or
radiculopathy and post-mortem
[90,95,110,124,126–128]
IL-17A protrusion, extrusion and scoliosis [123]
IL-15, IFN-g, CXCL9,
TLR-2, TLR-4, MCP-3
post-mortem [95]
RANTES discogenic pain and post-mortem [110]
MCP-1 discogenic pain, scoliosis, sciatica, extrusion,
sequestration and post-mortem
[90,95,127]
TFGF-b1 discogenic pain, scoliosis, sciatica and post-
mortem
[95,127]
substance P myelopathy or radiculopathy [126]
bFGF scoliosis, sciatica and discogenic pain [127]
PGE2 degenerate, scoliosis, sciatica and discogenic
pain
[89,121,128–130]
COX-2 extruded and sequestrated IVD tissue [121]
NGF post-mortem [95,113]
NGF receptor (trkA) post-mortem [113]
PGF2a degenerate [128]
NO degenerate, scoliosis [89,124,129,130]
ICAM-1 (CD54) degenerate and scoliosis [89]
MMPs degenerate, non-degenerate, extrusion and
sequestration
[90,92,112,130]
NOTCH protrusion [109]
pathway analysis
NF-kB, MAPK and
C/EBPb! CCL3
discectomy IVD cells and infiltrating cells [115]
NF-kB!ADAMTS-4
and -5
DDD and myelopathy NP and infiltrating cells treated with IL-1b
and TNF-a
[131]
NF-kB!Sox9 and
collagen type II
spine trauma IVD cells treated with IL-1 [132]
NF-kB and
MAPK!NOTCH pathway
protrusion NP cells [109]
rsif.royalsocietypublishing.org
J.R.Soc.Interface
12:20141191
7
samples taken from post-mortem non-degenerated IVDs [122].
The majority of these reports used post-mortem IVD samples
as healthy controls, exposing the role of IVD native cells in
IVD homeostasis. This knowledge is of potential interest for
the development of endogenous therapeutic routes to restore
homeostasis in DDD.
3.1.2. Degenerated samples
Regarding human degenerated IVD samples, early studies
detected the presence of IL-1, intracellular adhesion molecule-
1 (ICAM-1), lymphocyte function-associated antigen (LFA)
and fibroblast growth factor (FGF) [133]. Immunoreactivity
for some cytokines (IL-4, IL-6, IL-12, IFN-g, TNF-a) seemed
modest but evident in herniated and degenerated discs, with
substantial macrophage infiltration [116,122]. Also, pathologic
discs highly expressed IL-17, suggesting the involvement of
Th17 lymphocytes in disc herniation [123]. Others have
shown a higher expression of TNF-a, IL-1b, IL-6, IL-8, IL-20,
PGE2 and nitric oxide (NO) in herniated discs [17,90,117].
Some inflammatory key players have also been associated
with pain in human IVD: RANTES and IL-1b expression was
significantly higher in painful versus painless discs, contrarily
to IL-6 and IL-8 [110]. A strong difference was observed in
the levels of nerve growth factor (NGF), neurofilament-68,
growth-associated protein (GAP)-43, and substance P in invad-
ing nerve fibers, in and around the outer layer of uncontained
herniated versus spondylotic IVDs [116]. Another study that
evaluated 91 cytokine- and chemokine-associated genes in
human NP cells showed that NP cells are a source of IL-16,
CCL2, CCL7 and CXCL8 [88]. Some of the pro-inflammatory
cytokines usually present at increased levels in human degen-
erated discs, such as IL-1b and TNF-a, may mediate catabolic
effects, decreasing proteoglycan production and enhancing
MMP expression [71,111,134,135].
3.2. In vitro studies
Different in vitro studies have focused on studying the sources
and role of some inflammatory mediators associated with her-
niated and degenerated IVD. An increase in IL-6, IL-8 and
PGE2 was observed in control and degenerated human IVD
tissues upon lipopolysaccharide (LPS) stimulation [127].
Furthermore, it was shown that substance P, expressed by
IVD cells, upregulates IL-1b, IL-6 and IL-8 in both NP and
AF, and RANTES and TNF-a in AF only [126]. Also, NP
cells were shown to express the CCL3 ligand (also known as
macrophage inflammatory protein (MIP)-1a), which is well
known for its chemotactic and pro-inflammatory effects,
through activation of the MAPK, NF-kB and C/EBP signalling
pathways after treatment with IL-1b or TNF-a [115]. These
studies suggest a contribution of native IVD cells to the inflam-
matory milieu. However, others have defended the hypothesis
that immune cells, such as macrophages, neutrophils and T
cells, can be recruited to degenerated IVD [135]. This hypoth-
esis is supported by evidence that Th17 cells expressing
CCR6 are recruited to degenerated IVD by CCL20 secretion
from NP [123], and that macrophages can migrate after stimu-
lation with conditioned medium from rat NP cells treated with
IL-1b or TNF-a [115].
TNF-a, which is one of the most studied pro-inflamma-
tory molecules, is known to promote aggrecan degradation,
disc catabolism and expression of pro-inflammatory cyto-
kines and NGF, without any recovery [136]. TNF-a is an
adipokine that has been associated with higher numbers of
bovine IVD senescent cells and is therefore implicated with
the inability of degenerated IVD to repopulate by itself
[137]. Curiously, although many studies have focused on
the role of TNF-a in IVD degeneration [136], Hoyland and
co-authors suggest instead that IL-1b is the key regulator of
matrix degradation in degenerated IVD: IL-1 has greater
expression in the IVDs clinically associated with chronic
LPB and treatments against IL-1b were shown to inhibit
matrix degradation [92]. IL-1 is upregulated in degenerated
human discs, inducing MMP7, MMP13 and ADAMTS
(a disintegrin and metalloproteinase with thrombospondin
motifs)—suggesting a deregulation of the normal IVD
homoeostasis [138]. TNF-a blockers had no effect on
matrix-degrading activity, suggesting that its upregulation
in DDD is not associated with matrix degradation [92] but
instead with neighbouring nerve root irritation, which is
confirmed by other studies [134,139]. Hence, TNF-a might
be contributing to discogenic pain in cases where nerve
ingrowth into IVD degenerative fissures occurs [140,141].
3.3. In vivo studies
Although some IVD degeneration related inflammatory
mediators identified in vitro have not yet been studied
in vivo, recent evidence has shed light on the role of several
molecules. The majority of studies have been conducted in
rat, rabbit and porcine animal models.
In a rat animal model of IVD herniation, NP exposure led
to increased IL-6, TNF-a and IFN-g levels. Other cytokines
(IL-1b, IL-10, IL-1a and IL-2), already increased by the surgical
procedure, were not altered [142]. In another study, TNF-awas
identified in rat herniated IVDs and associated with radicular
pain [139]. Also, a rat model of caudal annular incision demon-
strated a transient peak in IL-1b 4 days following injury. This
model was characterized by NP size decrease, annular collagen
layer disorganization, and cellular metaplasia of annular fibro-
blasts to chondrocyte-like cells. However, no significant
changes in TNF-a or IL-6 were seen [143]. In a lumbar rabbit
annular incision model, no alteration in IL-1a or TNF genes
was observed in whole IVDs at either one or three weeks
after injury [144]. In the same model, IL-1b, transforming
growth factor (TGF)-b1 and iNOS (inducible nitric oxide
synthase) gene expression increased after three weeks, but
decreased between weeks 6 and 12, having a second peak at
24 weeks—possibly showing a long-term pro-inflammatory
action [145]. In a rabbit model of IVD herniation, the presence
of TNF-a, IL-1b and MCP-1 (which has been demonstrated
to be a potent macrophage chemoattractant [146]) was also
analysed: TNF-a and IL-1bwere detected after day 1 (via immu-
nohistochemistry) followed by MCP-1 3 days post-injury.
Infiltrating cells, mainly macrophages, were also observed
after day 3 [147]. Interestingly, in a lumbar porcine model of
annular incision, a significant increase in IL-8 accompanied by
a decrease in IL-1was observed in IVDs subjected to discectomy
at 12weeks post-injury,while nodifferencewas observed indisc
morphology, proteoglycan content, or in levels of IL-6 and TNF-
a expression between untreated and injured IVDs. Whereas
both IL-1 and IL-8 have pro-inflammatory properties, the
authors propose that such discectomy procedure may be
capable of initiating a repair response in the IVD, given that
expression of IL-8 (an anabolic agent) is increased when the
catabolic IL-1 decreases [148].
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The TLR4-ligand LPS triggered inflammation when
injected in a rat caudal IVD [149]. LPS injection in a rat IVD
led to an increase in the levels of IL-1b, TNF-a, HMGB1
(high-mobility group box 1) and MIF (macrophage migration
inhibitory factor), which correlated with morphological
changes in tissue organization, namely interruption of NP/
AF border, contraction of NP shape and decrease of IVD
height [149]. Recently, different components of the tissue
renin-angiotensin system (tRAS) (angiotensin converting
enzyme, Ang II, Ang II receptor type 1, Ang II receptor type
2 and cathepsin D), that contribute to inflammation in many
organs, have been found for the first time in the normal rat
IVD, at both mRNA and protein levels [150]. However, the
association between tRAS and IVD degeneration and its
relationship to IVD inflammation has yet to be elucidated.
Most of these in vivo studies mainly identify and quantify
inflammatory mediators in IVD, but fail to produce a mechanis-
tic explanation of their role in either IVD degeneration or
regeneration. One of the reasons for this failure may be the diffi-
culty of unravelling the complex inflammatory mechanisms in
injury models of IVD pathology. In this context, animal
models of spontaneous IVD degeneration such as the sand rat
[151] and both younger chondrodystrophic (with cervical or
thoracolumbar IVD disease) and older non-chondrodystrophic
(caudal cervical or lumbosacral IVD disease) dogs [152,153]
could bring new insights to the clinic. However, as far as we
are aware, the inflammatory response has not been addressed
in these models. Importantly, differences between species
could also bring some intricacy to this issue. For instance, noto-
chordal cells (NC) seem to disappear in the adult human IVD,
while in many other species they are retained throughout adult-
hood [154]. As more models become available, it is central to
translate information between species and to interpret the
models appropriately to understand in greater depth theprocess
of inflammation.
4. Strategies to target and modulate
inflammation towards intervertebral disc
regeneration
Promoting IVD regeneration relies on restoring naive IVDprop-
erties by: (i) recovering IVD biomechanics, (ii) re-establishing
cell biological activity, including production of healthy ECM,
and (iii) reducing IVD-associated pain. Biological approaches
focusing on IVD regeneration or IVD-associated pain relief
begun in the early 1990s, and have since increased in number
and diversity as reviewed elsewhere [4].
A well-balanced approach supporting tissue regeneration
and control of inflammatory response could be successful in
reducing IVD-associated pain. Although themolecularmechan-
isms behind IVD pathology and inflammatory response remain
to be elucidated in detail, some inflammatory-relatedmolecules
are key targets of novel therapies in DDD [155,156]. In this sec-
tion, an overview of the strategies targeting inflammatory
mediators towards IVD regeneration will be given.
4.1. Injection of molecules
The more direct approaches to control inflammation in IVD are
to inject regulating agents close to the IVD. Example agents are
TNF-a blockers, such as infliximab, adalimumab, etanercept
[136,157–160], or IL-1 inhibitors, such as IL-1 receptorantagonist
(IL-1Ra) [161]. Other TNF-a blockers include amonoclonal anti-
body tested in herniated IVD patients, who showed less leg and
back pain after antibody administration [162], and a p38-TNF-a
inhibitor, which was tested in the spine to address neuroinflam-
mationbut not specifically for IVD [163].Other strategies involve
injecting corticosteroids into the IVD [164], or the anti-cholester-
olemic drug simvastatin [165], which appeared to retard IVD
degeneration in animal models.
The therapeuticpotential of IL-1Ra for sustainedattenuation
of IL-1b has also been explored using poly(lactic-co-glycolic
acid) (PLGA) microspheres as a delivery system [166]. IL-1Ra-
PLGA microspheres inhibited NO production in NP cell
cultures and partially restored the levels of iNOS, ADAMTS-4,
MMP-13, IL-1b, IL-6 and TLR-4, which were increased in the
presence in IL-1b [166].
Another candidate to control inflammation in IVDs is
COX-2, which regulates PGE2 synthesis in inflammatory con-
ditions. Epidural injection of COX-2 inhibitors was shown to
reduce pain in a rat model of IVD herniation [167]. Another
approach uses platelet-rich plasma (PRP) as a therapy for
degenerated IVD [168]—PRP was able to rescue chondrocyte
degeneration induced by IL-1b and TNF-a [169].
Other approaches to reduce IVD-associated pain have
been suggested. Resveratrol, a naturally occurring polyphe-
nol present in red wine, was able to reduce IL-6, IL-8,
MMP1, MMP3 and MMP13 expression when injected into
the IVD [170]. Rhein (4,5-dihydroxyanthraquinone-2-car-
boxylic acid), an anthraquinone molecule derived from the
rhizome of Rheum palmatum that exhibits anti-inflammatory
activity and is used in the treatment of osteoarthritis and
pain relief, was hypothesized to be a therapeutic agent for
IVD through the regulation of IL-1 activity [171]. Fullerol, a
derivative from fullerene and known anti-oxidant, retards
cellular apoptosis and suppresses dorsal root ganglion
(DRG) and neuron TNF-a-induced inflammatory responses,
which when incorporated into nanoparticles is relevant for
LBP treatment [172].
A very recent and promising approach to target inflam-
mation in IVD is the inhibitor of IkB kinase-b (IKKb),
involved in NF-kB activation. The intradiscal injection of
IKKb reduced the levels of TNF-a, IL-1b and IL-6 of an
injured IVD while suppressing high levels of neuropeptides
within DRG neurons [173].
Despite good results in other therapeutic areas, injected
molecules might be inefficient in DDD due to the short
half-life of proteins in solution and the limited effect of a
single protein in a complex process such as IVD degeneration
[174]. Also, the risk of inducing IVD degeneration by punc-
turing of the IVD should be considered [175], although
more recent studies describe alternative routes for molecule
delivery [176]. Furthermore, given the predominantly avascu-
lar nature of IVD, systemic delivery of soluble molecules is
unlikely to be effective in this situation. This view is sup-
ported by the report that the concentration of antibiotics in
IVDs was undetectable in the NP of patients with IVD infec-
tion under systemic administration of antibiotics [177]. In
addition, it has been shown that the rate of diffusion of anti-
biotics into the IVD is reduced by endplate calcification,
increase in IVD size and solute molecular weight [178,179].
Moreover, although some nutrients’ diffusion to the NP
may occur via the endplates, the short half-life of pharma-
ceutical drugs or proteins can result in limited therapeutic
doses that reach the NP [166].
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4.2. Gene therapy
Gene therapy promises more prolonged effects in DDD, by
introducing the possibility of locally modulating the
expression of a specific gene and the consequent production
of its protein [174]. As early as 1997, a study suggested gen-
etic modifications as a therapy for DDD [180]. At that point, a
retrovirus vector was proposed to transduce bovine chondro-
cytic endplate cells with IL-1Ra [180]. Cell transfection
resulted in IL-1Ra production in 48 h, and injection of trans-
fected cells in degenerated NP explants considerably reduced
expression of several enzymes (such as MMP3) for two weeks
after injection. This strategy aims at decreasing IL-1 mediated
matrix degradation and stopping DDD progression [181].
In vivo, TGF-b1 transfection of rabbit IVD cells also enhanced
proteoglycan synthesis for six weeks [182]. In agreement with
this result, cells from human degenerated IVD transfec-
ted with TGF-b1 increased both proteoglycan and collagen
production [183,184].
Gene therapy in a clinical setting may be limited by the
safety of the gene transfer vector. Aspects such as exposure
to high doses, long-term use, misplaced injections and the
possibility of oncogenesis are key concerns when treating a
chronic disease like DDD [185]. Progress in the development
of more reliable viral vector constructs and in a better control
of transgene expression would improve the safety of these
therapies. Also, elucidation of molecular mechanisms
behind the degenerative process and characterization of cell
populations in IVD, as well as their role in ECM production,
could bring new advancements to this field [174].
4.3. Cell-based therapies
Several cell-based therapies to stimulate IVD regeneration
have been proposed in recent years: haematopoietic stem
cells (HSC) [186], fetal spine cells [187], immortalized NP-cell
lines [188], autologous IVD chondrocytes [189], embryonic
stem cells (SC) [190], induced pluripotent SC [191], olfactory
SC [192] and MSCs (derived either from bone marrow
[193] or from umbilical cord blood [194]) have all been
suggested to have potential for IVD repair/regeneration. NP
progenitor cells were isolated from the NP (with approxi-
mately 1% frequency) and differentiated into chondrogenic
and neurogenic lineages, suggesting potential for IVD
regeneration [195]. Besides IVD regeneration, progenitor cells
might play a protective role in regulating inflammation
in IVD: rabbit NC were shown to reduce the levels of pro-
inflammatory cytokines, IL-6 and IL-8, as well as iNOS, in
in vitro co-cultures of AF cells with macrophages [196].
MSCs are one of the most attractive candidate cell types for
IVD regeneration, partly because they could be autologous
transplants. In a canine model, MSCs were able to increase col-
lagen type II expression while decreasing cell apoptosis in IVD
[197]. In rabbits, MSCs were able to remain in the IVD up to
24 weeks [198]. However, the number of transplanted MSCs is
crucial; in the canine model 106 MSCs per IVD was ideal,
since 105 MSCs resulted in decreased cell viability while 107
MSCs induced cell apoptosis [197]. Besides MSC multi-
differentiation capacity, an associated immuno-modulatory
effect has been suggested [199]. MSC role in inflammation is
based on their active role as cytokine-release factories that inter-
act directlywith injured cells [200]. In this novel scenario, MSCs
were shown to secrete IL-1RA in a mouse model of lung injury
[201] or produce a potent anti-inflammatory protein (TNF-a
stimulated gene/protein 6, TSG-6) in a mouse infarct model
[202]. Interestingly, TSG-6 was also identified as a key player in
a rat model of corneal injury after MSC systemic administration
[203]. After implantation of MSCs into beagle nucleotomized
IVDs, the expression of Fas ligand (FasL) (a protein found in
other immune privileged sites) was restored. It was suggested
that MSCs either differentiated into cells expressing FasL, or
stimulated the few remaining NP cells to produce this mol-
ecule—thus contributing to the recovery of immune privilege
in degenerated IVDs [204]. Although the beneficial effects of
these cells have been demonstrated in several models, the
mechanisms behind MSC-based therapies are not clear.
In vitro studies showed that MSCs repress IgG production of
peripheral blood lymphocytes co-cultured with IVD fragments
from the samedonors [205].MSC influence in IVD inflammatory
response has not been fully dissected until now due to its multi-
factorial complexity and time dependence [205]. Human MSCs
were able to downregulate gene expression of pro-inflammatory
cytokines (IL-3, IL-6, IL-11, IL-15, TNF-a) and MMPs when in
co-culture with rat NP cells [198].
In humans, two clinical trials took advantage of autolo-
gous MSCs, albeit with controversial results. MSCs were
either directly injected in NP [206] or implanted in the IVD
after seeding in collagen sponges [207]. In the first case,
when MSCs were directly injected in patients diagnosed
with DDD, but with preserved external AF and persistent
LBP, the lumbar pain was strongly reduced after three
months. However, no improvement on IVD height was
detected by imaging [206]. Injection of MSCs in degenerated
IVDs seems to promote an analgesic effect, due to trophic
effects, which can occur quicker than detecting possible
regenerative effects [206]. Given this, the authors suggest
that the MSCs exhibited immuno-modulatory properties.
The second case reports the implantation of MSCs after seed-
ing in collagen sponges [207]. Two years post-surgery, the
published results reported relief or disappearance of LBP
and improvement of the vacuum phenomenon (gas in the
intervertebral space, associated with intervertebral regressive
degeneration). However, besides the small number of
patients used (two), this study also lacks experimental details
such as the controls used and effective number of cells trans-
planted [207]. More recent studies propose IVD injection of
umbilical cord-derived MSCs as a promising therapy to over-
come chronic discogenic LBP [208]. In this study, pain and
lumbar function were recovered after cell transplantation
and preserved over a 2-year follow-up period; however,
only two patients were studied. Another recent study injected
bone marrow concentrate cells into 26 patients [209]. In the
1-year follow-up study, the majority of the patients showed
improvement of pain score and reduced impairment, with
only some of them presenting IVD rehydration. The authors
emphasize the use of critical unmanipulated cell doses.
Usually, MSC-based therapies involve cell expansion
in vitro to obtain sufficient cell numbers, but this in vitro
manipulation risks modifying their receptor expression and
can introduce contaminants.
One interesting feature of MSCs is their capacity to
migrate into injured tissues and participate in the regenera-
tive process, interacting with the surrounding environment
through secretion of numerous molecules such as growth fac-
tors, cytokines and chemokines [210]. Nevertheless, contrary
to leukocyte migration and haematopoietic SC homing, the
mechanisms that regulate MSC migration to injured sites
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are not well characterized [211]. In vitro, in a pro-inflammatory
environment stimulated by TNF-a, MSCs migrate towards
SDF-1, RANTES and MDC gradients, amongst others [212].
Furthermore, MMPs and their inhibitors have also been
shown to enhance MSC migratory capacity [213]. In a
recent study, MSCs were recruited in vitro by conditioned
medium from IVDs cultured under degenerative-simulated
conditions [214]. CCL5/RANTES has been identified as a
key chemoattractant released by degenerative IVD in organ
culture [215]. Moreover, CXCL12/SDF-1 delivery in IVD
organ cultures promotes MSC recruitment towards NP,
especially if MSCs were harvested from young donors
[216]. This does not exclude the possibility that other cyto-
kines involved in IVD degeneration pathogenesis, namely
TNF-a and IL-1b, might play a role in regulation of MSC
recruitment to the IVD [181]. A hypothetical migration
route of high-proliferative cells lateral to the epiphyseal
plate and the outer border region of the IVD was recently
described [217]—if this route is confirmed, new strategies
envisaging IVD regeneration may be attempted.
5. Future perspectives
Recent findings from in vitro studies, animal models and
clinical trials have started to unveil the role of inflammation
in IVD degeneration. However, no evidence for a beneficial
role of inflammation in maintaining homeostasis has been
presented, owing to the difficulty in studying IVD tissue
homeostasis. In other tissues, such as bone [218,219] or cardi-
ovascular tissue [220], the control of inflammation has
already proven to be critical in shifting the degeneration/
regeneration balance towards regeneration. In particular,
our group has focused on modulating inflammation in
bone [5,221–224]. Hence, we believe that novel therapies
for DDD should aim at restoring the homeostatic inflamma-
tory conditions in the disc, rather than totally inhibiting
inflammation, thus enabling endogenous repair mechanisms
to operate.
Our group has recently shown that incorporating fibrino-
gen, a well-known inflammatory protein, into a biomaterial
leads to increased bone formation [5]. In vitro studies have
shown that fibrinogen-modified biomaterial stimulates NK
cell-mediated MSC recruitment without affecting the MSC
differentiation marker alkaline phosphatase [222]. Moreover,
a broad analysis of macrophage-secreted factors showed
that fibrinogen modified macrophage response, leading to a
downregulation of the expression of inflammatory cytokines
and a stimulation in the production of growth factor [224].
Factors such as MIP-1d, platelet-derived growth factor-BB,
bone morphogenetic protein (BMP)-5 and BMP-7 were sig-
nificantly promoted by fibrinogen [224], which may impact
tissue regeneration.
Recent advances in development biology also highlight
the crucial role of immune cells. An efficient nuclear repro-
gramming to obtain induced pluripotent stem (iPS) cells
was shown to require activation of an innate response [225]
and was achieved via activation of TLR3 in the work of
Yamanaka and colleagues [226]. The importance of this find-
ing in physiological situations remains unclear, but it is
becoming increasingly evident that activation of the
immune response, particularly the innate response, may con-
tribute to regulation of stem cell behaviour [225,227].
Moreover, it has been known for a long time that the post-
inflammatory wound repair process recapitulates basic
phenomena that occur during embryogenesis [228]. There-
fore, future studies should focus on trying to understand
what happens early in development, to discover more cues
on how to modulate inflammation in a disease situation.
Although diverse studies have presented data on inflam-
matory key players in IVD, the inherent variability and
contradictions arising from the different in vitro culture con-
ditions and animal models used in these studies may be
hampering translation of the research to a clinical setting.
The standardization of methods, the correlation of results
with different IVD clinical problems, the use of alternative
ex vivo models (based on organotypic cultures or bioreactors)
and the use of more physiologically accurate in vivomodels of
IVD degeneration could bring further advances to the IVD
research field.
For IVD regeneration therapies to succeed, it will be impor-
tant to address IVD degeneration together with inflammation.
Until now, most studies have focused on only one of these
two aspects. An integrated strategy, which addresses both the
synergistic interplay that exists between the multiple factors
associated with IVD degeneration and balances the inflamma-
tory response, could be a step closer to the success of IVD
regenerative strategies and bring relief for those suffering
from LBP.
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Glossary
ADAMTS A disintegrin and metalloproteinase with throm-
bospondin motifs
AF Annulus fibrosus
BMP Bone morphogenic protein
C/EBPb CCAAT/enhancer-binding protein beta
CCL Chemokine ligand
CEP Cartilaginous endplates
COX Cyclooxygenase
CPPD Calcium pyrophosphate dihydrate
CXCL9 Monokine induced by gamma interferon
DDD Degenerative disc disease
DRG Dorsal root ganglion
ECM Extracellular matrix
FasL Fas ligand
FGF Fibroblast growth factor
fHA Hyaluronic acid fragments
GAG Glycosaminoglycan
GAP Growth-associated protein
GDF-1 Growth and differentiation factor-1
GM-CSF Granulocyte macrophage colony-stimulating
factor
HA Hyaluronic acid
HMGB1 High-mobility group protein box 1
HSC Haematopoietic stem cells
ICAM-1 Intracellular adhesion molecule-1
ICE IL-1b-converting enzyme
IFN-g Interferon-g
IKKb 3-Phosphoinositide-dependent protein kinase-1-
mediated IkB kinase b
IL Interleukin
IL-1Ra Interleukin-1 receptor antagonist
iNOS Inducible nitric oxide synthase
iPS Induced pluripotent stem cells
IVD Intervertebral disc
LBP Low back pain
LFA Lymphocyte function-associated antigen
LPS Lipopolysaccharide
MAPK Mitogen-activated protein kinases
MCP Monocyte chemoattractant protein
MDC Macrophage-derived chemokine
MIF Macrophage migration inhibitory factor
MIP Macrophage inflammatory protein
MMP Metalloproteinase
mRNA Messenger ribonucleic acid
MSC Mesenchymal stromal cells
NALP3 NACHT, LRR and PYD domains-containing
protein 3
NC Notochordal cells
NF-kB Nuclear factor kappa-light-chain-enhancer of acti-
vated B cells
NGF Nerve growth factor
NLRP3 NOD-like receptor family, pyrin domain contain-
ing 3
NO Nitric oxide
NP Nucleus pulposus
PGE2 Prostaglandin E2
PGF2a Prostaglandin F2 alpha
PLA2 Calcium-dependent phospholipase A2
PLGA Poly(lactic-co-glycolic acid)
PRP Platelet-rich plasma
RANTES Regulated on activation, normal T-cell expressed
and secreted
Rhein 4,5-Dihydroxyanthraquinone-2-carboxylic acid
SC Stem cells
Sox-9 Transcription factor Sox-9
TGF Transforming growth factor
TGS-6 TNF-a stimulated gene/protein 6
TIMP Tissue inhibitor of metalloproteinase
TLR Toll-like receptor
TNF-a Tumour necrosis factor alpha
TrkA High affinity NGF receptor
tRAS Tissue renin-angiotensin system
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Age-Correlated Phenotypic Alterations in Cells
Isolated from Human Degenerated Intervertebral
Discs with Contained Hernias
Maria Molinos, MSc,!,y,z Carla Cunha, PhD,!,y Catarina R. Almeida, PhD,!,y,§ Raquel M. Gonc¸alves, PhD,!,y
Paulo Pereira, MD, PhD,{,jj Pedro Santos Silva, MD,{ Rui Vaz, MD, PhD,!,{,jj and Ma´rio A. Barbosa, PhD!,y,z
Study Design. Human intervertebral disc (hIVD) cells were
isolated from 41 surgically excised samples and assessed for
their phenotypic alterations with age.
Objective. Toward the design of novel anti-aging strategies to
overcome degenerative disc disease (DDD), we investigated
age-correlated phenotypic alterations that occur on primary
hIVD cells.
Summary of Background Data. Although regenerative medi-
cine holds great hope, much is still to be unveiled on IVD cell
biology and its intrinsic signaling pathways, which can lead the
way to successful therapies for IDD. A greater focus on age-
related phenotypic changes at the cell level would contribute to
establish more effective anti-aging/degeneration targets.
Methods. The study was subdivided in four main steps: i)
optimization of primary cells isolation technique; ii) high-
throughput cell morphology analysis, by imaging flow cytometry
(FC) and subsequent validation by histological analysis; iii)
analysis of progenitor cell surface markers expression, by
conventional FC; and iv) statistical analysis and correlation of
cells morphology and phenotype with donor age.
Results. Three subsets of cells were identified on the basis of
their diameter: small cell (SC), large cell (LC), and super LC
(SLC). The frequency of SCs decreased nearly 50% with age,
whereas that of LCs increased nearly 30%. Interestingly, the
increased cells size was due to an enlargement of the pericel-
lular matrix (PCM). Moreover, the expression pattern for CD90
and CD73 was a reflexion of age, where older individuals show
reduced frequencies of positive cells for those markers. Never-
theless, the elevated percentages of primary positive cells for the
mesenchymal stem cells (MSCs) marker CD146 found, even in
some older donors, refreshed hope for the hypothetical activa-
tion of the self-renewal potential of the IVD.
Conclusion. These findings highlight the remarkable morpho-
logical alterations that occur on hIVD cells with aging and
degeneration, while reinforcing previous reports on the gradual
disappearance of an endogenous progenitor cell population.
Key words: aging and degeneration, CD146, chondrons,
human IVD cells, pericellular matrix.
Level of Evidence: N/A
Spine 2017;42:xxx-xxx
C urrent treatments for degenerative disc disease(DDD) fail to address intervertebral disc’s (IVD’s)pathophysiology and to restore its function, and
bioengineered sophisticated solutions are still in their infan-
cy, with very few having reached Phase-I clinical trials.1 In
fact, much is still to be unveiled regarding the cell biology of
the IVD and its intrinsic signaling pathways. Particularly,
a greater knowledge about age-related cellular changes
will contribute to establish more effective anti-aging/
degeneration targets.
In the adult IVD, chondrocyte-like cells frequently as-
semble in a fibrous capsule, forming chondrons similar
to those found in articular cartilage.2 It has been suggested
that these encircling layers result from accumulation of
cellular products, as a consequence of aging3,4 with histo-
pathological analysis revealing evident remodeling of the
pericelullar matrix (PCM) occurring with age and disease
progression.3,5,6 On the contrary, PCM plays an important
role in governing the local mechanical environment of
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chondrocytes and IVD cells,7,8 as well as in maintaining
their phenotype and viability.9,10
Despite findings indicating that degenerated human discs
may have an endogenous regenerative capacity,11–15 there
might be an age-limit for the efficient activation of its cell
progenitors.16–18
The aim of this work was to investigate age-related
phenotypic alterations on primary human IVD cells from
degenerated tissue. Taking advantage of a multiparameter
image analysis tool, which guarantees robust quantitation of
morphological features, we correlated IVD cells size, clus-
ters prevalence and PCM area with age, while monitoring
changes in expression of known stem cell related (CD90,
CD73, CD105, CD146, CD34, Stro1) and NP-progenitor
(GD2 and Tie2) markers.
MATERIALS AND METHODS
Surgical IVD Tissue Dissection and Cell Isolation
Degenerated human lumbar IVDfragments,with grade III-IV
(Pfirrmann scale), were isolated from patients undergoing
microdiscectomy, after informed consent and ethics commit-
tee approval. The surgeries were performed under general
anesthesia in a sterile operating room and prophylactic anti-
biotic therapy with cefazolin 1 g IV was given. Patients were
placed in a knee-chest position and a standard posterior
approach to the appropriate interlaminar window was un-
dertaken. After removal of the yellow ligament and medial
retraction of the nerve root, the disc herniation was exposed.
The posterior longitudinal ligament and the annulus fibrosus
(AF)were incised and IVD fragmentswere excised, as deemed
necessary by the surgeon. No more disc samples than those
considered clinically appropriate were collected. In cases
where the disc fragment was in contact with the epidural
space or indistinguishable from the AF, the excised tissuewas
not included in this study.Thus,AF-contained IVDfragments
were collected, andcellswere isolatedbyenzymaticdigestion,
as previously described,19 using one of three enzymatic for-
mulations: collagenase-type-I (Coll-I), collagenase-type-II
(Coll-II), or collagenase-type-XI (Coll-XI) (C0130, C6885,
and C7657, respectively; Sigma-Aldrich, Sintra, Portugal),
at 0.5mg/ml (more detailed information in Supplemental
Methods, http://links.lww.com/BRS/B288).
Assessment of Yield and Viability upon Isolation
Immediately upon digestion, cell yield was quantified by
trypan blue exclusion and subsequently normalized against
initial wet tissue weight. Cell viability was assessed by flow
cytometry (FC) (FACS Calibur; BD Immunocytometry Sys-
tems, San Jose, CA) upon propidium iodide (PI) staining.
Characterization of Cell Morphology by Imaging
Flow Cytometry (IFC)
Cells from nine different donors were fixed in 4% w/v
paraformaldehyde (PFA) solution at room temperature
for 15minutes and washed with phosphate-buffered saline
(PBS). Cells were labeled with DRAQ5 (1:1500 dil. per
2.0"105 cells, 65-0880; eBioscience), run on ImageStream
(IS; Millipore, Billerica, Massachusetts, MA), and analyzed
with IDEAS software for: cell diameter, frequency of
small cell (SC), large cell (LC), and super large cell (SLC),
frequency of single cells and multinucleated events (See
Supplemental_Figure1A, B, and C: Cell Morphology Anal-
ysis Tutorial, http://links.lww.com/BRS/B289).
Cells were identified as SC, LC, and SLC based on their
diameter: 10mm<SC<20mm; 20mm<LC<30mm; and
30mm<SLC<50mm. To quantify the percentage of single
andmultinucleated events, aswell as the numberof single cells
within LC and SLC populations, a specific mask and feature
was created and applied to images of DRAQ5 stained nuclei
(Supplemental_Figure1B, http://links.lww.com/BRS/B289).
To identify the presence of PCM, cells were permeabilized
for 5minutes with 0.2%Triton and incubated for 20minutes
at room temperature with Phalloidin-AlexaFluor488 (1:40
dilution per 2.0"105 cells, A12379; LifeTechnologies, Porto
Salvo, Portugal), previously prepared in aPBS-1%w/vbovine
serum albumin (BSA) solution, as described in.19 This
allowed the distinction of the cells actin cytoskeleton (cell
per se) from the surrounding cell-attached matrix, when
merging brightfield images and the fluorescence images of
actin staining on IDEAS software. To further quantify the
PCM area, a specific mask was designed (Supplemental_
Figure1D, http://links.lww.com/BRS/B289).
Histological Analysis
Human IVD fragments were fixed in 10% neutral buffered
formalin, processed for paraffin embedding and 5mm sec-
tioned in a microtome (Leica). Tissue sections throughout
the IVD were stained for Alcian blue/Picrosirius red and
analyzed by upright optical microscope (Olympus). For each
section, delimitation of the area of the pericellular matrix
(either proteoglycan- or collagen-rich) was determined for
each cluster using ImageJ software. Around 15 sections were
analyzed per donor and values were plotted as frequency
distribution of the areas obtained in mm2, using GraphPad
Prism.
Analysis of Markers Expression by Flow Cytometry
(FC)
Expression of surface markers (Table 1)20 was analyzed by
conventional FC, as described in Supplemental Methods,
http://links.lww.com/BRS/B288.
Statistical Analysis
Statistical analysis was performed using GraphPad-Prism.
All tests used are identified in the respective figure legend
(additional details in Supplemental Methods, http://links.
lww.com/BRS/B288).
RESULTS
Sample Characterization
To characterize the morphology and phenotype of primary
hIVD cells from degenerated tissue, a total of 41 samples
BASIC SCIENCE Age-Correlated Alterations in hIVD Cells # Molinos et al
2 www.spinejournal.com Month 2017
Copyright ! 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
CE: S.W.; SPINE 154534; Total nos of Pages: 11;
SPINE 154534
were collected from patients undergoingmicrodiscectomy—
24 males and 17 females. All samples were collected from
disc levels between L3 and S1. The donors age ranged from
18 to 66 years for males (average of 45 $ 11 years) and from
25 to 77 years for females (average of 48 $ 13 years)
(Figure 1A), whereas donors’ weight ranged from 69 to
110 kg for males (average of 86 $ 12kg) and from 50 to
90 kg for females (average of 62 $ 10 Kg) (Figure 1B). The
weight of collected tissue ranged from 0.2 to 5.2 g for males
(average of 1.7 $ 1.2 g) and from 0.5 to 8.0 g for females
(average 2.8 $ 2.2 g) (Figure 1C). No correlation was found
between tissue weight and donors’ age or weight (Figure 1C1
and C2, respectively).
From the 41 human samples collected, 36 were digested
to obtain the IVD cells to 1) optimize the protocol for
primary cells isolation (n¼9), 2) analyze cells morphology
(n¼9), and 3) study cells phenotype by FC (n¼18, of which
two were discarded after cell isolation, due to insufficient
number of cells to be acquired). The remaining five tissue
samples were formalin fixed for histological validation of
the cell morphology analysis performed by IFC.
Optimization of Cell Isolation
Because surgical tissue excised from human degenerated
IVDs is normally scarce in cell content, it is important to
guarantee that the cell isolation protocol will result in a high
yield of viable cells. Three different enzymatic digestion
protocols (with Coll-I, -II, or -XI, 0.5mg/mL, overnight)
were tested, similarly to what we did previously with bovine
NP tissue.19 Independently of the protocol used, cells via-
bility was always above 90%, as determined by FC (PI-
negative cells) (Figure 2A). In terms of cell yield, the proto-
col using Coll-I originated higher cell numbers
[(2.6 $ 2.7)"105 cells/g wet tissue], although no significant
differences were detected when comparing to the other
protocols used [Coll II: (1.4 $ 1.0)"105 and Coll XI:
(1.4 $ 0.7)"105 cells/g wet tissue] (Figure 2B). Thus, sub-
sequent cell isolation procedures were performed using Coll-
I. Interestingly, although no correlation was found between
the amount of IVD tissue collected from microsurgery and
donor age, the cell content (yield) shows a negative correla-
tion (Figure 2C; !!P<0.01), suggesting that independently
of the isolation method used, age is a heavy counterproduc-
tive factor for cell yield.
Characterization of Cellular Morphology
Inorder to characterize themorphologyof humandegenerated
IVD cells, along with its age-related changes, freshly isolated
cells were fixed and analyzed by IFC, using masks for bright-
field images of cells and for fluorescence images of the cyto-
skeleton and nuclei (representative analysis tutorial is depicted
in Supplemental_Figure 1, http://links.lww.com/BRS/B289).
TABLE 1. Antibodies used in flow cytometry analysis
Function Fluorochrome mg/mL Clone
Catalog No.,
Manufacturer
Primary antibodies
IgG1 MAH CD34 Marker for hematopoietic
progenitors and vascular
endothelial cells
FITC 2.5:50 581 (Class III) CD34-581-01, Invitrogen
IgG1 MAH CD45 Hematopoietic lineage-restricted
surface marker
PE 3:50 MEM-28 21270454, ImmunoTools
IgG1 MAH Tie2 NP progenitor cell markers
20 PE 5:50 83715 FAB3131P, R&D Systems
IgG2a MAH GD2 — 2:50 14.G2a 554272, BD Pharmigen
IgG1,k MAH
CD90
Typical MSC markers APC 5:50 eBio5E10 17-0909-41, eBioscience
IgG2a MAH
CD105
FITC 3:50 MEM-226 21271053, ImmunoTools
IgG1 MAH CD73 PE 5:50 AD2 550257, BD Pharmigen
IgM MAH Stro1 — 10:50 STRO-1 MAB1038, R&D Systems
IgG1 MAH
CD146
Marker for vascular endothelial
cells, smooth muscle cells,
pericytes, and MSCs
AlexaFluor647 5:50 OJ79c MCA2141A647T, Bio-Rad
Secondary antibodies
IgM RAM Biotinylated 1:50 E 0354, Dako
IgG RAM AlexaFluor647 1:500
Isotype controls
Mouse IgG1 FITC/R-PE 2.5:50 M1FP, Invitrogen
Mouse IgG1 AlexaFluor647 5:50 MCA928A647, Bio-Rad
Mouse IgG1,k APC 5:50 P3.6.2.8.1 17-4714, eBioscience
Mouse IgG2a FITC 3:50 21275523, ImmunoTools
Mouse IgG2a — 2:50 G155–178 556651, BD Pharmigen
T
MAH indicates mouse anti-human; MSCs, mesenchymal stem cells; RAM, rabbit anti-mouse.
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Analysis of the distribution of the cells diameter with age
revealed the presence of small cell (SC), large cell (LC), and
super large cell (SLC) (Figure 3A), with an average diameter
of 16 $ 2, 25 $ 1, and 34 $ 1mm, respectively (Figure 3B).
Representative images of these cells are shown in Supple-
mental_Figure1C, http://links.lww.com/BRS/B289. Over-
all, the average frequency of SLC (17 $ 14%) was
significantly lower (!P<0.05) than the average frequency
of SC or LC (39 $ 29% and 43 $ 18%, respectively), al-
though there was a high variability between donors with
ages from 36 to 55 years. Interestingly, correlation analysis
revealed a decrease in SC frequency with age (!!P<0.001),
while the frequency of LC and SLC increased (!!P<0.001
and !P<0.05, respectively) (Figure 3C).
The percentage of single and multinucleated events
was also quantified for each donor (Figure 4A–C and Sup-
plemental_Figure1B, http://links.lww.com/BRS/B289). Inter-
estingly, within the large and SLC populations, the majority
of events were single cells: 87$ 9% and 63$ 19%, respec-
tively (Figure 4C), although cells had a diameter above
20mm. Simultaneously, there was no correlation between
the prevalence of multinucleated events and age (Figure 4B).
Together, these results suggest that the increase on the fre-
quency of LC with age is not due to cell fusion, but is most
probably due to an increase of the PCMarea surrounding the
cells. And indeed, the PCM area of cells within single-SLC
population was larger than within the SC (!P<0.05) and
single-LC populations (P¼0.5) (Figure 5AB).
A
C C1 C2
B
Figure 1. Sample characterization. (A) Donors age. A total of 36 samples were collected—20 from male donors and 16 from female donors.
(B) Donors weight by gender. Male donors were heavier than female donors, !!!P<0.001 (nonparametric Mann-Whitney test). (C) Collected
tissue weight. An average 1.7 and 2.8 g of tissue was excised from male and female donors, respectively. No correlation was found between
collected tissue weight and age (C1) or donors weight (C2). Line on scattered dot plots presents mean values.
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Figure 2. Optimization of cell isolation protocol. Three different methods to isolate human primary cells were evaluated, where cells were
incubated overnight with collagenase-type I, -type II, or -type XI. (A) No differences were found in terms of cell viability, as quantified by flow
cytometry upon PI staining. All protocols rendered high (>90%) cell viability. (Coll I: n¼9; Coll II: n¼3; Coll XI: n¼4). (B) Tissue overnight
digestion with collagenase-type-I allowed the isolation of more cells per g of excised tissue, although this number decreased with donors’ age
(C) (n¼9, Pearson r¼& 0.8, !!P<0.01; nonlinear regression r2¼0.78). Data on bars are presented as mean $ standard deviation.
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Figure 3. The diameter of human IVD cells increases with age. (A) Histograms showing the
diameter distribution of IVD cells from 9 different donors (left). A shift to the right is visible
with increasing age [between 36 (up) and 55 (bottom) years old]. Donor age, gender, and
total number of cells analyzed are indicated on each histogram (bottom right corner). The
observation of distinct diameter peaks with age allowed identification of three cell types
based on cells size: small cells (SC), large cells (LC), and super large cells (SLC). (B) Aver-
age diameter of the gated populations from the same 9 different donors. (C) Frequency of
cells within each gate and its correlation with age. The frequency of cells within SLC
population was significantly lower than within SC or LC populations (data analyzed for
statistical differences using ordinary one-way ANOVA and Bonferroni multiple-comparisons
test, n¼9, !P<0.05, !!!!P<0.0001). Correlation analysis revealed that SC frequency
decreased with age (n¼9, one-tailed !!P<0.01, Pearson r¼& 0.76, linear regression
r2¼0.58), whereas LC and SLC increased (n¼9, one-tailed !!P<0.01 and !P<0.05,
Pearson r¼0.78 and r¼0.61, linear regression r2¼0.60 and r2¼0.38, respectively).
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Histological Analysis
The morphological analysis performed by IFC was further
validated on histological sections of degenerated IVD tissue
from five donors (ages between 37 and 62 years), using
Alcian blue/Picrosirius red staining, which differentiates the
main extracellular components within the tissue, staining
collagen in red and proteoglycans in blue, readily allowing
the identification of the PCM for each cell cluster. Figure 6A
shows the PCM area distribution for the different donors, as
quantified from the images represented in Figure 6B, C. This
analysis indicates an increase in the prevalence of larger
events (corresponding to LC and SLC identified by IFC)
with age, especially evident in older donors (60 and 62 years
old), accompanied by a decrease in the frequency of smaller
events (SC identified by IFC), resulting in a shift to the right
in 60 and 62 years old donor’s histograms. This effect on
clusters area can be observed in Figure 6B for a younger
donor and in Figure 6C for an older donor.
Analysis of Surface Markers Expression
To assess the correlation between the presence of progeni-
tor-like cells within freshly isolated human IVD cells and
aging, expression of nine surface markers was evaluated
(Table 1 and Supplemental Figure 2, http://links.lww.com/
BRS/B290). No expression of Tie2, CD45, and CD34 was
found, while CD146 expression ranged from 0% to 16%,
Stro1 from 0% to 19%, CD90 from 0.3% to 64%, CD73
from 0% to 55%, CD105 from 0% to 17%, and GD2 from
2% to 5% (Figure 7A). A negative correlation was estab-
lished between the frequency of CD90& and CD73þ cells
and age (Figure 7B, !P<0.05), but not for the other
markers. These data suggest there is a decrease, but not
elimination of progenitor cells with aging. Moreover, seek-
ing to correlate cells size with these markers expression, it
was verified that, within the positive events for each marker,
there is a smear, containing small and large events, and no
distinct subset was found to be more or less prevalent with
age (Supplemental_Figure 3, http://links.lww.com/BRS/
B291).
DISCUSSION
The aim of this study was to take advantage of available
surgical material from microdiscectomy procedures, which
in normal circumstances would be discarded as surgical
waste, to characterize how IVD degenerated tissue changes
with ageing. Hence, the material was not collected for
research purposes, but as a necessary therapy for the donor.
Moreover, in a typical microdiscectomy performed to treat a
Figure 4. Characterization of large cells. (A) Examples of brightfield (left) and fluorescence (right) images of single and multinucleated event
and its nuclei. (B) No correlation between the frequency of single or multinucleated events with age (n¼9, P¼0.36 and 0.29, respectively).
C) Quantification of the percentage of single cell events within SC, LC, and SLC populations. Only SLC population revealed a significantly
lower frequency of single cell events (ordinary one-way ANOVA, Bonferroni multiple-comparisons test, !!!P<0.001, n¼9). Hence, LC and
SLC (( 40%) greater diameter is not necessarily due to cell clustering.
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disc herniation through a posterior approach, at best 30%of
the entire disc can be obtained. Indeed, although in anterior
and lateral approaches the quantity of material collected
may be larger, these are not so common. Nevertheless, the
tissue collected was quite homogeneous and representative
of the whole degenerated IVD.
Cell isolation techniques should be standardized in order
to avoid variability between different studies. Enzymatic
digestion is a common procedure to isolate IVD cells, but
cell yield is rarely reported, and cells are often expanded
in culture before FC analysis of cells phenotype.18,21,22
Moreover, pronase pre-treatment is many times applied,
not preserving cells with its PCM attached.23 Here, we apply
an improved and inexpensive method to efficiently isolate
primary hIVD cells, which could be further adopted by other
researchers in this field. Of note, a clear negative correlation
between cell yield and donor age is evident, supporting
previoushistological observations on IVDcell depopulation.3
Morphology of IVD cells was assessed using IFC, a
technique that provides high-resolution images of thousands
of cells in flow. A clear shift on the distribution of the cells
diameter occurred with aging, with a decrease in the fre-
quency of small cells and an increase with that of larger cells.
The enlarged cell morphology was due to an increase in the
PCM area (Figure 5). This effect was previously reported for
chondrons in osteoarthritic cartilage24,25 and proven to be a
consequence of matrix synthesis and/or deposition rather
than due to an increase in cell hydration.26 Theoretically,
this alteration may occur following an inflammatory stimu-
lus [e.g., Interleukine-1 (IL-1) exposure], which triggers
metalloproteinases (MMPs) upregulation, initiating the de-
struction of fibrilar collagens around the chondrocyte
(diminishing its tensile capacity), while the high intrinsic
concentrations of pericellular aggrecan and hyaluronan
ensures the hydrodynamic expansion of the chondron.5
Of note, even though formation of cell clusters has been
previously associated with age and degeneration, we did not
find a significant correlation between the frequency of
multinucleated events and donors age.27–29 Histological
data validated the results from IFC (Figure 6), although a
discrepancy in cells size was detected. The maximum area
value quantified for cells in flow (from brightfield images of
cells with its attached PCM) was about 0.002mm2, whereas
in the tissue some larger events had a PCM area (including
attached collagens and aggrecan) as great as 0.024mm2.
Nevertheless, this result is in accordance with previous
studies using enzymatic digestion to isolate chondrocytes,
where the PCM was shown to be substantially reduced
in size, due to a loss of some enzyme-sensitive PCM com-
ponents, such as aggrecan, type II collagen, fibronectin, and
hyaluronic acid.30–33 However, chondrocytes enhanced vi-
ability, and particularly that of chondrons, when compared
with alternative isolation methods, makes enzymatic diges-
tion a better choice.34
To better understand the consequences of ageing on
IVD cells, expression of markers for progenitor and
Figure 5. Pericellular matrix area quantification. (A) Examples of IFC images of IVD cells with various morphologies. The panel shows
brightfield images of cells (right), alongside with composite fluorescence images of the respective DRAQ5-stained nuclei and the phalloidin-
FITC stained actin (middle). The right column shows the masks (dark green) created to determine the PCM area. Both single- and multinucle-
ated events are surrounded by a PCM. (B) PCM area was quantified within SC (all were single-cell events), single-LC, and single-SLC
populations from 3 different donors, with 36, 38, and 41 years old (n¼3, Kruskal-Wallis and Dunn multiple-comparison tests, !P< 0.05). LC
and SLC cells show an increased diameter due to a greater PCM deposition.
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inflammatory cells was assessed. Interestingly, the percent-
age of cells expressing CD73, CD90 was a reflection of age.
These findings reinforce previous reports stating that, al-
though mature IVDs may endogenously count on a progen-
itor cell population,13,35 its gradual disappearance with
aging and degeneration may dictate a limitation in time
for its activation.18,36 Overall, our results are in accordance
to a previous report,30 showing low expression (<1%) of
CD105 on primary unexpanded cells from degenerated IVD
tissue. As for Stro1, while a low expression profile (<5%)
was expected, even in younger individuals,13,35 here we
found some young donors with high Stro1þ numbers
(( 20%), and others with no expression at all. However,
no correlation with age, gender, or weight could be
determined, which could explain these results. In addition,
CD90 and CD73 expression, which was always below 40%
(with the exception of one 46 years old donor, also showing
higher expression of CD105, CD146, and Stro1), is different
from other studies, where MSC classical markers (including
CD105) were expressed by nearly 90% of cells.11,12,14,15
Nevertheless, in all those studies, cells were expanded before
acquisition, which might have induced phenotypic altera-
tions, as reported to occur with articular chondrocytes,37,38
mouse bone marrow derived MSC precursors,39 and rabbit
AF and NP cells.40 Moreover, Tie2 was not detected, even
though others have found around 10% expression in three
out of four donors (33–66 years old).18 Again, cells were not
expanded in this study and the isolation procedure was not
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Figure 6. Histological analysis of degenerated IVD tissue. (A) Histograms showing the
distribution of cell clusters area from 5 donors with ages from 37 to 62 years. There is
an increase in the frequency of larger clusters with age. (B, C) Representative images
of Alcian blue/Picrosirius red staining showing small (B) and large (C) cell clusters
producing proteoglycans (Alcian blue) embedded in a collagen matrix (Picrosirius
red). In (B), a small cell with no PCM (PCM area¼0mm2) is highlighted (arrow). In
(C), the proteoglycan-rich pericellular matrix (arrow) is surrounded by a deposition
of an outer pericellular collagenous red stained matrix (arrow heads). Scale bars:
100mm.
BASIC SCIENCE Age-Correlated Alterations in hIVD Cells # Molinos et al
8 www.spinejournal.com Month 2017
Copyright ! 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
CE: S.W.; SPINE 154534; Total nos of Pages: 11;
SPINE 154534
the same. In addition, for GD2 expression, an average 3%
expression was detected (n¼4, 33–66 years old), whereas
others reported only 1% expression in primary hNP cells.18
We cannot guarantee that these GD2þ are exclusively lo-
cated in the NP, explaining why we were able to detect
higher percentages of these progenitor cell markers in IVD
surgical samples (NPþ AF tissue). CD146 was also detected
in the great majority of samples analyzed. We have previ-
ously shown that two cell-subsets within the heterogeneous
bovine NP cell population were enriched in CD146þ .19
This protein has been suggested as a marker for endothelial
cells, melanoma cells, and MSCs. Interestingly, sorted
CD146þ cells isolated from late-stage osteoarthritic knee
joints showed high potential of clonogenecity and multi-
differentiation, while expressing high levels of MSC-specific
surface antigens. Moreover, when compared with adipose-
derived MSCs (ADMSCs) and unsorted chondrocytes, this
subpopulation showed higher chondrogenesis capacity,41
revealing a pool of chondroprogenitors within the diseased
tissue. In contrast, recent work showed that CD146þ were
not capable of multipotent differentiation, and were com-
mitted to express a contractile phenotype.42 However, be-
sides distinct species and cell isolation methods used, culture
conditions were also different (1-week expansion in nor-
moxia vs. 3-week expansion in hypoxia). Importantly, the
frequency of CD146þ cells found herein (0–16%, n¼16,
mean 6.5%) was much higher than that found in the OA
knee (0.01–2.12%, n¼6).41 We will address the functional
characterization of hIVD CD146þ cells in the near future.
In summary, we were able to accurately distinguish three
subsets of hIVD cells based on their different sizes, whose
frequencies varied significantly with age. Younger individ-
uals showed higher prevalence of small cells (diameter
below 20mm), whereas older donors had more large cells
(diameter above 20mm). Finally, the analysis of specific
surface markers expression lead to identification of
CD146þ cells within IVD degenerated samples, which sup-
ported even further the hypothesis that the aged/diseased
IVD may still have an intrinsic self-repairing potential.
Key Points
There is a shift in IVD cells size with age and
degeneration.
Younger individuals have higher frequencies of
small cells, whereas older individuals have more
large cells.
The increase in cells size is due to an enlargement
of its pericellular matrix (PCM).
There is also an age-associated disappearance
of progenitor cell markers within the IVD cell
population.
The expression of the mesenchymal stem cell
(MSC) marker CD146 within IVD degenerated
samples supports even further the hypothesis that
the aged/diseased IVD may still have an intrinsic
self-repairing potential.
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Figure 7. Primary human IVD cells phenotype. (A) Expression of 9
different cell surface markers. (B) Age-related changes on the fre-
quency of CD146, Stro1, CD73, CD90, and GD2-positive events.
Spearman correlation coefficient analysis revealed a significant de-
crease of CD90 and CD73 expression with age (n¼9, one-tailed
!P<0.05, Spearman r¼& 0.69 and r¼& 0.63, respectively).
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Supplementary	Methods	
	
	
Human	 IVD	 cell	 isolation:	 Briefly,	 tissue	 was	 collected	 in	 Dulbecco’s	 modified	 Eagle’s	
medium	 (DMEM;	 21885	Gibco),	 supplemented	with	 10%	 v/v	 penicillin–streptomycin	 (P/S,	
PAA	 Laboratories	 GmbH)	 and	 20%	 v/v	 amphotericin	 B	 (Amph-B,	 PAA).	 Within	 3h	 upon	
collection,	 tissue	 was	 digested	 in	 DMEM	 supplemented	with	 5%	 P/S,	 10%	 Amph-B,	 2.5%	
(v/v)	 HEPES	 buffer	 1mM	 (Lonza),	 1.5%	 (v/v)	 NaCl	 5	M	 and	 KCl	 0.4	M	 solution	 (to	 adjust	
osmolarity	 to	 400	 mOsm),	 1.3	 U/mL	 DNAse,	 and	 one	 of	 three	 different	 enzymatic	
formulations:	 collagenase-type-I	 (Coll	 I),	 collagenase-type-II	 (Coll	 II),	or	collagenase-type-XI	
(Coll	XI)	(C0130,	C6885,	and	C7657,	respectively,	Sigma	Aldrich),	at	0.5	mg/mL.	All	enzymatic	
preparations	contain	a	mixture	of	the	type	I	and	II	forms	of	the	purified	collagenase	enzyme,	
differing	 in	 their	 affinity	 for	 different	 substrates	 as	 assessed	 by	 the	 manufacturer	
(www.sigmaaldrich.com/life-science/metabolomics/enzyme-explorer/learning-
center/collagenase-guide.html).	Tissue/medium	ratio	was	set	at	10%	w/v	to	prevent	the	pH	
dropping	 below	 6.8	 during	 incubation.	 Tissue	 was	 digested	 overnight,	 in	 a	 humidified	
atmosphere	 at	 37°C/5%	 CO2,	 and	 under	 gentle	 stirring.	 ECM	 contaminants	 were	 filtered	
with	a	70	μm	cell	strainer.	
	
Analysis	of	surface	markers	expression	by	flow	cytometry:	Cells	were	first	 left	 to	recover	
from	digestion	 for	30	min	 in	a	humidified	atmosphere	at	37°C/5%	CO2,	and	 then	washed	
with	PBS-2%	fetal	bovine	serum	(FBS),	prior	to	incubation	with	primary	antibodies	(Table	1),	
in	the	same	solution,	for	1h	at	4°C.	In	the	case	of	non-conjugated	anti-Stro1	antibody,	cells	
were,	 in	addition,	 incubated	with	a	secondary	rabbit	anti-mouse-Biotinylated	antibody,	for	
30	min	at	RT,	washed	again	with	PBS-2%FBS	and	additionally	 incubated	with	Streptavidin-
APC	 (BD	Pharmigen,	#554067;	dilution	1:1000)	 for	10	min	at	RT.	After	 labeling,	cells	were	
washed	with	2	mL	PBS-2%	FBS,	fixed	in	1%	w/v	paraformaldehyde	(PFA)	solution	and	run	in	
a	 FACSCanto	 II	 within	 24h.	 Results	 were	 analyzed	 with	 FlowJo	 software,	 Version	 8.7.	
Supplementary	 Figure	 2	 shows	 representative	 dot	 plots	 from	 flow	 cytometry	 analysis	 of	
surface	markers	expression.	
	
Statistical	 Analysis:	 D’Agostino	 and	 Pearson	 omnibus	 normality	 test	 was	 used	 to	 assess	
Gaussian	 distribution	 of	 data.	 Results	 that	 did	 not	 follow	 a	 normal	 distribution	 were	
analyzed	 for	 statistical	 differences	 using	 non-parametric	 Mann-Whitney	 test	 (donors	 age	
and	weight	by	gender)	or	Kruskal–Wallis	and	Dunn’s	multiple-comparison	test	(cell	viability	
and	 yield,	 surface	markers	 expression	 and	 PCM	Area).	When	 results	 followed	 a	 Gaussian	
distribution	(collected	tissue	weight	by	gender	and	frequency	of	single	events	within	LC	and	
SLC	gates)	an	unpaired	t	test	was	applied.	Finally,	cells	diameter	and	SC,	LC,	SLC	populations	
frequency	followed	a	Gaussian	distribution,	for	which	groups	were	compared	using	ordinary	
one-way	ANOVA	(Bonferroni’s	multiple-comparisons	test).	In	all	cases,	a	confidence	level	of	
at	 least	 95%	 (*p	 <	 0.05)	 was	 considered.	 Correlations	 with	 age	 were	 analyzed	 using	 the	
Spearman	correlation	coefficient	for	non-parametric	data	(surface	markers	expression),	and	
the	Pearson	correlation	coefficient	for	parametric	data	(cell	yield,	frequency	of	SC,	LC,	SLC,	
and	single	and	multinucleated	events).	Data	is	plotted	as	linear	correlation	(straight	line)	±	
5%	confidence	intervals	(dashed	curves),	also	presenting	the	assigned	correlation	coefficient	
“r”	and	p	value. 
Supplemental Figure 1: Imaging flow cytometry morphological analysis flow chart. A) 
Live cells gating procedure. B) Gating of single and multinucleated events, by creating 
mask for cells nuclei and a feature to calculate the number of nuclei within each live cell. 
C) Diameter histogram analysis, smoothing, and subpopulations fractioning by cell size 
in Small Cells (SC), Larger Cells (LC) and Super Large Cells (SLC). D) Pericellular 
Matrix morphology analysis by creating specific mask based on the subtraction of nuclei 
and actin fluorescent images from brightfield images of whole cells, and a feature to 
calculate PCM area. 
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Supplemental Figure 2: Representative dot plots from conventional flow cytometry 
analysis of Stro1, CD146, CD90, CD73 and GD2 surface markers expression. 
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Matrisome Profiling During 
Intervertebral Disc Development 
And Ageing
Joana Caldeira1,2,3, Cátia Santa4,5, Hugo Osório1,3,6, Maria Molinos1,2,7, Bruno Manadas5, 
Raquel Gonçalves1,2 & Mário Barbosa1,2,7
Intervertebral disc (IVD) degeneration is often the cause of low back pain. Degeneration occurs with 
age and is accompanied by extracellular matrix (ECM) depletion, culminating in nucleus pulpous 
(NP) extrusion and IVD destruction. The changes that occur in the disc with age have been under 
investigation. However, a thorough study of ECM profiling is needed, to better understand IVD 
development and age-associated degeneration. As so, iTRAQ LC-MS/MS analysis of foetus, young 
and old bovine NPs, was performed to define the NP matrisome. The enrichment of Collagen XII and 
XIV in foetus, Fibronectin and Prolargin in elder NPs and Collagen XI in young ones was independently 
validated. This study provides the first matrisome database of healthy discs during development and 
ageing, which is key to determine the pathways and processes that maintain disc homeostasis. The 
factors identified may help to explain age-associated IVD degeneration or constitute putative effectors 
for disc regeneration.
The intervertebral disc (IVD) is a complex structure capable of resisting spinal compression while allowing 
motion of intervertebral segments1, 2. Besides water, it is mainly composed by extracellular matrix (ECM) mol-
ecules. These include collagens, proteoglycans (PGs) and other matrix proteins that contribute to the structural 
and mechanical function of the disc3, 4. Matrix degrading enzymes are also present to regulate matrix breakdown, 
maintaining disc homeostasis5.
A young healthy disc consists of a highly plastic and hydrated region – the nucleus pulposus (NP) – and a net-
work of collagen fibres oriented in sheets around the nucleus – the annulus fibrosus (AF), which provides tensile 
strength and confines the NP, limiting bulging6.
During disc degeneration and ageing, significant changes are observed in the IVD at both cell and tissue level. 
From birth, notochordal cells gradually disappear from the NP7. Loss of cell density is accompanied by a shift 
towards a chondrocyte-like cell population3, less effective in NP-specific matrix synthesis8. Ultimately this results 
in NP fibrous transformation, from a translucent gel to a more solid and cartilaginous tissue1 making it difficult 
to distinguish between NP and AF6. Alterations in the composition and mechanical properties of the surround-
ing environment will in turn influence NP cell function and behaviour, in terms of differentiation, metabolism, 
proliferation and survival8.
Along with cellular changes, NP matrix remodeling is also an early step in the ageing process. Apart from 
overall matrix breakdown caused by MMPs (matrix metalloproteinases) and ADAMTS (a desintegrin and metal-
loprotease with thrombospondin motifs) overexpression7, PG and collagen synthesis patterns9, 10, as well as fibre 
crosslinking1 are also altered. This inhibits matrix turnover and, together with the already limited repair response, 
leads to dehydration and progressive ECM disorganization. Furthermore, it promotes mechanical failure, annu-
lar tears and many of the characteristic features of disc degeneration6. Over time, type II collagen is replaced by 
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type I collagen in the NP7 and aggrecan content decreases3. Along with structural changes, soluble factors, and 
cytokines may also be released11, further affecting cell activity and tissue homoeostasis7. The availability of oxy-
gen, nutrients and growth factors12, and the acidity of the environment, as well as the removal of metabolites, are 
also influenced by ECM calcification and impermeabilization7. With increasing age, this imbalance of the normal 
homeostatic mechanism impairs normal disc function, particularly in the NP13, ultimately resulting in reduced 
disc height, hernia formation and spinal pain, as nerve roots become compressed2.
Low back pain (LBP) causes disability and life quality deterioration, constituting a tremendous social and eco-
nomic burden14. In more than 40% of the cases, it is triggered by IVD degeneration, which mimics disc ageing but 
occurs at an accelerated rate1, 7. Conventional therapies for LBP predominantly involve treatments based on pain 
modulators and invasive surgeries, like spine fusion or arthroplasty. However, spine surgeries have a high risk of 
complications associated15, 16, and recurrent interventions are many times needed (15–30% of cases)17, increasing 
the personal and financial costs even further18. Of note, the underlying pathophysiology is not being addressed, 
nor is the restoration of IVD’s function or the slowing down of disease progression. To date, promising strategies 
for disc regeneration, based on the maintenance and/or increase of matrix synthesis, are being explored in vivo: 
protein injection19, 20, gene transfer21, 22 and cell implantation23, 24. Although rapid advances are being made in 
understanding and regulating the degenerative process, many challenges remain2.
Understanding IVD pathophysiology (particularly in terms of IVD matrix constituents and their altera-
tions in development and disease) is key to unveil molecular cues that might be used to slow, halt or reverse the 
age-associated degenerative cascade2, 4.
In this report, we have investigated matrisome changes observed with development and ageing in healthy 
bovine NPs, with the purpose of validating candidate molecules that might constitute novel therapeutic alterna-
tives to treat IVD degeneration.
Methods
Sample preparation and iTRAQ analysis. Bovine caudal IVDs from foetus (around 7 months of gesta-
tion), young (12 months) and old animals (16 to 18 years old) were obtained from the local abattoir and dissected 
within 3–4 hours after slaughter. The NPs from 7–8 discs from Cd1 to Cd7 or Cd8 were collected as described 
by Molinos et al.25 and stored at −80 °C in a batch of 500 to 800 mg. For protein extraction, 1100 µL of guanidine 
extraction buffer were used. Further details on the iTRAQ analysis, including technicalities of protein extrac-
tion, precipitation and quantification, reduction, alkylation and trypsin digestion, as well as iTRAQ labelling, 
sample distribution, fractionation and LC-MS/MS analysis, database searching and protein identification, bio-
informatics analysis and candidate selection criteria, can be found as Supplementary Data 1 and Supplementary 
Table 1. For cell extracts, cells were first isolated by Collagenase Type XI (2 mg/mL) treatment and posteriorly 
filtered to remove ECM contaminants, as previously reported25. Proteins were then extracted using the same gua-
nidine hydrochloride based protocol that was used for whole tissue extracts (Supplementary Data 1). The mass 
spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner 
repository with the dataset identifiers PXD005616 and PXD00492226.
Macroscopic characterization and scanning electron microscopy (SEM). For qualitative macro-
scopic evaluation of the different age groups, IVDs were excised and photographed under an Olympus SZX16 
stereomicroscope coupled with a DP71 camera (Olympus, Tokyo, Japan) at 10X magnification.
For SEM analysis, samples were fixed using 2.5% (v/v) glutaraldehyde (Agar Scientific) in 0.1 M sodium caco-
dylate solution (Sigma) and then stored in sodium cacodylate buffer 0.1 M at 4 °C until further use. IVDs were 
then dehydrated in serial diluted ethanol solutions of 50, 60, 70, 80, 90, and 99% v/v, being incubated for 10 min 
in each dilution. Following critical point drying, samples were sputtered-coated with a Au/Pd thin film, using the 
SPI Module Sputter Coater equipment. Samples were examined at CEMUP (Materials Centre of the University 
of Porto), using a High resolution Scanning Electron Microscope with X-Ray Microanalysis - JEOL JSM 6301 F/ 
Oxford INCA Energy 350 - at 300X and 5000X magnification. The following parameters (mean fibril diameter, 
mean pore area, number of pores and number of intersections) were obtained using “DiameterJ”, a plugin for 
ImageJ/FIJI software version 1.46r (NIH) for topographic comparison of samples under study27.
Western Blotting. Following denaturation for 10 min at 65 °C, protein samples were separated by sodium 
dodecyl sulphate (SDS) 9% polyacrylamide gel electrophoresis (PAGE), and electroblotted onto a Hybond 
enhanced chemiluminescence (ECL) membrane (Amersham Biosciences). Antibodies for Collagen Type XII, 
Collagen Type XIV, Collagen Type XI alpha 2, Fibronectin and Prolargin were used. Further details on blocking 
solutions, primary and secondary antibodies used, as well as their respective host species, working dilutions and 
commercial suppliers can be found in Supplementary Table 2.
After ECL detection (Amersham Biosciences), bands were quantified using Quantity One 4.6.8 Software 
(Bio-Rad) and values were normalized to the total protein loading (density value of each complete lane, 
obtained after staining of the membrane following immunodetection with Page Blue Protein Staining Solution 
(ThermoFisher Scientific), using a protocol adapted from Welinder and Ekblad28. All samples were run in the 
same SDS-PAGE gel, and background signal was measured in several different areas of the membrane. Average 
background signal was then subtracted to the band intensity signal to minimize background variation and 
interference.
Statistical Analysis. Statistical analysis was performed using non-parametric Mann-Whitney test in 
GraphPad Prism software 5.0, to compare two groups of non-related samples (e.g. foetus versus young or young 
versus old NPs). The parametric distribution of the data was evaluated by D’Agostino and Pearson normality test. 
Results (from at least three independent biological samples) are expressed as median ± Interquartile Range (IQR) 
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in box and whiskers plots or as mean ± Standard Error of the Mean (SEM). Values from p ≤ 0.05 were considered 
statistically significant.
Results
Structural characterization of different aged IVDs by SEM. At the macroscopic level, several differ-
ences could be identified (Fig. 1, left panel). Foetal intervertebral discs (IVDs) consisted of a well-distinguished 
annulus fibrosus (AF) formed of concentric lamellae delimiting a highly hydrated gel-like nucleus pulposus (NP). 
During ageing and degeneration, the boundary between AF and NP became less obvious. In addition, discs 
started looking increasingly dry and fibrous.
Scanning electron microscopy (SEM) has also been optimized, for a more detailed comparison of NP topog-
raphy from the three different age groups. NP SEM images clearly showed a fine network of randomly oriented 
fibres (Fig. 1, central and right panels).
Further quantitative characterization of the SEM images obtained for different aged NP samples revealed 
age-associated changes in matrix architecture. Using DiameterJ, a plugin of ImageJ/Fiji software, we evaluated 
the following parameters: mean fibre diameter, number of pores, number of intersections and mean pore area 
(Fig. 1b). Mean fibre diameter of elder (8.826 pixels) NPs was statistically higher than that of the adults (7.482 
pxels), whereas no differences were observed between foetal (7.803 pixels) and young NPs. Elder bovine NPs also 
presented significantly fewer (275.2 pores) but bigger (566.5 pixels2) pores in comparison to young animals (459 
pores and 432.6 pixels2, respectively) and also less fibre intersections (927 vs 1391 intersections). Foetal NP mean 
pore area (602.6 pixels2) was also significantly bigger than that of young IVDs.
Optimization of the proteomics workflow. Age-associated protein expression profiles were identified 
in the first place by the distinct one dimension (1D) SDS-PAGE band signatures obtained. By comparing foetal, 
young and old NPs, we found that band intensities differed depending on disc age (Fig. 2a). Foetus and young 
samples presented an enrichment of high molecular weight proteins, between 150 and 250 kDa, where some 
of the molecules identified were tenascin, collagen type VI and biglycan (Fig. 2a–1F and Y and Supplementary 
Data 4). This trend was also visible among proteins around 50 kDa that corresponded to actin, link protein 
(HAPLN1), biglycan and decorin among others (Fig. 2a–6F,Y and O, Supplementary Table 3 and Supplementary 
Data 4). Noteworthy, we observed that young NPs had increased protein expression levels at around 30 kDa 
(Fig. 2a–7F,Y,O and 8F,Y,O). These bands corresponded to collagen type II and chondroadherin (Supplementary 
Table 3 and Supplementary Data 4). Moreover, above 100 kDa a band presented a trend to increase in Young and 
Old animals when compared to Foetus (Fig. 2a and 3F,Y,O). Fibromodulin, biglycan, aggrecan and cartilage oli-
gomeric matrix protein (COMP) were identified within these bands (Supplementary Table 3 and Supplementary 
Data 4). In addition, prolargin (PRELP) was only identified in old samples (Fig. 2a–5O, Supplementary Table 3 
and Supplementary Data 4) and not in the same molecular weight bands of Foetus or Young animals (Fig. 2a–
5F and Y, Supplementary Table 3 and Supplementary Data 4). Nevertheless, the differences detected were only 
semi-quantitative and the fact that after MS identification of the molecules present in each of the gel bands, pro-
tein mixtures were found (Supplementary Table 3 and Supplementary Data 4), made it hard to dissect which were 
the ones accounting for the observed differences.
For a comprehensive age comparative analysis of the NP matrisome, we used a gel-free MS based high 
throughput proteomic approach. The first optimization step involved the decision on whether we could use the 
whole tissue extract or whether decellularization was needed. Comparing the protein band profiles of the whole 
tissue and of cell extracts obtained using the same buffer, more bands were observed within the cellular rather 
than the tissue extract. Nevertheless, MS/MS identification showed that the bands corresponding to ECM pro-
teins (namely collagen type II, chondroadherin and mimecan) were mainly present in the tissue extract (Fig. 2b–
1w, 2w and 3w, respectively, Supplementary Table 4 and Supplementary Data 5). In fact, most of the disc is made 
up of water, while ECM and cells represent a very small percentage in terms of tissue volume12. For this reason, we 
did not pursue further the laborious task of improving the decellularization step, given that it brought no added 
value.
We tested 3 different buffers taken from the literature29. For each of them, we evaluated the total number 
of bovine proteins identified, as well as the number of ECM-associated molecules obtained. For that we took 
advantage of the Functional Annotation Clustering Tool from DAVID (https://david.ncifcrf.gov/). Qualitative 
results from Liquid Chromatography coupled to tandem Mass Spectrometry (LC-MS/MS) enabled us to select 
Guanidine Hydrochloride as the best buffer for our analysis, given that it enabled the identification of more 
bovine total proteins (146) and, particularly, more ECM molecules (26) than the chondroitinase-containing buff-
ers (Fig. 2c and Supplementary Data 6).
The optimized workflow that was used for sample processing is summarized in Fig. 3. Briefly, NPs were excised 
from foetal, young and old bovine tails and stored at −80 °C until further use. Samples were then snap frozen in 
liquid nitrogen and pulverized prior to the 24 hour protein extraction with the 4 M Guanidine Hydrochloride 
buffer. Protein was then precipitated, quantified, and digested. Following 8-plex isobaric tag for relative and abso-
lute quantitation (iTRAQ) labelling, samples were pooled and fractionated by LC. Finally, the peptide mixture 
was analysed by LC-MS/MS and protein identification was performed using Protein Pilot. Of note, the labelled 
samples of each of the two batches were combined into one sample mixture (Batch 1: Y1, Y2, Y3, F1, F2, F3, O 
Pool, Total Pool; Batch 2: Y1, Y2, Y3, O1, O2, O3, F Pool, Total Pool – Supplementary Data 1 and Supplementary 
Table 1).
Identification of NP age related proteomic signatures by iTRAQ analysis. PCA-DA plots, 
obtained with MarkerView, show significant clustering and differentiation among foetus (green), young (blue) 
and old (red) animals (Supplementary Figure 2a). Despite biological variability within the distinct age groups, and 
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Figure 1. Gross view and topographical characterization of different aged IVDs. (a) - Macroscopic pictures 
from IVD transversal sections (left panels) and microscopy images from scanning electron microscopy (SEM) 
(central and right panels, with scale bars representing 200 µm and 10 µm, respectively) of foetal, young and 
old IVDs are presented. On the right panels are magnifications of the NP, representing the organization of 
ECM fibres. NP parameters such as mean fibril diameter, mean pore area, number of pores and number of 
intersections were also plotted regarding each age group (b). Box-plot lines represent median and interquartile 
ranges of the different parameters evaluated. (*) stands for p ≤ 0.05 (**) for p ≤ 0.01 and (***) for p ≤ 0.001, 
using the non-parametric Mann-Whitney test.
www.nature.com/scientificreports/
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the fact that iTRAQ data was obtained from two independent runs, the three major groups of samples (Foetus, 
Young and Old) were well separated from each other, suggesting that NPs from different age sets presented dis-
tinct proteomes.
Averaged values of relative protein expression data from iTRAQ based LC-MS/MS (8-plex) assays were sub-
jected to hierarchical clustering with Morpheus software. The heatmap and respective dendrogram generated 
are represented in Fig. 4a. This supervised analysis was performed by applying Spearman rank standardization. 
Foetuses were grouped together. Although they were part of the same cluster (showing that they both have similar 
protein expression profiles), Young and Old animals were also grouped according to their age status. Clustering 
data analysis demonstrated the ability to conduct global proteomics profiling on NP disc tissues, revealing that 
Figure 2. Sample complexity, age-associated SDS-PAGE band profile and extraction buffer evaluation. (a) 
- By comparing the band profiles observed in one dimension (1D) SDS-PAGE gels, for the three distinct age 
groups, there were already clear differences in the intensity of some of the bands identified by MS + MS/MS. 
Information on band identification from 1 F to 8 O can be found in Supplementary Table 3. (b) - With the 
same extraction buffer, we observed more bands within the cellular rather than the tissue extract. However, 
identification by MS + MS/MS (Supplementary Table 4) showed that the bands corresponding to ECM proteins 
were mainly present in the tissue extract (1 C–COL6A1/COL6A2; 1 W–COL6A1/COL2A1; 2 C–ANXA1/
ANXA2/GAPDH; 2 W–COL2A1/CHAD/OGN; 3 C–ANXA8/LDHA; 3 W–CHAD). (c) - We compared the 
number of proteins identified by LC-MS/MS when using distinct buffers recommended from the literature: 
guanidine hydrochloride buffer (Gnd HCl), the same buffer with a prior chondroitinase 6 h treatment 
(chondroitinase) and this last condition followed by a centrifugal filtration, using a molecular weight cut-off of 
100 kDa (chondroitinase <100 kDa). The extraction buffer with which more proteins in total were identified, 
and more ECM proteins, in particular, was Gnd HCl.
www.nature.com/scientificreports/
6SCIENTIFIC REPORTS | 7: 11629  | DOI:10.1038/s41598-017-11960-0
significantly different arrays of proteins were expressed depending on the age of the individuals, despite the fact 
that samples were collected from the same avascular organs in the bovine body.
To explore the biological processes affected by the 77 (out of 161) common proteins identified in all the 
samples, and thus related to NP function, we performed Gene Ontology (GO) and Pathway term enrichment 
using the Functional Annotation Clustering Tool from DAVID Database. This allowed us to determine GO and 
Pathway terms that occurred more frequently than expected by chance. Proteins were then clustered according to 
functional similarity (Supplementary Tables 5 and 6).
The most significant cluster of proteins, in comparison to Bos taurus proteome, included GO terms impli-
cated in extracellular matrix and GAG binding, which was in accordance to what we expected. Interestingly, we 
also detected a statistically significant group of interactors involved in collagen fibril organization, cartilage and 
blood vessel development, and also proteins implicated in lipid binding and vesicles. Other statistically significant 
biological terms that appeared were glycolysis, regulation of phagocytosis, response to wounding, inflammatory 
response and calcium ion binding, among others. Redoing the analysis concerning pathway term enrichment, we 
obtained “ECM-receptor interaction”, “Focal adhesion” and “integrin signalling”.
To integrate known and predicted protein-protein interactions and better understand the relationships 
between the 77 distinct proteins commonly identified in all 3 age groups, we used STRING (Supplementary 
Figure 2b).
The interactome obtained highlighted six different clusters marked in same colour circles, broadly repre-
senting: cytoskeleton (light green), fibril/collagen organization and skeletal/cartilage development (beige), GAG 
binding/crosslinking (dark green), glycolysis (red) and vesicle-associated proteins (magenta). Large protein inter-
action networks illustrated the high degree of connectivity and the presence of promiscuous hub proteins.
Finally, to further highlight correlations between the proteins within each of the 6 main heatmap clusters 
(cluster 1A, cluster 1B, cluster 2A, cluster 2A’, cluster 2B and cluster 2B’ – Fig. 4), we performed gene ontology 
enrichment analysis based on the proteins identified in the different clusters. Among the proteins within cluster 
1B (which increase with development and ageing), we found a significant enrichment of Gene Ontology terms 
related to extracellular matrix, glycosaminoglycan, polyssacharide, carbohydrate, hyaluronic acid and ion bind-
ing, as well as cell adhesion and membrane bound organelles. Among the proteins from cluster 2A, there was an 
enrichment of the term ion binding, whereas among the cluster 2B’ (proteins which decrease with development 
and ageing) there was an enrichment of terms such as melanosomes, cytoplasmic vesicles, collagen fibril organ-
ization, blood vessel development, endoplasmic reticulum and also ion binding. No other significantly enriched 
Figure 3. Proteomic sample processing workflow. Bovine caudal IVDs from foetus, young and old animals 
were dissected within a few hours after slaughter. The NPs were collected and protein was further extracted, 
precipitated and quantified. After digestion, peptides were marked with isobaric tags for relative and absolute 
quantitation (iTRAQ) prior to liquid chromatography – tandem mass spectrometry (LC-MS/MS).
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GO terms were found for other groups of samples. A detailed list of the enriched GO terms in each cluster can be 
found in the Supplementary Data 7.
Definition of NP matrisome changes during development and ageing. Given that GO analysis 
revealed enrichment of several ECM-related categories, we examined the overlap of the NP proteomic signature 
with the matrisome, a comprehensive list of genes coding for ECM molecules and regulators, which is signifi-
cantly more comprehensive for data mining and for posing questions relevant to matrix biology than GO terms30.
Of note, 47% of the genes composing the NP signature encode for matrisomal proteins (Fig. 5a), and 
ECM-associated molecules. Core matrisomal proteins (64%) are over-represented, particularly in terms of pro-
teoglycans (44%) and glycoproteins (39%). We further defined the NP matrisome as the 36 matrisomal proteins 
identified in the 3 age groups (relative protein quantification of such molecules is summarized in Fig. 5b).
Candidate validation by Western Blot. The rationale behind the identification of potential age-related 
matrix components deregulated during NP development and choice of candidates for further investigation was: 
the analysis of iTRAQ data (e.g. differential protein expression ratio cut-off >1.3 and <0.77 and ProteinPilot pro-
tein identification confidence), literature mining concerning promising associations with IVD ageing and degen-
eration or lack of published data suggesting novel potential candidate biomolecules. Given that most proteins 
overexpressed in Foetus had not been identified with the highest confidence scores, we decided to further explore 
additional results obtained by searching the original MS/MS data against the proteomes from all organisms avail-
able on Swiss-Prot (results available upon request), instead of only using the Bos taurus complete proteome set.
Following these criteria, 5 proteins were selected for further validation: Collagen type XII, Collagen type XIV, 
Collagen type XI, Prolargin and Fibronectin. To confirm if these NP matrisome candidates were expressed in an 
age-dependent manner, Western blot analysis was performed (Fig. 6, right panel and Supplementary Figure 3). 
Figure 4. iTRAQ data analysis. (a) - Heatmap with the respective dendrogram representing sample-based 
hierarchical clusters. Average expression levels were represented by colour scale from blue (low) to red (high). 
In terms of protein expression, there were six main clusters. (b–g) - Graphical representation of iTRAQ relative 
protein expression profiles for the molecules within each of the 6 main clusters: cluster 1 A (b), cluster 1B (c), 
cluster 2A (d), cluster 2A’ (e), cluster 2B (f) and cluster 2B’ (g).
www.nature.com/scientificreports/
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Figure 5. Characterization of the NP matrisome. (a) - The pie charts exhibit percentages of identified proteins 
distributed by matrisome categories. (b) - Comparison of the different aged NP matrisome signatures. iTRAQ 
relative protein expression levels (x axis) are displayed for each of the molecules identified (y axis). Foetal 
samples are in red, young in blue and old in green. iTRAQ protein quantification scores for individual samples 
can be found on the embedded table (colour scale from blue – low expression – to red – high expression). In the 
case of Young animals, the values represent an average of the technical replicates. The non-parametric Mann-
Whitney test was used to compare two groups of non-related samples. Standard error of the mean (SEM) is 
represented as the error bar. (*) stands for p ≤ 0.05, using the non-parametric Mann-Whitney test.
www.nature.com/scientificreports/
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Figure 6. Validation of the candidates’ protein expression levels. On the left are the graphics representing 
normalized protein expression levels from the iTRAQ LC-MS/MS analysis and on the right, of Western Blots 
(WBs), from Foetus, Young and Old animals. Collagen Type XII (COLXII) and XIV (COLXIV) expression 
levels are higher in NPs from foetus, Collagen Type 11 (COL11A2) is mostly expressed in Young animals, 
whereas Fibronectin (FINC) and Prolargin (PRELP) are typical from elder NPs. The non-parametric Mann-
Whitney test was used to compare two groups of non-related samples (Foetus vs Young and Young vs Old). 
Graphs correspond to the average of protein expression levels obtained by band quantification and subsequent 
normalization to the total protein loading (Supplementary Figure 3). Standard error of the mean (SEM) is 
represented as the error bar. (*) stands for p ≤ 0.05, using the non-parametric Mann-Whitney test.
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Collagen type XII and Collagen type XIV were significantly more expressed (6-fold and 9-fold, respectively) in 
NPs from Foetus rather than from Young animals (0.56 to 0.09 in Collagen type XII and 1.81 to 0.21 in Collagen 
type XIV). No other relevant protein expression differences were found for Collagen type XIV, when comparing 
Young and Old samples. Nevertheless, there was also a slight but significant 1.5-fold decrease of Collagen type 
XII from Young to Old age groups (0.09 to 0.06). Collagen type XI was shown to be expressed at significantly 
higher levels in Young NPs (0.17) in comparison to Old ones (0.06) and this enrichment at younger stages was 
also verified by immunofluorescence (Supplementary Figure 4). Fibronectin and Prolargin results reflected a 
significant (2-fold and 3-fold, respectively) overexpression (from 0.34 to 0.79 in Fibronectin and from 0.11 to 
0.33 in Prolargin) only in older tissues. The results of this analysis were consistent with the trends obtained by 
exploring iTRAQ data (Fig. 6, left panel) and thus highlight the implication of Collagen type XII, Collagen type 
XIV, Collagen type XI, Prolargin and Fibronectin in age mediated IVD degeneration.
Discussion
Disc degeneration and ageing are intimately associated. While disc ageing is a natural and gradually occurring 
process, disc degeneration involves more rapid and severe changes. In this study, we aimed to characterize NP 
proteomic changes that occur with development and ageing and that are closely related to disc degeneration, 
with a special focus on the ECM. For that, we have used iTRAQ labelling coupled to LC-based tandem mass 
spectrometry. This technique infers the relative abundance of individual proteins from peptide MS signal inten-
sities and has emerged as an effective tool for quantitative proteomic profiling of complex tissue extracts, like 
cartilage31. SEM analysis and Western blotting also helped us to highlight and validate structural and molecular 
differences between the different age groups. The significance of our results is summarized as follows: several 
well-known effector proteins and a number of novel putative players were identified, 5 of which were inde-
pendently validated.
Recently, proteomic-based studies have risen sharply and have started to be used to characterize normal 
and/or degenerated disc cells32, 33, secreted factors34, 35 and tissue composition36, showing promising results. 
To date, however, limited studies have used proteomic strategies to study IVD matrix composition. One of 
the few existing studies focuses on the comparison of matrix proteomic signatures in different tissues37, while 
another is centred on the identification of cartilage matrix patterns of zonal distribution38. To the best of our 
knowledge, Yee et al. were the only ones that dissected ECM changes of human discs in age and degeneration39. 
Nevertheless, they used scoliotic samples as controls, which have been shown to present a gene expression 
profile that differs from healthy tissues, and signs of calcification that might reflect a premature degenerative 
process40, 41. In addition, the age range of non-degenerated samples under study was very limited and not rep-
resentative of elder individuals.
Unlike existing approaches, we used healthy samples from different age groups, and included, for the first time 
in this type of analysis, foetal tissue and NPs from very old animals. At the macroscopic level, we demonstrated 
that tissues, particularly the NP, tend to gradually become less translucent and AF lamellae appears increasingly 
disorganized, as has been previously reported for degeneration1. These observations were supported by SEM anal-
ysis through which we thoroughly characterized NP collagen fibres. Mean fibril diameter was reduced in younger 
samples, indicating that fibrillogenesis was somehow affected at later developmental stages. Fibril organization in 
elder individuals was also disrupted. Matrix was sparser, with less intersections and reduced numbers of pores, 
which were bigger in size. Foetal pore area was also larger, possibly due to imbibed water42. This may explain the 
gel-like appearance of foetal NPs and their greater capacity to absorb load and tension.
iTRAQ technology enabled the identification of 161 proteins in total, 77 of which were detected in all samples. 
From the bioinformatics analysis of the common hits, a few observations were predictable. The highest ranking 
functional cluster of genes was for those involved in extracellular matrix, which was consistent with the guani-
dine extraction method selected43. Additional cytosolic components equally important for disc homeostasis and 
function might not have been identified, but these were not the focus of this study. A significant enrichment of 
other proteins and protein classes like GAG, polysaccharide and carbohydrate binding, collagen fibril organiza-
tion, blood vessel, skeletal system and cartilage development, as well as glycolysis, was also found and reflected 
a complex network of interactions, involving more than pure ECM biosynthesis. With regard to response to 
wounding, its link to disc de- and regeneration has been well established4. Interestingly, melanosome regulation 
and vesicle-mediated transport were also enriched and seem to have a role in embryonic elongation and spine 
morphogenesis44.
With respect to pathway term enrichment, ECM-receptor interaction, focal adhesion, integrin and TGF- β 
signalling, were expected, given that most of these pathways are connected. In most of the tissues, integrin cell 
surface receptors mediate cell-matrix interactions, which are key to control adhesion, survival and differentiation, 
among others, in response to environmental cues, like mechanical stimuli45, 46. Moreover, focal adhesion kinase 
(FAK) has been shown to be activated in response to strain in non-degenerate disc cells, in an integrin dependent 
manner47. TGF-β can also be activated by integrin signalling, which, in turn, is affected by TGF-β, whose bioavail-
ability is controlled by ECM binding48 Most of these NP-associated functions might be deregulated not only in 
development but also during ageing and degeneration.
By assessing the overlap of the NP proteomic signature with a list of nearly 300 ECM and ECM-associated mole-
cules generated by Naba and co-workers30, we defined the NP matrisome and how it is changed during development 
and ageing. Meta-analysis of such proteomic data was used to identify potential age-related components deregulated 
during NP development and select candidates for further investigation. Collagen Type XI, XII, XIV Fibronectin and 
Prolargin expression profiles were confirmed by Western Blot analysis. Collagen Type XI overexpression in young 
animals was also validated by immunofluorescence. Moreover, PRELP increase with age was additionally verified by 
SDS-PAGE band identification. Other proteins like Actin, Collagen Type II, Fibromodulin, Aggrecan and COMP, 
among others, presented the same trend in iTRAQ analysis as in gel band profiling.
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Fibronectin (FN) mediates a wide variety of cellular interactions with the matrix and plays important roles 
in cell adhesion, migration, growth, differentiation and survival, particularly through integrin interactions4, 46. 
It interacts with a broad range of collagens (type I, II, III, IV, V and X)49 and, in line with our results, FN has 
been shown to be upregulated in numerous models of disc ageing and degeneration35, 39, 50. Usually, 30 to 40%51 
of the protein content is in the form of fragments from enzymatic cleavage4, 52, 53, which in turn promote further 
degeneration54. While excessive FN deposition has been linked to fibrosis55, polymorphisms have also been asso-
ciated with disc degeneration56, given that it mediates collagen deposition and thus preserves matrix structural 
integrity57. FN may also be involved in the clearance of tissue denatured collagen in age and degeneration, or of 
circulating fibrin after trauma or in inflammation58, 59.
Prolargin (PRELP) is an ECM structural component that anchors the basement membrane to the underlying 
connective tissue4. Apart from binding GAG chains, it also binds type I and type II collagen60. PRELP overexpres-
sion in mice disrupts collagen fibres (which decrease in content and size), with no influence in fibril diameter61. 
In accordance, we have shown that the matrix of aged samples presented a lower density of fibres, resulting in 
a reduced number of fibre intersections, as well as in fewer but larger pores. Interestingly, PRELP is absent in 
neonatal articular cartilage ECM, in contrast to its abundance later in life62. This age-related accumulation agrees 
with our bovine data. In turn, human scoliotic NPs, also present PRELP increase with age39, whereas in dogs it 
has been associated with degeneration35.
Collagen Type XI is a fibril-forming collagen required for embryonic development and its abundance is 
inversely correlated with fibre diameter4, 63. This explains our observations (no differences between Foetuses and 
Young samples, where it is expressed, but an increase in fibre diameter in elder individuals, where it is absent). 
Apart from having a role in fibrillogenesis (controlling lateral growth of collagen type II fibrils) and in mineral-
ization, Collagen XI also binds PGs, particularly at the cell surface, being important to maintain tissue integrity 
and cohesion, particularly during matrix remodeling4, 64. In line with our results, Collagen XI polymorphisms 
have been associated with disc degeneration56. COL11A1 expression levels tend to decrease with the severity of 
degeneration, at least in part due to MMP-mediated degradation6, 65. Recent data from Yee et al. also seem to indi-
cate that collagen type XI declines in the human scoliotic NPs with ageing, in agreement with our bovine model39.
Collagen Type XII is a typical collagen-organizer molecule that binds to collagen I containing fibrils, as well 
as to other matrix proteins, like COMP, modulating fibril organization and mechanical properties4, 66. It has been 
suggested to take part in the development of stromal architecture and tissue cohesion67, particularly by promot-
ing matrix bridges formation essential for network communication68. In addition, Collagen XII seems to have a 
pro-regenerative role, at least in other tissues69, 70.
Collagen Type XIV is a fibril-associated collagen, transiently expressed in several epithelia, including those 
undergoing rapid remodeling. At later developmental stages, it only persists in the BM, where it co-localizes with 
Collagen XII71. Collagen XIV is thought to control collagen I fibrillogenesis during embryonic development (as 
has been supported by our results, it inversely correlates with fibril diameter and premature growth), as well as 
differentiation4, 66, 67. Interestingly, in the chick embryo it is expressed in a gradient around the spinal cord72. Like 
Collagen XII, it is key for the hydration and thickness (and therefore transparency) of tissues73, supporting our 
macroscopic observations of a gel-like appearance in foetal NPs. In other settings, type XIV collagen also appears 
to play a role in regeneration74, 75.
Overall, this study provides the first matrisome database of healthy discs during development and ageing, 
which is key to determine the pathways and processes required to maintain disc homeostasis. The integrated 
analysis of the proteomic datasets enabled us to discover novel components and characterize the developmental 
system in greater detail. The data herein presented may establish a solid foundation for better understanding 
the complex microenvironment of the IVD. Furthermore, they provide a starting point from which potential 
biomarkers and pathways that are altered during the dynamic disc degeneration process may be recapitulated 
or resumed, opening new possibilities for the development of novel therapeutic solutions for the disease. For 
instance, using these cues to modulate the ECM, recreating a microenvironment similar to early developmental 
stages, may enable the expansion and differentiation of autologous NP cells in vivo. In fact, others have shown 
that cell-free tissue engineering strategies are sufficient to promote disc regeneration76. Alternatively, the same 
approach could be combined with cell-based therapies currently under study23, 24.
Evidence about the use of bovine coccygeal discs as a model of ageing is still scarce. To date, existing studies 
have failed to use very old individuals. Nevertheless, a higher incidence of degenerative disc changes has been 
registered in elder specimens, indicating their clinical relevance77–79. In fact, ageing similarities between the two 
species were found, particularly in terms of extracellular matrix alterations77.
Moreover, although interspecies differences may naturally occur, bovine coccygeal discs are becoming 
increasingly accepted tissues for large animal organ culture, majorly because of their large size, low cost and 
availability. Given the similar aspect ratios, transport distances, and cell content, especially concerning the 
absence of notochordal cells during adulthood, between bovine and human lumbar discs, and contrarily to 
what happens in the vast majority of small animal models, they have been proposed as a suitable model to 
study several aspects of lumbar discs pathobiology12, 79–81. In particular, comparable types and distribution, 
synthesis and deposition of extracellular matrix molecules have been found in both human lumbar and bovine 
coccygeal discs82–86.
The work herein presented paves the way for future studies using human samples to validate the observed 
differences and investigating these constituents, thus further elucidating about their functional roles. Importantly, 
and since it is known that extractability of NP proteins reduces with age due to increased crosslinking and resist-
ance to degradation, particularly concerning the collagen fibrillar network, chemical digestion proposed by Chan 
and co-workers should also be addressed to analyze the insoluble fractions obtained39.
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In addition, reanalysis of this dataset focusing on the numerous cellular proteins identified will be of major 
importance, given that there are many other proteins equally important for disc homeostasis and function, which 
are still to be unveiled.
As a model (Fig. 7), we propose that remodeling of NP tissue architecture, which affects IVD mechanical 
properties and biological function of the tissue, reflects changes that occur in terms of matrix biochemical com-
position during development and ageing. Integrating information from the protein to the tissue level, taking into 
account the cell-matrix crosstalk, will provide helpful cues for disc regeneration26.
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